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ABSTRACT 
 
Kenneth D. Coburn: Search for a Practical Strategy to Disseminate Models of Advanced 
Preventive Care that Improve the Health of Chronically Ill Older Adults 
(Under the direction of Sandra B. Greene) 
 
Developing new, more effective models of preventive care for an aging, chronically ill population is 
an important public health imperative.  New models that provide more frequent and ongoing monitoring 
and assessments coupled with personalized preventive interventions are emerging.  Such models of 
“advanced preventive care” are operationally demanding and costly to implement.  Even when they 
improve health outcomes and reduce net health care expenditures, there are several barriers to the 
spread of such models and no guarantee they will come into widespread use.  Little research has been 
undertaken to assess the role that innovators of new care models might play in facilitating their 
dissemination.  The theoretical framework of Greenhalgh et al. helps conceptualize the position 
innovators hold relative to other entities involved in dissemination, but leaves unanswered the question of 
what direct actions innovators might take to facilitate dissemination (2008). 
Using an exemplar advanced preventive care program as a reference point, sixteen health care 
executives from hospital (n=12) and physician organizations (n=4) were interviewed regarding their level 
of interest in providing such a program to their service populations.  Informants were asked about three 
types of collaborations with the program’s developers to support their organization’s use of the program; 
direct service partnership, franchising, or regional cooperative. 
The research yielded a new model of collaborative partnership, replication consultancy, that would 
provide more robust support for the adoption and assimilation of advanced preventive care than typical 
consulting or knowledge purveyor offerings without institutionalizing long-term dependency on program 
developers.  The direct service partnership model that the originators of the exemplar model have relied 
on for years in their local service area, also appears to be a viable option to support broader 
dissemination among hospital organizations.  In some settings, potential adopters were interested in 
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franchise and regional cooperative models with the only model viewed favorably by the small number of 
physician organizations in the study being the regional cooperative (2 out of 4). 
These results inform an implementation plan program developers can use to further the 
dissemination of advanced preventive care and highlight opportunities for health policy to help advance 
this important public health imperative. 
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To all past, present, and future explorers who, without thought of personal gain, persevere to discover 
and disseminate innovations that better the human condition.  And to all who educate, train, support, 
share the journey with, and love them. 
 
 
“System awareness and system designs are important ... but are not enough … 
Ultimately, the secret of quality is love.”  Avedis Donabedian, 2000 
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CHAPTER 1 – INTRODUCTION 
 
Proposed Schema for an Emerging Innovation in Preventive Care 
Non-communicable chronic disease among older adults is the greatest threat to health in the United 
States.  The national toll of this modern epidemic in terms of health care expenditures, disability, and 
reduced quality and length of life is significant and growing (Valderas et al. 2009; “Chronic Care” 2010; 
American Diabetes Association 2008; Jeon et al. 2009; Christine Vogeli 2008) .  The World Health 
Organization (WHO) reported that non-communicable conditions “… are the leading global causes of 
death …” (“WHO | Global Status Report on Noncommunicable Diseases 2010” 2016), making scalable 
interventions to address these conditions a global health priority.  In the current American health system 
chronically ill patients often receive uncoordinated, costly care of inconsistent quality (Zingmond et al. 
2007; Wenger et al. 2003).  A systematic review of the quality of care elderly patients receive across 
different settings of care demonstrate many areas needing improvement (Askari et al. 2011).  The 
successful design and implementation of care management processes to better address the needs of 
those with chronic diseases has been limited (Casalino L et al. 2003).  The need to move from a reactive 
health system geared to provide costly acute care services to one designed to better avoid complications 
of chronic disease and preserve health, has spurred recent delivery and payment demonstrations and 
pilots in the U.S. such as Patient-Centered Medical Homes (PCMHs) and Accountable Care 
Organizations (ACOs). 
The limitations of the current United States systems of social services, public health, and health care 
delivery to address this epidemic highlights the need for better models.  Against a backdrop of many high 
quality evaluations showing little or no effect of various care management, care coordination, or disease 
management models, a few innovative health care models have recently been demonstrated to be 
effective in improving the health outcomes of chronically ill adults (Hirth, Baskins, and Dever-Bumba 
2009; Peikes et al. 2009; Peikes et al. 2008a; Boult et al. 2009; Schore et al. 2011a; Hong, Siegel, and 
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Ferris 2014; Coburn et al. 2012).  These models and others like them may constitute a new, emerging 
category of health care service, which could be described as models of advanced preventive care.  To 
date, a useful, standardized, and widely accepted schema for classifying these kinds of programs or the 
large number of those variously 
described as care management, 
disease management, care 
coordination, complex care 
management, public health 
nursing, etc., does not exist.  
Creating a framework that can 
differentiate programs in terms 
of their application of design and 
system principles as well as 
staffing roles, and 
implementation specifications 
may help better identify 
characteristics that distinguish 
more effective from less 
effective models and help health 
care and public health leaders 
better understand what is 
required for adoption and 
implementation to achieve 
reproducible results.   
Absent a generally 
accepted schema, for the 
purpose of understanding the 
approach taken in this study, a 
Advanced Preventive Care (APC):  
Definition and criteria proposed by K.D. Coburn, MD, MPH 
 
A comprehensive set of “best practice” preventive 
interventions, encompassing primary, secondary, tertiary, and 
quaternary prevention activities that are … 
 
1) Delivered in accordance with the following specifications; 
a) Coordination and collaboration within the APC delivery 
team, and with health care providers (especially primary 
care) and community services 
b) Continuously over time (longitudinal) and across care 
settings 
c) Using team roles that are defined and for which needed 
training is provided 
d) Process and performance monitoring systems capable of 
supporting high reliability and measuring variation in key 
processes 
e) Personalized by understanding and honoring the changing 
needs and preferences of participants 
 
2) Chosen to address key health determinants of a defined target 
population; 
a) Using the best available evidence to identify health 
determinants of a target population and selecting 
corresponding ‘best in class’ interventions to address those 
determinants  
 
3) Continuously improved by;  
a) Refining / rebalancing the preventive interventions included  
b) Improving effectiveness, participant experience, efficiency, 
and reliability of the delivery system Has strong evidence of 
effectiveness in preventing complications of chronic 
disease through rigorous and methodologically sound 
evaluation and testing (demonstrations, research trials, 
etc.)  
 
Models meeting the above criteria, but not yet rigorously 
evaluated for effectiveness may be designated as “provisional” 
Advanced Preventive Care programs 
 
Table 1 - Proposed criteria for a model of Advanced Preventive Care. 
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set of criteria to define a model of advanced preventive care is proposed.  These criteria are the result of 
15 years of work by the author and his colleagues at Health Quality Partners (HQP) to develop better 
models of preventive care to improve the health outcomes of vulnerable populations.  Though not yet 
accepted as a standard schema broadly, this framework has had great practical value for HQP, and it 
helps characterize the attributes of the exemplar innovation used in this study which is based on the 
model of advanced preventive care developed and rigorously tested by HQP.  The proposed criteria for 
qualifying as an advanced preventive care model is as follows;  
An integrated and coordinated set of primary, secondary, tertiary, and quaternary preventive 
interventions, delivered continuously over time and across care settings that address existing and 
anticipate emerging risks, needs, and preferences of individuals belonging to a defined (target) 
population, using well-defined team roles that require special training, as well as process and 
performance monitoring systems used for day-to-day management and continuous improvement.  
Finally, the model must be tested in a high quality evaluation and be shown to improve health 
outcomes. The last element of this definition, (evidence of effectiveness), differentiates those few 
programs with such evidence from those without it.1   
 
The paucity of full-fledged advanced preventive care models to date, seems to reflect; 1) the 
newness and limited history of efforts to develop and test models designed in this way and, 2) the 
challenge most health care and public health entities face in combining the program elements needed to 
do so; a broad portfolio of evidence-based preventive interventions congruent with the needs of a defined 
population along with the implementation capabilities the model requires (longitudinal and continuous 
service across care settings, explicit team roles and training, and process and performance monitoring 
systems).   
The scope, unfamiliarity, and complexity of tasks and resources associated with implementing a 
system of advanced preventive care make learning, adopting, and implementing such a model 
challenging for health care organizations.  Yet if such models have the promise of improving health 
outcomes for large segments of vulnerable populations their widespread adoption and use will be 
necessary.  In principle, the framework and objectives of advanced preventive care are congruent with 
and overlap those of primary medical care and public health.  In this researcher’s experience, however, 
                                                       
1 Models otherwise fulfilling the criteria, but not yet proven effective through high quality trials or 
evaluations could be referred to as a Provisional Advanced Preventive Care or Advanced Preventive 
Care (provisional). 
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neither primary care nor public health services have implemented all elements of the advanced 
preventive care model as a system of care to a defined target population on a large scale.   
Current models of innovations related to practice-based primary care, such as the Patient-Centered 
Medical Home (PCMH), typically address a broader target population, assess a smaller subset of risk 
factors and implement a less intensive set of preventive services than that defined by advanced 
preventive care.  The fact that “best practice” prevention for higher-risk populations often also requires 
periodic visits to the home (or other non-practice settings) over a prolonged time period makes such a 
model challenging for public health and primary care providers to fund and operate.  And home visits in 
and of themselves do not suffice to qualify a program as a model of advanced preventive care and do not 
guarantee model effectiveness.   
Even when preventive home visits are included in care management programs the precise set of 
interventions provided, the reliability with which they are delivered, and the impact that collaboration and 
coordination have on altering or enhancing other services is often unknown or unreported making results 
difficult to interpret and compare between programs.  For example, one recent meta-analysis of various 
preventive home visit programs did not demonstrate effectiveness for these programs, overall (Mayo-
Wilson et al. 2014).  Without a more complete and specific classification schema it is impossible to know 
whether any of the programs in the Mayo-Wilson study met the criteria for advanced preventive care. 
 
A Specific Exemplar of “Advanced Preventive Care” 
A functioning program fitting the definition of an advanced preventive care program, which has been 
rigorously tested and proven effective in serving chronically ill older adults, will be used in this study to 
represent the larger class of interventions qualifying as advanced preventive care models.  In this study 
health care leaders will be asked about their interest in collaborating with the innovators of the exemplar 
advanced preventive care program to enable their organization to provide this service.  By describing an 
actual program that exists, specific questions informants have can be answered, and informant responses 
are expected to be more specific and have greater face validity.  While the key informant responses will 
be particularly relevant to the specific advanced preventive care program described during the interview, 
they may also offer more general insights into the structure, terms, and conditions of collaborations 
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between resources systems (innovators that developed the program) and user systems (organizations 
that will adopt, implement, and assimilate the model).  Of prime interest is whether such 
collaborations could accelerate the dissemination of programs with attributes characteristic of 
advanced preventive care. 
The community-based nurse care management program of Health Quality Partners (HQP) is the 
exemplar advanced preventive care model used in this study.  It is designed to prevent avoidable 
complications of chronic diseases and geriatric frailty among older adults by providing a comprehensive 
set of preventive services including health behavior modification, medication reconciliation and adherence 
counseling, assessment of adherence to evidence-based guidelines, self-management support, disease 
management, geriatric care management and overall care coordination.  Several social determinants of 
health are addressed in HQP’s program as part of standardized assessments and individualized plans as 
listed in Appendix A, Table 12.  These include social, family, economic, and home and community 
environmental factors including personal safety, housing, food security, and access to medical care and 
social support services. 
A fuller description of the interventions and management elements of the program can be found in 
tabular form in Appendix A and B, respectively.  Both of these tables were previously published as 
Supplemental material to a study of the model’s impact on mortality done by this author and colleagues at 
HQP (Coburn et al. 2012).    
HQP’s model has undergone extensive testing in a national Medicare study, the Medicare 
Coordinated Care Demonstration (MCCD).  The HQP model has been found to significantly lower 
hospitalizations and health care expenditures and improve longevity in high-risk chronically ill older adults 
(Peikes D et al. 2009; Peikes et al. 2008b; Schore et al. 2011b; Peikes, Peterson, and Brown 2009; 
Coburn et al. 2012) .  It fulfills the criteria of an advanced preventive care program and delivers a complex 
set of interventions using a community-based care management approach with a strong emphasis on 
preventing avoidable complications of aging and chronic disease.  Nurse care managers with significant 
nursing experience are specifically trained on an array of protocols and processes in order to deliver the 
program.  Close management and monitoring of performance by means of program-specific process 
measures increases the reliability and effectiveness of the service.  When delivered by HQP, health 
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systems and physician practices have reported that the program is easy for them and their patients to 
access and utilize. 
For over 8 years, from April 2002 through September 2010, the HQP model was delivered by a 
single organization (HQP) in collaboration with primary care physician practices in a four county region of 
eastern Pennsylvania as part of the Medicare Coordinated Care Demonstration.  Beginning in October 
2010, the Centers for Medicare and Medicaid Services extended HQP’s demonstration project, but 
required a significant change in participant eligibility criteria and expansion of the program into adjacent 
geographic regions.  This second phase of the demonstration was characterized by periodic disruptions in 
services due to delays in CMS reauthorizations, and required HQP to modify its population targeting 
strategy, data sources and processes for case-finding, program implementation strategy, and 
interventions.  In addition, it challenged HQP to expand its use of collaborative partnerships with hospital-
based health systems to support care delivery across a larger and more demographically diverse 
geographic region of southeastern Pennsylvania.   
The collaborative partnership model used by HQP to deliver this program required health systems to 
help recruit, hire, and provide human resource services and benefits to employees that are leased to, 
trained, managed, deployed, and paid for by HQP.  In this particular scenario, funding flowed from CMS 
to HQP to health system partners.2  These staff (nurses) are employed by the health system, but are 
selected, trained, evaluated, and managed day-to-day by HQP in order to ensure the delivery of HQP’s 
model with fidelity. In addition, health systems are also required to provide hospital discharge data reports 
to support case-finding and recruitment by helping HQP to identify all discharged patients that are 
potentially eligible for the demonstration.  Finally, the health systems must assist HQP to find workspace 
for staff and to facilitate introductions with local primary care providers whose patients are admitted to 
their hospital.  During the course of the entire CMS demonstration, from April 2002 through December 
2014, a total of five health systems in the greater Philadelphia area participated in this form of 
collaborative partnership for varying periods of time.  The term “direct service partnership” succinctly 
captures this model of collaboration and will be used to refer to this approach.  
                                                       
2 The same kind of arrangement also enables HQP to provide services to higher-risk Medicare Advantage 
members under a contract HQP has with Aetna, Inc. a large U.S. health care insurance company. 
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The HQP experience and insights gained from developing and implementing direct service 
partnerships with health systems in the greater Philadelphia area led to the notion that creative 
collaborations between innovators and adopting organizations may be an under-recognized opportunity to 
support the diffusion of innovations in health care delivery, especially, perhaps preventive care models 
implemented in the community, with which few acute care health systems have much experience. This 
experience also highlighted the difficulty that health systems and physician groups would face as user 
systems3 attempting to implement a demanding advanced preventive care program without significant 
expert support.  HQP’s experience suggests that the direct service partnership model of collaboration in 
which user systems work closely with and support the resource system to implement the program in their 
service area is practical and resilient.  It is possible that over time user systems sufficiently motivated to 
do so might accrue sufficient expertise to allow them to become less dependent on the resource system 
(HQP) for direct oversight and management of program implementation. 
In addition to helping to identify key factors in resource system–user system collaborations that may 
be important in the dissemination of advanced preventive care programs, the actionable output of this 
study will be a strategic implementation plan for dissemination of the HQP program.  Action taken to 
pursue such a plan could provide a means to prospectively validate factors identified in the current study 
as important elements of collaborative models that can gain health system and physician group support 
and lead to effective dissemination of the HQP program. 
 
Evaluation and Impacts of the Health Quality Partners (HQP) Program  
Health Quality Partners model of community-based nurse care management has been tested at a 
single region in a long-term (12 ¾ year), prospective, randomized trial conducted as part of a national 
demonstration project designed to help identify promising new models of care coordination for chronically 
ill older adults (R. S. Brown et al. 2001).  During the first 8 1/2 years of the demonstration, community-
dwelling older adults, aged 65 and over, were eligible to receive the program if they had heart failure, 
                                                       
3 The terms user system and resource system refer to elements of the theoretical model of dissemination 
offered by Greenhalgh, et al., described later in this introduction.  Note: key terms italicized throughout 
this dissertation include; advanced preventive care; elements of the theoretical model of Greenhalgh et al. 
(e.g., resource system); and the collaborative partnership models studied (e.g. direct service partnership). 
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coronary heart disease, diabetes, asthma, high blood pressure, or high cholesterol and did not have a low 
risk score on a pre-randomization health risk assessment (Archibald and Schore 2003).  Unlike all other 
sites participating in the MCCD, HQP intentionally enrolled a heterogeneous group of participants with a 
wide range of risk for adverse health outcomes.  That this was achieved is supported by the fact that the 
average monthly Part A & B Medicare expenditure for those randomized into the HQP study was $497 
versus a 2003 national Medicare average or $552.   
The HQP program uses nurses to provide all of its services, though it has other senior staff from 
other professional backgrounds (social worker, physician) providing input on program design, guidelines, 
quality improvement, program oversight, case reviews, and training.  There was a capitated monthly fee 
paid by the Centers for Medicare and Medicaid Services (CMS) to HQP to provide this service in the 
context of the Medicare Coordinated Care Demonstration (MCCD).4  This payment was not intended to 
replace or substitute for any other Medicare-covered benefit, which continued to be paid in the usual way 
through the traditional, fee for service Medicare program.  
Highlights of the impact of HQP’s model (compared to a randomized, usual care, control group) 
based on analyses undertaken by Mathematica Policy Research, Inc. (MPR) under contract to CMS and 
contained in the Fourth Report to Congress on the Evaluation of the Medicare Coordinated Care 
Demonstration (Schore et al. 2011b) included the following: 
• A 25% reduction in all-cause mortality for the intervention group (p=0.02) (1,721 combined 
treatment and control) 
• Among participants identified as at high risk, based on results of a health risk assessment 
completed prior to randomization, a 30% reduction in all-cause mortality was observed for the 
intervention group (p=0.03) (502 combined treatment and control) 
• Among all randomized participants (1,721), HQP’s program had modest (not statistically 
significant) impacts on hospitalizations -7% and net cost (including program fee) +9% 
                                                       
4 In the case of HQP’s service to higher-risk Aetna Medicare Advantage members, payment to HQP is 
also on a monthly capitated basis, but with an additional gain-sharing opportunity if Aetna calculated that 
net savings exceeded a pre-defined threshold. 
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• Among a higher-risk subgroup5 chosen by the program evaluators (248 combined treatment and 
control) the treatment group had; 
o A 39% reduction in hospitalizations (p<0.01) 
o A 37% reduction in emergency room use (p=0.05) 
o  A net savings (including program fees) of -$397 per beneficiary per month equal to a 
28% reduction in total Part A & B Medicare expenditures (p=0.05) 
An article by the same evaluators (R. S. Brown et al. 2012), provided additional data on the impact of 
HQP’s program in the MCCD across a wider variety of higher-risk subgroups as summarized in the 
table below.  
 
Table 2 - Impacts of HQP's model of advanced preventive care from Brown et al. 2012 
  Hospitalizations Medicare Part A & B  
net expenditures  
(including program fee) 
Subgroup n (treatment 
and control) 
% change p value $ PBPM 
change 
% change p value 
Heart failure 199 -13.8 0.39 -$136 -9.4 0.59 
HF, CAD, or COPD 695 -24.6 0.005 -$116 -10.4 0.22 
(HF, CAD, or COPD) AND 1+ admission 
in year before enrollment 
229 -37.6 0.008 -$419 -28.5 0.05 
([HF, CAD, or COPD] AND 1+ admission 
in year before enrollment)-OR-([1+ 
chronic condition] AND 2+ admissions in 
the 2 years before enrollment) 
273 -33.1 0.02 -$293 -21.5 0.15 
 
Since 2010, Aetna, Inc., a leading health insurance company in the U.S., has contracted with HQP to 
provide its model of advanced preventive care to Medicare Advantage members it identifies as at high 
risk of poor health outcomes and increasing health care costs (using its own proprietary risk algorithm) 
receiving primary care from participating physician practices in southeast Pennsylvania.  Aetna’s medical 
economics division has assessed the program’s impact using a difference-in-differences analysis 
comparing trends in hospital utilization (inpatient admissions and outpatient services).  In this approach, 
hospital utilization over time for the target intervention group is compared to hospital utilization among a 
                                                       
5 The higher-risk subgroup analyzed in this report included participants who had; heart failure, coronary 
artery disease, or chronic obstructive pulmonary disease and had at least one hospitalization in the year 
prior to enrollment. 
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cohort of members meeting the same eligibility criteria, but belonging to practices not participating in the 
program.  The analysis was conducted on an intention to treat basis and included all Aetna members 
identified as at high risk and referred to HQP whether they could be engaged and went on to actually 
enroll in the advanced preventive care program provided by HQP or not.  In public press releases over 
the past few years, Aetna reported that the program reduced hospital admissions 17-20% and lowered 
hospital expenditures 16-18% (“Aetna, Health Quality Partners See Lower Costs, Fewer Hospital 
Admission With Care Management Program For Medicare Advantage Members” 2011; “Aetna, Health 
Quality Partners See Fewer Admissions, Lower Costs from Care Management Program” 2013).   
Not all implementations or variations of this model have been effective.  For example, in the second 
phase of the Medicare Coordinated Care Demonstration (from Oct 2010 thru December 2014) the 
program did not appear to offer any advantage compared to usual care (Peterson et al. 2015).  In this 
phase of the demonstration, there were marked differences in the conditions under which this 
implementation occurred compared to the first phase of the MCCD, including: greater dependence on 
hospital (as opposed to primary care) data sources for case-finding, greater severity of illness among the 
enrolled population (older age, greater number of chronic conditions, and more baseline hospitalizations, 
nursing facility usage and higher costs), a shorter intervention and follow-up period, a more limited scope 
of preventive care services (almost no group programs), and greater disruption and discontinuity of 
services due to administrative factors related to CMS authorization cycles.  The authors of the final report 
felt that all of these differences could be controlled for statistically on a retrospective basis and concluded 
that the similar outcomes of the usual care and intervention groups was most likely due to significant 
improvements in the care received by the usual care control group compared with the first phase (8 
years) of the demonstration.  HQP believes that a more cautious interpretation of these findings is 
appropriate given the multiple factors operating during the second phase of the demonstration that may 
have diminished HQP’s program effectiveness.  There was no direct measure of any specific services 
newly applied to the usual care control group during the second phase with which to support a hypothesis 
that these were causally related to the observed outcomes.  Finally, concurrent with the second phase of 
the MCCD, in the same health care marketplace, the HQP model was observed to have sustained 
effectiveness relative to usual care in supporting a Bundled Payment for Care Improvement initiative for 
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heart failure patients (2014-2015, unpublished communications from senior leaders at St Mary Medical 
Center, Langhorne, PA) and in support of the previously mentioned contract with Aetna. 
While further research to more precisely define the magnitude of the benefit of the HQP model and 
the conditions under which it is most reliably effective is ongoing, the overall experience and evidence of 
effectiveness is sufficient to warrant testing the model in other locations and among different populations 
to determine if initial program results can be replicated in these settings.  Doing so will require 
dissemination of the program; the relative success or failure of which may dictate the future utility of this 
model and others like it.  
To help ensure reliable and effective delivery of its program, HQP has adopted a theoretical 
framework of “core implementation components” to specify, at a high level, the general organizational 
requirements for implementation (Fixsen et al. 2009).  This theoretical model closely matches the 
approach that developers of the HQP program had independently developed and used since the 
program’s inception.  Use of this framework represents the highest level of a broad and deep set of 
specifications necessary to implement HQP’s model.  The core components of implementation include; 
staff recruitment and selection, pre-service training, consultation (mentoring) and coaching, staff 
performance evaluation, decision support data systems, facilitative administrative supports, and system 
interventions.   
Core Implementation Components – Essential framework to be required of adopting organizations interested in 
implementing the HQP model of community-based nurse care management: 
Figure 1- Core Implementation Components - Taken from (Fixsen et al. 2009, 534) 
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In order to ensure consistent effectiveness of advanced preventive care models, organizations must 
be willing and able to implement these programs with a high degree of adherence to well-defined process 
and operating specifications.  Evidence to support this comes from a comparison of performance between 
programs (Peikes et al. 2008b; Schore et al. 2011b).  Allowing user systems to freely make changes they 
prefer for local adaptation and reinvention may well foster broader program adoption, but in the case of 
advanced preventive care models, may also risk diminishing program effectiveness.  This highlights the 
importance of finding ways to reduce the burden of adoption and implementation while supporting 
organizations to implement the program with high fidelity.  The research undertaken in this study to 
explore such collaborative options will be guided by the theoretical model of innovation spread in health 
care organizations recently put forth by (Greenhalgh et al. 2008) and described later in this chapter.  
 
Efforts to Spread HQP’s Model of Advanced Preventive Care 
Before this study was conducted, the primary approach by which HQP spread its model of advanced 
preventive care across southeast Pennsylvania (the only geographic region in which the program had 
been tried) had been by employing a direct service partnership with health systems in the region.  Key 
elements of the support provided by partnering health systems in this approach, which correspond to 
interview questions 3 b,c, and d, respectively, include; 1) introduction of HQP leadership to primary care 
providers for HQP to describe the program to PCPs and enlist their participation, 2) Human Resource 
(HR) support including the employment of staff (primarily nurse care managers) ‘leased back’ to HQP 
which trains and manages these staff to implement the care model, and 3) sharing of patient data for 
case finding and care management.  Through its separate funding sources (CMS, Medicare Advantage 
health plan) HQP is able to repay the sponsoring health systems the salaries and benefits of leased staff.  
This arrangement has allowed HQP, as a small non-profit, to continue to focus on its core mission of 
health care model R&D while supporting regional dissemination of its care model and strengthening 
collaborative relationships with area health systems. This is the approach that HQP has successfully 
employed to date in southeast Pennsylvania from 2002 to present.  By including questions about the 
specific capability and willingness of study participants to utilize the direct service partnership model, this 
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study will help determine whether such an approach might be feasible beyond southeastern 
Pennsylvania.  
 
Knowledge Gap – Possibilities for Direct Innovator-User Linkage 
Most research on the spread of innovations in health care has focused on the spread of new 
technologies or processes used by individual health care providers or small groups of providers (e.g., 
tightly defined teams or work units within an organization) by means of diffusion.6  That research has 
focused largely on; a) characteristics of innovations that make them more amenable to diffusion, b) 
characteristics of adopting organizations that enable them to adopt and implement innovations, and c) in 
the case of intentional efforts to spread innovation (dissemination7), the role of knowledge purveyors and 
change agents to facilitate organizational adoption and implementation.  Little research has been 
undertaken to understand how the interface or linkage between the organization or unit that originally 
developed the innovation (the resource system) and the organization that puts the innovation to use (the 
user system) might affect the rate of adoption and use of an innovation.  The authors of a systematic 
literature review on this subject commissioned by the United Kingdom’s National Health Service noted;  
“We found virtually no empirical studies focusing on the input of the resource system in 
innovation implementation, and none at all from the health services literature.” 
(Greenhalgh et al. 2008, 190)   
 
This is an especially important question with regard to advanced preventive care, which will likely require 
resource systems to make a significant contribution to effective implementation.  To help fill this gap in the 
existing knowledge base, this study is designed to assess potential strategies to enhance the 
dissemination of advanced preventive care models through collaborative partnerships between the 
resource system (designer and primary producer of the innovation) and user system (health care 
organizations wishing to help make the innovation available to populations they serve).  In this context, 
organizations (user systems) with which the resource system can collaborate could play the role of user 
                                                       
6 Diffusion is has been defined as the passive spread of a new innovation through informal channels and 
is largely a social process (Rogers 2003; Lomas 1993)(Lomas 1993). 
 
7 Dissemination has been defined as the spread of an innovation promoted by an active, planned, and 
intentional effort to facilitate wider adoption (Lomas 1993). 
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system in a number of creative ways.  The user system could, for example, play the classical role 
whereby the organization takes the primary responsibility for adopting and implementing the innovation 
with or without some outside help, or it could play more of a supporting and enabling role by which it 
helps the resource system expand its implementation capabilities, acting more as a supporting partner or 
as a franchisee. An example would be an organization that is a user system committing facility space, 
data, human resources, funding or other resources to enable the resource system to implement the 
model on its behalf to the user system’s service population.  It might also be possible to have user 
systems simultaneously play the adopter/implementer and sponsorship roles to varying degrees.  In this 
regard, it is hypothesized that making advances in creating and utilizing new approaches to health care 
delivery will require as much innovation with regard to inter-organizational collaboration as in pioneering 
new programs or interventions.  The aim is to evaluate the potential such collaborative relationships have 
in promoting the successful spread of this emerging class of innovations to improve the health outcomes 
of chronically ill older adults. 
 
The Conceptual Model for this Research 
Application of a Theoretical Framework to Guide the Research 
Greenhalgh, et al. (2008) offer a theoretical model for the diffusion and dissemination of innovations 
in health service organizations based on an extensive recent systematic literature review commissioned 
by the UK Department of Health via the National Health Service (NHS) Service Delivery and Organisation 
(SDO) Programme undertaken between October 2002 and December 2003.  Two schematics of the 
model are shown below – a simplified and a more detailed depiction, both taken from Greenhalgh, et al. 
(2008). 
Highlighted in blue is “Dissemination (planned spread)” the ultimate purpose for which the current 
study is undertaken.  Note the overlap of knowledge purveyors and change agency roles with regard to 
the process of dissemination.  Significant research exists that helps define the potential opportunities and 
limitations of those two roles in fostering dissemination.   By contrast, the focus of this research will be to 
explore the opportunities and limitations with regard to how the linkage between a resource system and 
user system can promote widespread use of advanced preventive care models. 
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Figure 2 - Basic schematic of a theoretical model for the dissemination and diffusion of innovations in 
health care organizations. Taken from Greenhalgh, T et al. “Diffusion of Innovations in Health Care 
Organisations: A Systematic Literature Review”, (2008, 6) 
 
 
 
  
 
Figure 3 - A complete and detailed schematic of a theoretical model for the dissemination and diffusion of innovations in health care organizations. 
Taken from Greenhalgh, T et al. “Diffusion of Innovations in Health Care Organisations: A Systematic Literature Review”, (2008, 201)
16 
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Table 3 - Definition of terms associated with the conceptual model of Greenhalgh, et al. and as applied in 
this study.  [Minor edits and spelling changes applied to verbatim terms selected from the glossary of 
Greenhalgh et al. (2008, 293–295). With addition of ‘knowledge purveyor’ definition from page 194).] 
Term Definition 
Adoption of innovations 
(organizational) 
An organization’s means to adapt to the environment, or to pre-empt a change in the 
environment, in order to increase or sustain its effectiveness or competitiveness. 
Assimilation of innovations Another term for the adoption of innovations by organizations, often used in the 
literature relating to service sector innovations.  Assimilation is the preferred term for 
adoption in organizations, since it emphasizes the long and complex processes 
involved, with multiple decisions made by multiple agents. 
Change agency An organization or other unit that promotes and supports adoption and 
implementation of innovations. 
Diffusion The process by which an innovation is communicated through certain channels over 
time among the members of a social system (Rogers 2003). 
Dissemination Actively spreading a message to defined target groups (Mowatt et al. 1998). 
Implementation Dissemination plus action to actively encourage the adoption recommendations 
contained in a message (Mowatt et al. 1998) 
Inner context  
(user system) 
…the intra-organizational determinants of innovation, including structural 
determinants (size, maturity, functional differentiation and so on …), leadership and 
locus of decision-making …, receptive context for change … and absorptive capacity 
for new knowledge ... 
Innovation  
(relating to health service 
delivery and organization) 
A set of behaviors, routines, and ways of working, along with any associated 
administrative technologies and system, which are (a) perceived as new by a 
proportion of key stakeholders; (b) linked to the provision or support of health care; 
(c) discontinuous with previous practices; (d) directed at improving health outcomes, 
administrative efficiency, cost-effectiveness, or the user experience; (e) 
implemented by means of planned and coordinated action by individuals, teams or 
organizations.  Such innovations may or may not be associated with a new health 
technology. 
Knowledge purveyors  
(page 194) 
Media and public relations; conference organizers; publishers and distributors of 
books, journals, and reports; guideline distributors, educational organizations, who 
package and present the results of research to the services sector. 
Outer context … extra-organizational determinants of innovativeness, including the extent and 
quality of informal inter-organizational networks …; the nature and success of 
planned strategies to promote inter-organizational collaboration …; the prevailing 
political, economic, sociological and technological environment (and whether it is 
static or changing; … and the nature and timing of particular policymaking streams 
and other political initiatives … 
Resource system An organization (or other unit – e.g. a research institution) that develops innovations. 
User system An organization (or other unit of adoption) that considers the innovation for adoption. 
 
Previous research has convincingly shown that several key attributes of innovations8 are associated 
with their rate of spread.  This is not the focus of the current study.  Based on HQP’s experience in the 
                                                       
8 Relative advantage, compatibility, complexity, trialability, and observability (Rogers 2003).  
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MCCD9 and the framework that HQP itself uses for implementing its model (core implementation 
components) the current working assumption is that, for program effectiveness to be preserved, 
dissemination of the model will require a high degree of fidelity to the original program design.  In other 
words, for all but the most minor operational adaptations, the specifications for implementing the 
innovation (in this case the HQP model) are not to be significantly “reinvented” at each implementation 
location.  Combined with the fact that so much research has already been undertaken on this general 
topic, no effort will be made in the current study to seek correlations between attributes of HQP’s program 
and its ease of dissemination. 
Studies also indicate that the inner milieu of an organization is a powerful determinant of the 
organization’s ability to adopt and implement innovations.  In particular, system antecedents and system 
readiness, defined along several dimensions, have been shown to correlate with an organization’s 
adoption and implementation of innovations. (for an overview of this extensive literature see Chap. 7, pp 
134-156 of Greenlagh, et al).  Assessing these would help identify organizations that are more likely to 
adopt the HQP model and therefore be more fruitful targets of dissemination efforts.  Given the wealth of 
existing research and the limitations of time and access to internal organizational information, these 
attributes will not be specifically probed in the key informant interviews undertaken for this study. 
The extent to which, if at all, partnerships or collaborations between resource systems and user 
systems can impact the adoption and use of innovations by health care organizations is not well 
researched, is an area that Greenhalgh, et al. believed warranted further study, and is the focus of the 
current research. 
“The outer context.  Research at the interorganizational level might fruitfully explore 
the process of informal interorganisational networking and more formal 
interorganisational collaboration, with an emphasis on the role of the change agency 
(and how this might be enhanced).  An explicit study of the process and effectiveness of 
interorganisational knowledge transfer activities through boundary spanners (such as 
the appointment, training, and support of knowledge workers) might provide 
generalisable lessons for the organisations seeking to develop their capacity in this 
area.”  (pgs. 17-18) 
“Overall, and in contrast to the findings from the commercial sector, there is almost no 
research aimed specifically at developing the role of the resource system or change 
                                                       
9 Fidelity to the principles and key elements of the original HQP program is presumed essential for 
reproducible effectiveness given the lack of effectiveness of several ‘similar’ programs tested within the 
MCCD and the diminished impact of the HQP program when the model was changed / disrupted by 
external requirements (CMS). 
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agency.  Perhaps this is partly because service delivery innovations are not a ‘product’ 
produced in a s factory or laboratory, but it may also be because there is less 
commercial incentive for the resource system to evaluate and enhance their own role.” 
(pg. 191) 
 
Overarching Research Question 
The immediate objective of this research is to find a mechanism for a resource system (HQP) to 
support the replication of advanced preventive care by a relatively small number of other organizations at 
different locations in order to create the confidence and momentum needed to gather the resources 
required for broader program dissemination.  The longer term goal is broad dissemination - the active, 
intentional spread - of HQP’s evolving model of advanced preventive care.  The specific research 
questions pursued in this study are designed to support this stepwise approach.  The path laid out in the 
implementation plan will provide more opportunities to continue to innovate both the advanced preventive 
care model and the mechanisms for its dissemination through applied R&D as the work unfolds.  This 
research represents an important starting point.  Others interested in the framework of advanced 
preventive care and working toward similar goals may find this approach and the information gained from 
this research useful in pursuing replication and dissemination. 
What kinds of collaborative partnerships would health systems, physician groups, and health 
system-physician alliances (user systems) be willing to engage in with a resource system to adopt 
and implement advanced preventive care?  More generally, what kind of collaborative support could 
resource systems offer user systems to help implement advanced preventive care and vice versa? 
Specifically, this study will investigate what role health care organizations perceive a resource 
system can play to help accelerate dissemination, with the following realistic constraints assumed; 
1. there is limited opportunity for local adaptation (modification) of the innovation 
2. adopting organizations will not have the necessary internal capabilities to implement 
advanced preventive care without significant support and assistance 
Under these constraints, the working hypothesis is that organizations would be more willing and 
better able to adopt or make use of an innovation if they had well-designed, high value support services 
or collaboration partners to directly implement the innovation on their behalf, or significantly guide and 
assist them in doing so themselves.  Some organizations may be more likely to adopt an innovation if 
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they have an opportunity to participate in an organizational partnership that could significantly reduce the 
burden of implementation - e.g., provide collaborative (shared or fully outsourced) operational 
management, staff training and evaluation, data management, performance analysis, or some 
combination of these.  
 
Specific Research Questions 
1. What is the willingness and ability of health system, physician group, and health system-physician 
alliance leaders to collaborate with program innovators to provide an exemplar model of 
advanced preventive care to their patient populations? 
2. What objections, barriers, or difficulties do health system, physician group, and health system-
physician alliance leaders associate with such collaboration? 
3. Are there specific structures of collaborative partnerships that health system, physician group, 
and health system-physician alliance leaders are more willing to accept? 
a. Direct Service Partnership 
b. Franchise Model 
c. Regional Cooperative 
4. To what extent do the pattern of responses of health systems, physician groups, and health 
system-physician alliance leaders differ?  In what ways and why? 
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Figure 4 - Framework for addressing study research questions and their relationship to the 
theoretical model of Greenhalgh et al. 2008 
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How this Research Can Help and Why it’s Important 
Whether the specific exemplar model of advanced preventive care used in this study will ultimately 
prove to be a major innovation to improve the health of chronically ill older adults or not is less important 
than is the strong likelihood that care models significantly different than ones commonly used today that 
are more robust and more demanding to implement will be needed to effectively combat this growing 
public health challenge.  As one example, none of the four models of complex chronic care with the 
strongest evidence of effectiveness in a recent systematic review have yet spread broadly in the U.S. 
(Hong, Siegel, and Ferris 2014).  This suggests that these models may share attributes that make them 
difficult to diffuse; such as an intensive commitment of resources, new training methods, unfamiliar 
processes or team models, etc.  Whether new models of collaborative partnerships between innovators 
(resource systems) and adopting organizations (user systems) will prove to be helpful in improving the 
dissemination of such models remains to be seen, but at least a framework and rationale for considering 
such efforts can be informed by the current study. 
If these new models are to spread, it will likely require intentional efforts to disseminate them.  While 
there will be important roles for health care policy and financing in helping do so, the possibility that the 
innovators of such models might play an important role as well has, up till now, gone largely unexplored.  
It may be that to be successful in disseminating these models, all possible supports will be needed; 
policy, financing, and new (more effective) roles for innovators, knowledge purveyors, and change 
agents.   
It also seems likely that there may be an increasingly important role for organizations like HQP that 
has as its dedicated mission undertaking the applied R&D required to design and test new care 
innovations even when doing so provides no immediate commercial, strategic, or political gain.  If so, how 
are such organizations to be sustainable?  It might be that if they diversified in ways that supported 
collaborative partnerships that enable dissemination this could help fulfill their missions and provide 
revenues to do so.  
The results of this study will inform an implementation plan for HQP to prioritize the development of 
collaborative partnership models that are feasible and likely to be accepted among health care 
organizations interested in adopting a model of advanced preventive care.  In order to sustain its 
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commitment to its organizational mission to design, test, and spread innovations in advanced preventive 
care, HQP must be successful at both innovating and rigorously studying such models as well as 
partnering with others to spread their use and to generate revenues to support operations. In effect, if 
executed as intended, this strategic (implementation) plan will provide a test case for the practical utility of 
the findings of this study, at least for a single organization. 
On a larger scale, it is possible that other organizations involved in health care or public health 
innovation might find these results useful and apply them in a similar manner to inform their strategic 
planning. To the extent this occurs, it could provide a more robust validation (or refutation) of the 
generalizable utility of this approach to supporting the work of innovators in the field of preventive health.  
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CHAPTER 2 – REVIEW OF THE LITERATURE 
 
From (Greenhalgh et al. 2008) page 190 
“We found virtually no empirical studies focusing on approaches to enhance the input of 
the resource system in innovation implementation, and none at all from the health 
services literature.  We found two relevant studies: one from the education sector and 
one from health care, both of which we rated as high quality, and which we feel raise 
interesting methodological issues.” 
 
The quote above summarizes the paucity of published research literature on the role a resource 
system might play in supporting the implementation and dissemination of innovations circa 2008.   Four 
main strategies were used to search for research articles relevant to the current study: 
a) Review the two references cited in the quote above by Greenhalgh 
b)  Review articles citing each of the two references 
c) Use Google Scholar to review all works citing Greenhalgh et al. 2008 
d) Search PubMed and Google Scholar databases10 for works published from 2005-15 
e) Selected information related to the Nurse Family Partnership (NFP) model of care11 
 
References found through these four mechanisms were reviewed for relevance to the main research 
question, which in the broadest possible sense, would include any description of resource system - user 
system interactions or collaborations in the context of the dissemination of innovations.  Unless, otherwise 
stated, all searches sought works published through 2015.  Because this study addresses innovations in 
                                                       
10 The overall evidence from recent reports suggests that while PubMed and Google Scholar are each 
powerful literature search databases, using both in combination, is a robust and efficient approach to 
conduct a systematic review; especially for health-related topics with a limited number of published 
articles (Bramer, Giustini, and Kramer 2016; Giustini and Boulos 2013; Gehanno, Rollin, and Darmoni 
2013; Shariff et al. 2013; Bramer et al. 2013; Haddaway et al. 2015). 
 
11 NFP is an innovation in care with strong evidence of effectiveness that has been disseminated with the 
support of its originators.  It is therefore a resource system.  Reports of dissemination efforts that describe 
the resource system – user system relationship will be sought and reviewed. 
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health care delivery (involving human to human interactions), exclusion criteria include innovations of a 
purely technological or information system nature or those associated solely with the dissemination of 
clinical guidelines (absent any change in the care delivery system).   
A study of eight successful diffusion initiatives occurring within the Global Diffusion of Healthcare 
Innovation study, provides a useful context for thinking about this literature review and exemplifies some 
challenges.  By analyzing interviews of those involved in each of these initiatives, the authors concluded 
that “Purposeful and directed change management is needed to drive system transformation” (Parston et 
al. 2015).  One element deemed critical to supporting such intentional change efforts was “a 
specific agency to promote diffusion.”  Given the information provided in the study, however, it’s not 
clear what the exact nature of these agencies was, how they varied, how they interacted with user 
systems, or to what extent they had attributes consistent with a resource system as defined by 
Greenhalgh et al. (2008).   
They were described only as having certain functions and characteristics; “The creation of a specific 
program or initiative to promote diffusion can help translate a vision into reality by providing the impetus, 
coordination, resources, and structures needed to diffuse the innovation throughout the system.  The 
leaders of the agency must have credibility; the capacity to mobilize change; and the necessary technical, 
communication, and project management skills.  In each of the eight case studies, there was a dedicated 
program or organization in place to help create an enabling environment and drive diffusion across the 
system.”  More information regarding whether such agencies were most like resource systems, 
knowledge purveyors, change agents, some combination or mix of these, or an altogether different kind of 
organizational entity would help position this work in the context of the current study.  As is true for most 
of the articles identified through this literature review, they offer little or no description of the structural or 
operational features of the resource system - user system relationship. 
 
Logic and Perspective 
Dissemination and implementation are closely related and interdependent.  With increasing 
frequency, the two terms are being used together to describe an emerging field or science.  One example 
is a paper titled “Developing the next generation of dissemination and implementation researchers: 
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insights from initial trainees” (Stamatakis et al. 2013).  Even when the term “Implementation Science” is 
used alone, it is usually in the service of disseminating effective innovations  (Newhouse et al. 2013).  In 
the context of the current study, a distinction is to be made between the unqualified (more general) 
concept of a ‘researcher’ versus an ‘innovator’ or ‘inventor’.  The latter is more consistent with the 
definition of a resource system as described in the model of Greenhalgh et al. and as applied in the 
current study.   
The ideal resource system brings deep understanding of a program, operational expertise, extensive 
experience successfully implementing the innovation, and the insight required to balance disciplined 
program adaptation and rigorous fidelity.  These requirements may be more akin to Deming’s “system of 
profound knowledge”12, than to a narrower scope of research or technical expertise.  This field is new and 
our understanding of the full potential of a resource system remains largely unexplored and 
underdeveloped.  “A major new scientific challenge for prevention involves understanding the processes 
that facilitate or impede quality implementation of programs demonstrated to have positive effects. To 
date, few of these successful programs have been implemented in communities, and the scientific 
community is in need of new methodological approaches to understand the implementation processes. 
Unlike the first phase of prevention research that was based on efficacy and effectiveness trials, this new 
phase of implementation is still in an early stage and has no single accepted paradigm to guide the 
scientific work.”   (C. H. Brown et al. 2012) 
In addition to the model of Greenhalgh, et al., many other frameworks and models have been 
proposed to describe factors influencing the implementation of innovations; Rogers’ Diffusion of 
Innovation Model (Rogers 2003), Interactive Systems Framework for Dissemination and Implementation 
(ISF) (Wandersman et al. 2008), Consolidated Framework for Implementation Research (CFIR) 
(Damschroder et al. 2009), the theoretical domains framework (TDF) (Michie 2005; Cane, O’Connor, and 
Michie 2012), Promoting Action on Research Implementation in Health Services (PARIHS) (Rycroft-
Malone 2004),  translating research into practice (TRIP) (“Translating Research Into Practice” 2016), 
push\pull framework (Zmud 1984), and several others.  These varied models all seek to describe factors 
                                                       
12 Consisting of a combination of; appreciation for a system, knowledge of variation, theory of knowledge, 
and psychology (“The System of Profound Knowledge” 2016). 
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important to implementation effectiveness and by extension the dissemination of innovation.  One 
approach to synthesizing the available literature might have been to review key articles describing such 
models and hypothesize how an aspiring resource system, like HQP, could interact with a user system by 
applying the framework of one or more such models.  Within such a context, one could hypothesize and 
compare the mechanisms, benefits, risks, barriers, and facilitators arising from the use of each of the 
selected models. 
There are several reasons why this approach was rejected.  First, it would predispose the analysis 
toward conceiving of the resource system as a substitute for knowledge purveyors, change agents, 
boundary spanners, business consultants, or other players commonly providing implementation support 
such as training, facilitation, technical assistance, and management consulting.  Second, attempting to 
map elements of these theoretical models, learned only by reading landmark articles describing them, to 
the capabilities of a resource system, risks articulating a “pseudo-understanding” rather than a more 
grounded set of insights with practical utility (Fredriksson, Ebbevi, and Savage 2015). 
Finally, such an approach would diminish the possibility of discovering novel means by which 
resource systems could support the implementation of innovations that are not described in any of these 
models.  This seems especially relevant given HQP’s experience of successfully providing a unique 
collaborative partnership to user systems for several years and having an experience-informed intuition 
about other types of collaborative partnerships it could offer to facilitate dissemination of advanced 
preventive care.  Therefore, the search strategies for this literature review were designed to seek 
reports that describe the direct work of resource systems in support of user systems to 
implement and disseminate innovations. 
 
Two References Cited by Greenhalgh 
One of the references cited by Greenhalgh et al. 2008 models the benefit a supplier might receive by 
“triaging” customers with regard to their innovativeness to provide more support to those most likely to 
adopt an interorganizational information system (Nault, Wolfe, and Dexter 1997).  Such systems when 
fully deployed have advantages in terms of monitoring customer needs and more reliably and efficiently 
fulfilling orders.  To the extent HQP’s model of advanced preventive care includes a cloud-based 
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information technology platform (SPERO®) enabling the user system and the resource system (in this 
case HQP) to monitor and address variations in program implementation and performance, there is some 
overlap with the premise put forth in this paper.  A key difference, however, is that the information 
technology application is but one of several critical program elements required for a user system to fully 
implement HQP’s model of advanced preventive care.  All 18 articles that cited Nault et al., identified 
using Google Scholar, were reviewed in full, and none, (other than two works by Greenhalgh et al.) 
directly addressed resource system – user system collaboration and its potential role in dissemination. 
The other citation referenced by Greenhalgh et al., was a study of how university-based innovators 
describe and communicate key attributes of their innovations and how such descriptions are perceived by 
potential adopter organizations (government regulators, industrial scientists, and consulting engineers).  
This ‘early stage’ communication about emerging innovations undertaken by innovators is believed to 
influence how potential adopters learn about, form initial impressions of, and ultimately adopt innovations.  
The results indicated that university innovators did not always positively represent their own innovations 
and, that as a group, they may be able to improve the effectiveness with which they communicate key 
attributes of their innovations to strengthen the rate of adoption by different categories of potential users 
(Dearing, Meyer, and Kazmierczak 1994).   
While effectively communicating key attributes of an innovation is one aspect of the work HQP is 
undertaking to promote the dissemination of its model of advanced preventive care, it is not the main 
focus of the current study.  Review of the 33 Google Scholar identified articles citing Dearing et al. 1994, 
did not yield any works directly relevant to the current study.  The closest was a work by the same lead 
author (Dearing et al. 2013) that proposes an overall approach for more effective dissemination of pre-
exposure prophylaxis for HIV.  That paper offers a thoughtful and comprehensive schema that includes 
“agenda setting”, “diffusion-system readiness”, communication and social networking strategies, 
“partnering to build delivery capacity and infrastructure support”, “training and technical assistance”, 
“evaluating and sharing rapid improvement results”, and “monitoring for diffusion outcomes”.  Though a 
helpful, high-level roadmap, it does not address any specific structural or operational elements of a 
resource system - user system collaboration. 
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References citing Greenhalgh 
Google Scholar identified 518 articles published through 2015 that cited Greenhalgh et al. 2008.  
Title and abstract reviews of all these works, yielded 29 meriting full text review.  Twenty-eight articles 
were thoroughly reviewed (one was unobtainable) of which only two are relevant to the current study (de 
Korne et al. 2010; Durlak and DuPre 2008).  
One report described how an outside resource system of aviation safety experts assisted an Eye 
Hospital in the Netherlands in the adoption and implementation of several aviation safety practices (Dirk 
F. de Korne et al. 2014; de Korne et al. 2010).  Several aspects and processes of care were addressed, 
with the main initiative being the adoption of a Team (Crew) Resource Management system focused on 
“increasing awareness of safety, its causes and characteristics, improvement of communication, 
leadership and reflection on one’s own behavior” (Dirk F. de Korne et al. 2014).  Following 
implementation, the hospital observed a significant decrease in wrong-sided surgery errors and a 
substantial increase in the reporting of “near miss” events.  Extensive, multi-pronged, and sustained 
efforts were made to assimilate and routinize the new ways – not all of which “took” successfully.  In the 
context of the current study, this is an example of a resource system bringing unique expertise through an 
extended and multi-layered resource system – user system engagement, and is compelling with regard to 
its transformation of accepted norms of hierarchical professional relationships and communications.  It 
suggests that a framework of resource system – user system collaboration, at least under certain 
circumstances, can deliver profound and significant enhancements to the capabilities of a user system. 
An extensive review entitled Implementation Matters: A Review of Research on the Influence of 
Implementation on Program Outcomes and the Factors Affecting Implementation found ample evidence 
among published reports that the effectiveness of implementation (as assessed by measures of fidelity, 
dosage, program reach, quality, and adaptation) significantly impacts program outcomes (Durlak and 
DuPre 2008).  The studies included in their review involved “… prevention and health promotion 
programs for children and adolescents related to the following topics: physical health and development, 
academic performance, drug use, and various social and mental health issues such as violence, bullying, 
and positive youth development.”  By reviewing additional qualitative and quantitative studies, the authors 
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went on to identify 23 specific factors within five major domains that influence the effectiveness of 
implementation: 
a) Community level factors 
b) Provider characteristics 
c) Innovation characteristics 
d) Factors related to organizational capacity 
e) Training and technical assistance 
 
The authors noted that this schema corresponded in many respects to the findings of other 
researchers who had also reviewed this same topic “…21 of the 23 factors identified in our review were 
also identified in some fashion by Greenhalgh et al. (2005), 13 were noted by Fixsen et al. (2005), and 15 
were noted by Stith et al. (2006).”  Apart from training and technical assistance, this study did not mention 
other roles a resource system might play in addressing this set of factors. 
 
Diffusion versus Dissemination 
In his classic work, The Diffusion of Innovations, Rogers defines diffusion as “the process in which 
an innovation is communicated through certain channels over time among the members of a social 
system.  It is a special type of communication, in that the messages are concerned with new ideas” 
(Rogers 2003, 5).  Rogers does not distinguish between diffusion and dissemination stating that “In this 
book we use the word “diffusion” to include both the planned and the spontaneous spread of new ideas” 
(Rogers 2003, 6).  To many researchers, however, diffusion connotes the passive spread and adoption of 
innovations, while dissemination represents uptake that occurs through intentional efforts (Lomas 1993; 
Greenhalgh et al. 2008).  In practice, both diffusion and dissemination are widely used in the research 
literature, often interchangeably, so both have been used in the search term algorithms applied for this 
literature review. 
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‘Resource System’ and Synonyms 
The term “resource system” used in the conceptual model of Greenhalgh et al. 2008, does not 
appear to have been widely adopted in the research literature.  Its use, as a phrase, in search algorithms 
would often return works related to “human resource management systems.”  Efforts to identify an 
alternative term widely and consistently applied in the research literature for those individuals (or 
organizations) who originally developed an innovation did not yield a satisfactory alternative.  As a result, 
in addition to “resource system”, a variety of synonyms for this term were tried in search algorithms, 
including; “innovator”, “pioneer”, “originator”, “inventor”, “developer”, and “researcher”. 
 
Search Algorithms and Results  
A detailed listing of all search algorithms applied and the number of articles retrieved by each is 
provided in Appendix C.  Overall, 39 unique algorithm-database pairs were assessed with most (n=32; 
82%) yielding no relevant articles.  The subset of 7 algorithm-database pairs that yielded one or more 
relevant articles, returned a total of 28 articles based on full text review.  A summary of the algorithm-
database pairings that yielded relevant articles is given below; 
 
Table 4 - Search algorithms yielding relevant articles 
Search terms Database Total 
returned 
Title/Abstract 
reviews 
Full article 
reviews 
Relevant 
articles 
allintitle: innovation + diffusion + health Google 
Scholar 
35 35 9 1 
(pioneer[Title/Abstract] AND 
dissemination[Title/Abstract]) AND 
("2005/01/01"[PDAT] : "2015/12/31"[PDAT]) 
PubMed 10 10 2 2 
(developer[Title/Abstract] AND 
dissemination[Title/Abstract]) AND 
("2005/01/01"[PDAT] : "2015/12/31"[PDAT]) 
PubMed 6 6 3 1 
healthcare "resource system" -TEKS 
innovation 
Google 
Scholar 
1240 1240 42 8 
("research personnel"[MeSH Terms] OR 
("research"[All Fields] AND "personnel"[All 
Fields]) OR "research personnel"[All Fields] 
OR "researcher"[All Fields]) AND 
("diffusion"[MeSH Terms] OR "diffusion"[All 
Fields]) AND ("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 949 949 37 13 
All citations to Greenhalgh (2008) Google 
Scholar 
518 518 28 
1NAvail 
2 
"nurse-family partnership"[All Fields] AND 
("2005/01/01"[PDAT] : "2015/12/31"[PDAT]) 
PubMed 73 73 26 1 (best) 
article 
was used 
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Few articles were identified that offered well developed descriptions of a resource system (as 
defined by Greenhalgh et al. 2008) supporting one or more user systems to implement an 
innovation.  It was also often hard to tell whether supporting organizations described in articles had been 
involved in the original design, creation, or development of an innovation.  An example of this is an article 
that offered a construct, based on a single case, of a formal logic model for the work of “purveyors” 
supporting “provider organizations”, the former described as “individuals or organizations that operate as 
outside experts representing a particular program; they support organizations, systems, and practitioners 
in striving to adopt and implement the program with fidelity” (Oosthuizen and Louw 2013).  The theory 
offered, in this example, mapped specific elements of a purveyor program to the domains of; inputs, 
functions, proximal outcomes, intermediate outcomes, and distal outcomes.  In addition to not including 
any evidence that the “purveyors” qualified as a full-fledged resource system, the construct pays little 
attention to factors affecting the effectiveness or durability of the collaborative relationship between 
purveyor and provider.  By contrast, these are the primary concerns of the current study. 
An article that better addresses the focus of the current study, describes how innovators that 
undertook the original R&D needed to develop and validate a program of Methadone Medical 
Maintenance (MMM) went on to support program implementation by others.  After testing the MMM model 
and demonstrating its effectiveness (King et al. 2006), these innovators provided educational seminar 
presentations and consultative support to five methadone maintenance treatment clinics that agreed to 
participate (King et al. 2008).  They discovered that being a resource system does not, in and of itself, 
eliminate the challenges that other types of players face in supporting user systems to implement new 
programs.  For example, the attendance by clinic leadership at their presentations was meager for three 
clinics and only two clinics sought and received additional consultation.  These authors noted that “Many 
of the factors pointed out in previous studies—the inertia of current policies and procedures, lack of 
adequate training in how to provide innovative methods of treatment, and demanding clinical workloads 
that interfere with implementing new interventions—were factors in this project … Significant effort is 
required to surmount these formidable hurdles, and this intervention did help to address some of these 
issues. However, our experience may indicate that even lengthier relationships (N1 year) may be needed 
to adequately address follow through in any plans to change complicated systems of care using relatively 
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low intensity interventions such as this” (King et al. 2008).  The recognition that longer periods of 
collaboration are often needed to provided adequate support to user systems mirrors HQP’s experience. 
One case study of the implementation of an evidence-based fall prevention program in an aged care 
organization in Australia, demonstrates the application of the Greenhalgh model.  All of the elements of 
the model were mapped to features of the implementation initiative.  The resource systems were “two 
regional falls networks” [fall prevention consortia]  providing “… evidence synthesized into a range of 
products.” “These included locally developed tools such as brochures, posters, screening and 
assessment forms, as well as distributing nationally developed resources such as guidelines and 
resource kits.” “Staff have developed ongoing links with the local regional network at the management 
level, participating in the advisory group, while clinicians made substantial use of the training 
opportunities offered. Thus the organization both contributed to, and utilized the services of the networks” 
(van Kessel 2012).  Unfortunately, few details were provided as to how the resource system - user system 
relationship was structured and operationalized. 
One study using ethnographic observations and process tracking provides insights into how a 
resource system (a community-based research organization) that originally designed and tested an 
intervention collaborated with a user system (a behavioral health care organization offering long-term 
outpatient substance abuse treatment) to help translate and expand implementation of an innovation.  
The Risk Avoidance Partnership (RAP), “is a health promotion intervention originally designed to train 
active drug users to become Peer Health Advocates” (Weeks et al. 2015).  “Findings indicated that RAP 
core components can be met when implemented in these settings and RAP can fit with the goals, 
interests, and other programs of the clinic. Balancing fidelity and fit requires recognition of the mutual 
impacts RAP and the clinic have on each other, which generate new interactions among staff and require 
ongoing specification of RAP to keep abreast of clinic and community changes. Collaboration of 
multiple stakeholders [emphasis added] significantly benefited translation and pilot processes.” 
Researchers from the University of Washington Health Promotion Research Center developed a 
framework for dissemination in which “Researchers create new knowledge to aid dissemination of best 
practices. Disseminating organizations (“disseminators”) use that knowledge to lead dissemination efforts. 
User organizations put best practices into place” (Harris et al. 2011).  The argument made by the authors 
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for separating these functions had to do with focus and cultural fit.  “Although researchers can serve as 
disseminators, disseminators have at least 2 advantages in disseminating best practices: 1) they can 
focus on dissemination, rather than on research objectives and funding, and thus focus on the support 
systems needed to reach the scale necessary to make a difference at a population level; and 2) they may 
be closer in culture and values to user organizations than are researchers and thus better able to promote 
best practices and adapt them to local needs.”  Unlike a resource system that delivers care using the 
innovation it created while providing support for implementation and scaling, in the framework of Harris et 
al., it is possible, perhaps likely, that the researcher-disseminator dyad will have had no direct experience 
or accountability for operationalizing the program being disseminated.  While the dyad model may be able 
to support user organizations, it may be less able to provide the kind of insights, knowledge, and problem-
solving that a resource system could by virtue of its experience developing and delivering an innovative 
model of care.  
A thoughtful paper by researchers assessing the dissemination phase of the Canadian Heart Health 
Initiative (CHHI) (Masuda et al. 2009), highlights how complex it can be to ascertain the impact of varied 
types of implementation support.  They note in providing a background to their work that “although there 
has been increasing support for the idea of complex interactional (i.e., two-direction or multidirection) 
engagement between organizations for more effective dissemination of health promotion innovations in 
health systems (Lee & Garvin, 2003), empirical investigations to confirm these assumptions are 
surprisingly sparse (Maibach, Van Duyn, & Bloodgood, 2006).”  In their analysis of CHHI dissemination, 
the “level of interaction” between project teams (resource systems) and recipient organizations (user 
systems) did not correlate with “dissemination outcomes (as evaluated independently by each provincial 
project).”   
Despite marked variation in the approach and level of interaction of project teams across provinces, 
most provinces deemed themselves successful in delivering the intended “dissemination objects” to the 
intended “target organizations.”  These findings were interpreted as suggesting “that effectiveness is 
improved when projects are responsive to contextual variables more than if they had attempted to adhere 
to universal good practice principles of maintaining original plans. In the context of such “natural” 
experiments in large-scale systems approaches to influencing health promotion efforts, it may be neither 
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realistic nor desirable to insist on intervention fidelity at certain scales.”  An alternative interpretation, not 
put forth by the authors, is that none of the implementation supports provided to provinces was very 
effective and that the self-assessment of dissemination success was generous.  Under such a scenario, 
the same pattern of results might have been observed; “good” outcomes with a poor correlation between 
the dissemination approach taken and the outcomes observed. 
 
Reflections on the Nurse Family Partnership (NFP) Program 
Nurse Family Partnership (NFP) is the program individuals most often spontaneously associate with 
HQP’s model of advanced preventive care (including some key informants participating in the current 
study).  The comparison is made, not because of any similarity in name, program-specific interventions or 
target populations, but because of shared attributes of both programs’ innovators; sustained commitment 
to ongoing, long-term, program development; insistence on rigorous program evaluation methods, 
including randomized controlled trials; use of registered nurses; and the use of stringent program 
standards, staff training, and implementation processes.   
The NFP program was started in the 1970’s by Dr. David Olds.  The model is a well-designed 
nursing intervention providing support, education, and counseling to low-income, first-time mothers and 
their babies, through home visits by a registered nurse beginning early in pregnancy and continuing 
through the first two years of a child’s life.  The creation of a resource system with the help of the 
originators of this program in order to facilitate the dissemination of the program is especially 
noteworthy in the context of the current study.  After multiple randomized controlled trials 
demonstrating favorable program outcomes, a non-profit organization, the Nurse-Family Partnership 
National Service Office (NSO), was created in 2003 “ … to facilitate quality replication of the Nurse-Family 
Partnership program across the U.S. and to provide implementing agencies with ongoing support in 
nursing education and practice, program quality assurance, marketing, public policy, and more” 
(“Program History | Nurse Family Partnership - NFP” 2016).  This organization’s website is easily found, 
being the first one listed when searching Google for “nurse family partnership”. 
In addition to offering general information about the model, the website also provides at-risk mothers 
a way to search for a program in their area, lists job postings for nursing staff at sites across the nation, 
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and describes the array of supports the NSO provides to state and local program sponsors (including 
business development, nursing practice, program quality support, marketing and communications, public 
policy and government affairs).  The model elements and the importance of fidelity for achieving 
reproducible outcomes is also presented.  Meanwhile, Dr. Olds and his colleagues at the Prevention 
Research Center for Family and Child Health, University of Colorado School of Medicine, Department of 
Pediatrics continue to undertake a prodigious amount of research to improve the quality and effectiveness 
of the program. 
With respect to identifying work this group has done on the question of enhancing resource system – 
user system collaborations, one article of the 73 identified in PubMed using the search algorithm "nurse-
family partnership"[All Fields] AND ("2005/01/01"[PDAT] : "2015/12/31"[PDAT])” stands out in particular.  
In the “Influence of Collaboration on Program Outcomes: The Colorado Nurse-Family Partnership”, the 
degree to which the quality of the collaborative relationship between program sites and organizations 
supporting them and program outcomes is explored.  As the authors explain, “The Colorado NFP is 
unique in that it devotes greater attention than other states in the use of a collaborative site-development 
strategy. In Colorado the adoption of the NFP is done though collaborative partnerships including county 
health departments, community health agencies, county human services departments, school boards, 
local head starts, county commissioners, and business and civic leaders. The program is then 
implemented by local health agencies and supported by and planned for by these collaborative 
partnerships. At the time of this study, 16 collaborative partnerships, ranging from citywide to multicounty 
collaboratives, were in place, …” (Hicks et al. 2008). 
This study offers the most thorough and insightful description of how a resource system can support 
a user system found in this literature review; 
“… These collaborative partnerships are facilitated by Invest in Kids (IIK), a nonprofit 
organization based in Denver, Colorado that partners with communities to implement 
evidence-based programs targeting children (prenatal to age 5), particularly those from 
low-income families. IIK has played a critical role in bridging the gap between the 
resources and commitments of the community and the requirements of implementing 
the NFP. IIK is most heavily involved in the formative stages of the collaborative 
partnership: recruiting stakeholders from key sectors, building community commitment 
to establish the program, and facilitating the implementation of the program by a 
community agency.  IIK also facilitates the establishment of a community advisory 
board in each site that provides ongoing support for the program, including facilitating 
interagency collaboration between multiple sectors in areas such as funding needs, 
client referral, and hiring home-visitation nurses. In addition, IIK provides ongoing 
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technical assistance and support to the 16 communities, acting as a bridge between the 
communities and the National NFP office.   
We have evaluated the site development and implementation strategies of IIK and 
these collaborative partnerships since 1999. The primary interest is in determining the 
relationships between features of community collaboration, particularly the quality of the 
process and the program outcomes reported by the Colorado NFP …” (Hicks et al. 
2008). 
The results show that the quality (authenticity) of the collaborative process between resource 
system and user system is statistically correlated with the attrition rate of participants (individual 
clients) from the program (a key program outcome measure), even after controlling for other 
variables like nurse attrition.  The authors surmise that the quality and authenticity of the collaboration 
strongly and durably impacted the morale, energy, commitment, positive expectation, and effectiveness of 
site staff. 
“It took many years and much hard work for health care professionals and social scientists to 
conclude that events and experiences in infancy and early childhood had lasting effects on the child’s, 
and then later, the adult’s health and well-being. In fact, this assumption underwrites both the theoretical 
foundations of the NFP and the body of evidence demonstrating its success. We are arguing 
analogously that the events and experiences in the infancy and early stages of the collaborative 
process have lasting effects on the commitment to and ultimate success of the programs that 
process engenders [emphasis added]” (Hicks et al. 2008).  This construct is completely congruent with 
the experience HQP has had in working with collaborative partners for the past sixteen years.  It also 
hints at a potentially powerful, but largely unrecognized and untapped possibility within the construct of 
resource system – user system collaboration. 
 
Conclusions 
There seem to be few high quality studies that explore the potential attributes, opportunities, 
structures and mechanisms of resources system – user system collaborations in support of 
disseminating innovations.  A few of the relevant articles identified provide provocative evidence that 
the quality of the collaboration in such a construct may have significant and long-lasting impact on 
program effectiveness.  Though this seems logical on the face of it and corresponds to HQP’s 
experience, if confirmed, this is an extremely powerful and potentially transformative insight.  More 
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thorough descriptions of resource systems in published studies, including their lineage with respect to 
innovation design and development would be very helpful.  Additional refinement of methods to measure 
the quality of collaboration as well as additional studies exploring this idea further through robust 
experimental designs would likely contribute significantly to the field. 
The successful dissemination of the Nurse-Family Partnership and the conscious decision by 
its originators to help support the development of a readily accessible, high quality resource 
system in the form of the NFP National Service Office deserves recognition.  It may not be 
coincidental that the best study describing the relationship between the quality of resource and user 
system collaboration and program outcomes comes from this set of researcher / innovators.   Nor is it 
surprising that this team remains extremely active in ongoing program design modifications and quality 
improvement related research.  Such a mindset may be an essential attribute of a successful, sustained 
and periodically revitalized innovator / resource system. 
Caution, as to the completeness or robustness of the current literature review is warranted.  
The fact that the best paper in this review was not found through structured search algorithms 
incorporating terms associated with the major models of innovation diffusion, dissemination, or 
implementation or through citation threads of such publications, suggests that search algorithms 
structured along these lines may be flawed or that a recalibration of descriptive terms and publication 
assigned keywords and MeSH headings in this field may be warranted, or both.13  This raises the 
question of what other studies have gone “missing”.  Therefore, caution, as to the completeness of the 
current review is warranted, though great effort was made to cast a wide net then narrow results through 
investigator manual review to avoid missing relevant works. 
The current study undertaken for this thesis is likely to contribute new knowledge to the field.  
Notwithstanding that some references may have been overlooked, it appears that the current study 
addresses aspects and possibilities for resource system – user system collaboration in a novel way that 
has not been previously researched.
                                                       
13 As reference the MeSH heading for (Hicks et al. 2008) included; Colorado; Cooperative Behavior; 
Humans; Nursing Evaluation Research; Nursing Staff, Hospital*; Outcomes Assessment (Health 
Care)/organization & administration*; Professional-family Relations*; Program Evaluation.  Some of these 
terms would likely be useful in future reviews on this subject to ensure more complete capture of relevant 
studies. 
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CHAPTER 3 – METHODOLOGY 
Overall Study Strategy 
Key informant interviews were conducted with individuals in senior leadership positions (decision 
makers/influencers) from different types of health care organizations that might have an interest in 
adopting and implementing an innovation in preventive care for higher-risk chronically ill older adults.  
Interviews collected information about current work the informant’s organization was pursuing in this area, 
described the exemplar innovation, and then solicited reaction to various collaborative partnership models 
by which the innovation developer (resource system) might collaborate with the subject’s organization to 
assist it in delivering the innovation to the organization’s service population.  The interviews were digitally 
recorded with subject permission, transcribed verbatim, and analyzed to assess what models of 
collaboration between a resource system (HQP) and user system (the informant’s organization) offered 
the most pragmatic opportunity to facilitate dissemination of advanced preventive care. 
 
Protections of Human Subjects 
All subjects provided verbal consent to participate in the study at the beginning of the telephone call 
before information was collected in the interview.  All subjects were also asked for their permission for the 
researcher to digitally record the interview and all subjects consented.  Safeguards to protect 
confidentiality and anonymity include data security measures and the lack of reporting any specific 
personal or organizational information that could lead to the identification of study participants or their 
organizations.  As necessary, distinguishing features of the informant or the informant’s organization (for 
example, a very unique position title) have been changed to more generic terms to protect the identity of 
study participants.  The study was approved by the University of North Carolina Institutional Review 
Board (UNC IRB Study # 12-0999). 
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Rationale for Selection of Potential User System Organizations 
The goal was to select health care organizations that could be potential champions and supporters of 
HQP’s model of advanced preventive care, possessing sufficient resources, understanding, interest, 
incentives, and position within the larger health system to enable them to play such a role. 
Organizations were sought that were likely to have attributes essential for adopting the HQP model 
including: 
• Interest in improving the long-term health outcomes of chronically ill older adults.  
• Experience working with or relating to health care delivery systems – including an ability to 
collaborate with primary care providers, hospitals and community service organizations. 
• Experience with and appreciation for utilizing nurses as staff for service delivery. 
• Direct access to health care data relevant for case-finding and program referrals. 
An effort was made to identify and enlist senior executives from the following types of organizations 
to participate in key informant interviews: 
1. Hospital organizations – This category includes general medical/surgical hospital 
organizations (excluding Veterans Health Administration facilities); both larger, hospital-
based health systems and smaller, standalone community hospitals.  Four states were 
chosen at random from which to select this class of informants; Michigan, Virginia, Texas, 
and New Mexico.  
2. Physician led organizations – Independent Practice Associations (IPAs), primary care 
networks, medical groups, or physician practices (with 5+ primary care providers and/or 
National Committee for Quality Assurance (NCQA) Patient-Centered Medical Home 
(PCMH) certification).  Four states were chosen at random from which to select this class 
of informants; Florida, Maryland, Mississippi, and Vermont. 
3. Health system - Physician alliances (e.g., PHO – Physician Hospital Organization or 
other similar types of partnerships).  Organizations to enlist in this category were sought 
from the same four states as physician led organizations. 
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Other organizations meeting criteria for inclusion were considered for participation in this study (for 
example, visiting nurse and community service organizations, and health insurers), but the final selection 
was based on the time available and logistics necessary to conduct interviews.   A key objective was to 
identify organizations that already had or were likely to seek financial agreements offering incentives for 
improving care to a population of “attributed” lives as defined in emerging payment models (e.g, certain 
value-based, Accountable Care Organization, and Bundled Payment programs).  Such organizations had 
shown interest in HQP’s program. 
The intended goal was to interview and collect useable information, perspectives, and opinions from 
senior executives with significant decision-making authority for adopting and contracting for new services 
for their organization from among randomly selected organizations within each of the three organizational 
categories above.  In practice this meant addressing the invitation to participate in the study to the CEO, 
Executive Director, Administrator, COO, or equivalent role within each organization.  These individuals, in 
turn, could delegate other senior executives to participate in the study. 
 
Conduct of the Study 
Key Informant Outreach and Recruitment 
The original study design envisioned completing a roughly equal number of 4 to 6 interviews for each 
of the three organizational categories targeted – for a total of 12 to 18 interviews.  In practice, it was 
difficult to identify and obtain useful contact information for physician led organizations like IPAs and 
medical groups and health system-physician alliances like PHOs.  At the time of study implementation, 
there was no comprehensive, publicly available information source to search for IPAs, medical groups, 
and PHOs.  One relatively affordable proprietary data source for this purpose was selected and used; The 
National Directory of Physician OrganizationsTM, published by Health Resources Publishing, copyright 
2012, in association with the Managed Care Information Center.  This was the principle information 
source used in identifying both physician-led organizations and health system-physician alliances.  
Physician practices were identified using publicly available sources from Healthgrades® and NCQA 
(online certification center).  The NCQA site made it possible to outreach to practices that had received 
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certification as Patient-Centered Medical Homes (PCMHs) and therefore might have a greater awareness 
and interest in care coordination and care management. 
The total set of data sources to identify physician organizations included: 
f) The National Directory of Physician OrganizationsTM, published by Health Resources Publishing, 
copyright 2012, for the Managed Care Information Center 
g) Healthgrades® Physician practices (selecting 5+ providers) http://www.healthgrades.com/group-
directory  
h) NCQA’s online certification directory to identify NCQA-certified PCMH’s (current web address 
http://recognition.ncqa.org)  
 
Several free, publicly available data sources existed from which to identify hospital organizations, but 
a subscription to the American Hospital Directory (https://www.ahd.com/) proved especially convenient for 
obtaining key informant roles and contact information enabling invitation letters to be more precisely 
targeted. 
In an effort to obtain some geographic variation in study participant locations, while preserving some 
efficiency of outreach efforts, four states were randomly selected from which to recruit hospital 
organizations and a separate random selection of four states was made for physician organizations and 
health system-physician alliances.  The four states from which hospital organizations were selected 
included Michigan (MI), Virginia (VA), Texas (TX), and New Mexico (NM).  The four states from which 
physician organizations and health system-physician alliances were recruited were Florida (FL), Maryland 
(MD), Mississippi (MS), and Vermont (VT). 
Using the previously described data sources, organizations within the selected states were randomly 
selected and outreach to a potential key informant in a senior management position was initiated via a 
letter of introduction delivered by 1st class mail (Appendix C).  The letter briefly summarizes the purpose 
of the study, and requests a participant who can speak knowledgably about the organizations’ decision-
making process for entering into collaborative partnerships to participate in a 45 to 60-minute interview.  
The letter contained contact information for the principal investigator and research assistant, and 
described how invitees can ask questions about the study or indicate their interest in participating. 
  43 
Seventeen days following the initial mailing, a second notice was mailed; an identical letter with the 
phrase SECOND REQUEST in large all caps red font added to the right upper section of the letter.  
Uncertain of the response rate of invited participants, but expecting it to be low, 20 hospitals for each 
target state were randomly selected and senior executives from these were invited to participate in the 
study (for a total of 80 hospital organizations).  In anticipation of a very low response rate among senior 
leaders of physician organizations and PHOs, a total of 194 invitation letters to this these organizations 
was mailed as detailed in the table below.   
Table 5 - Mailed study participant invitation letters by organizational type 
Physician Category FL total n=79 MD total n=61 MS total n=25 VT total=29 TOTAL n=194 
Practices [1] 21 14 12 10 57 
NCQA PCMH 13 27 2 14 56 
PHO 22 11 10 5 48 
IPA 19 8 1 0 28 
Medical Group [1] 2 1 0 0 3 
Primary Care 
Network 
2 0 0 0 2 
[1] Practices and Medical Groups were selected if they included at least 5 providers delivering primary 
care. 
 
Interviews 
All interviews were conducted by the principal investigator between December 2012 and April 2013 
by telephone using a structured interview guide to manage the flow and consistent wording of key 
questions (Appendix D). Based on test runs using the interview guide it was anticipated that interviews 
would last a total of 45 to 60 minutes, including explanations related to two separate verbal consents for 
the interview and the recording and answering any questions before the interview itself began.  At the 
outset of the interview informants were encouraged to offer any other related thoughts or experiences 
(not necessarily asked for by the interviewer) they felt might be relevant or help explain their 
organizational context. A set of initial opening questions focused on information about the informant’s 
organization, the informant’s professional role in the organization, their prior experience with and 
expected future allocation of resources to care management for chronically ill older adults, and 
experience with risk-bearing contracts.  Because the focus of the research was about the various 
structures and options for collaborative partnerships and not about financial or business barriers or 
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incentives, per the interview guide, if an informant raised concerns or questions about the financial impact 
of adopting the exemplar model they were instructed by the interviewer … 
“… to answer the question under the assumption that payment models and incentives in 
place would yield a break-even or modest net improvement in their organization’s 
‘bottom line’ for supporting and encouraging use of this model.” 
 
Prior to the scheduled interview (usually one or two days before) a brief summary of attributes and 
results of the exemplar advanced preventive care model, identical to the description that was also read 
aloud by the researcher during the interview, was emailed to the informant for them to read and review in 
advance of the interview.  After obtaining the initial set of information about the informant, their 
organization, and experience with care management, the following description was read aloud by the 
interviewer: 
“I’d like to take a few minutes to briefly describe a new model of community-based 
nurse care management for chronically ill older adults.  The model has been rigorously 
tested for over ten years in a Medicare demonstration project.  It is a highly effective 
program, but one that is demanding to implement.  It represents an innovation with the 
potential to improve our health care system if it could be effectively deployed on a large 
scale.  After I describe the program, I will ask you questions about some approaches to 
enable a (health system/physician group/ health system-physician alliance) to provide 
this program to their patients. 
The program utilizes experienced nurses who receive 6 to 9 months of intensive pre-
service training followed by ongoing supervision and mentorship.  These nurses deliver 
a broad portfolio of evidence-based preventive interventions in the community through 
frequent in-person contacts, group programs, and telephone monitoring in collaboration 
with a participant’s primary care provider. 
The program is administered and tightly managed according to explicit protocols using 
a customized data and reporting system.  Patients receive an average of 2 to 3 contacts 
per month, to provide a set of services that match their needs as their condition 
changes over a long-term follow up period.  These services include chronic disease 
self-management coaching, healthy life style behavior change coaching, structured 
group education, physical activity, gait and balance training, medication reconciliation, 
transition of care support, ongoing assessments and monitoring, and help coordinating 
medical care and community-services. 
According to results of a carefully done randomized trial, for high-risk individuals, the 
program reduced hospitalizations 39%, decreased emergency room visits 37%, lowered 
all-cause mortality 30%, and reduced net health care costs 28%.  Other models of care 
coordination and care management tested by CMS have not been as effective and it is 
believed that tight adherence to the program’s rigorous process specifications, training, 
performance reporting, and management practices are essential for its effectiveness.” 
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The interviewer would then ask, “Before I ask you questions about how your organization might view 
utilizing a program like this, do you have any questions about the program I’ve just described or anything 
that you’d like me to repeat or review?” 
Questions following this description began to explore the perception of the informant with regard to 
collaborating with the innovators of the exemplar program so that they could help the informant’s 
organization adopt and implement the model.  This was first explored in an intentionally general and 
conceptual way and then was explored using specified models of collaborative partnership (direct service, 
regional cooperative, and franchise).  The overall flow of the topics explored in the interview (from top to 
bottom) relating to collaborative partnerships and the objective and rationale for including each is outlined 
in the table below. 
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Table 6 - Key areas of interview inquiry related to collaborative partnerships, objective, rationale 
 
With the exception of the direct service partnership model of collaboration, the interview was not 
structured to probe reactions to the operational details of these collaborative models, but rather to allow 
the interviewee to guide the depth at which they wished to respond to each model.  Because the direct 
Interview Queries Objective Rationale 
Reading of the description of the exemplar model of Advanced Preventive Care 
General view/perception  
(Question 3a) of collaborating with the 
innovators of the exemplar model to 
implement advanced preventive care  
With probing, assess extent to which 
key informant is supportive of or 
resistant to collaborative partnerships 
(in general) with external groups 
A general aversion to collaboration would 
make interest in any collaborative 
partnership in support of advanced 
preventive care less likely  
Direct Service Partnership Model 
(not referred to as such in the interview) 
(Questions 3b,c,d) 
Reflected in the interview by a) general 
willingness to partner with a resource 
system and b) willingness and ability for 
the organization to provide three core 
elements: 
1. Introductions to primary care 
and/or hospital systems 
2. Data sharing for case finding and 
management 
3. Employment and lease back of 
staff needed to deliver care  
Identify whether key informants are 
open to the model of collaboration 
that HQP has been using since 
inception including with health 
systems in its most recent regional 
expansion 
Do these key informants seems as 
receptive to this approach as actual 
systems HQP has been working with; If 
not, why? 
Franchise Model 
(Question 4) 
Determine whether a collaboration 
model based on a franchise 
relationship is of interest to key 
informants 
Tests one way to more formally structure 
and standardize a collaborative interface 
that might facilitate replication; could help 
identify perceived strengths and 
weaknesses of this approach 
‘Independent’ Model 
(not referred to as such in the interview) 
(Question 5) 
preference to ‘go it alone’ with minimal 
reliance on outside help – probed in the 
interviews with a query related to a 
preference for doing it themselves 
Assess whether a key informant 
interested in advanced preventive 
care would prefer little or no 
significant collaborative partnership to 
assist in adoption and implementation 
(including, as volunteered, a 
preference for working with 
knowledge purveyors or change 
agents)  
If this is the preferred approach of a key 
informant it would be helpful to try to fully 
understand the basis for rejecting 
collaborative assistance  
Regional Cooperative Model 
(Question 6) 
Determine whether a shared regional 
resource that collaborates with 
program developers to deliver 
advanced preventive care to a region, 
and is jointly owned and governed by 
local health care organizations is of 
interest to key informants 
Tests one way to more formally structure 
and standardize a collaborative 
partnership that might be possible to 
replicate; could help identify perceived 
strengths and weaknesses of this 
approach 
Other ways to disseminate / 
collaborate  
(Question 7) 
suggestions generated by key informant 
to open-ended inquiry 
Invite creative thinking by key 
informant to identify what they 
perceive could work best 
Elicit other possibilities not envisioned by 
investigator 
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service partnership was the principal means by which HQP has implemented its program in southeastern 
Pennsylvania for many years, more detail was focused on that model in an effort to see whether it might 
be a practical approach to use in other areas of the country.   
 
Data Capture 
All sessions were recorded with good audio quality and all recordings were subsequently transcribed 
verbatim.  Transcription of each interview was captured in Microsoft Word which was then directly copied 
as a primary document into a software application for qualitative analysis (Atlas.ti, GmbH Berlin, version 
7.5.9). 
 
Analysis 
The most important findings from analysis were the specific insights and issues raised by the 
informants with regard to the prospects of collaborative partnerships as pragmatic vehicles for 
dissemination (including adoption, implementation, and assimilation).  These are best captured in the 
words of the informants themselves that often need no additional analysis and are shared liberally in the 
reported results.   
In an effort to gain some appreciation for the pattern of responses obtained regarding each of the 
collaborative partnership models, responses of each informant to each area probed was scored by the 
principal investigator as primarily positive (+), negative (-), or neutral/ambivalent (0).   Given the 
subjective element of interpretation in making these categorizations, separate cycles of coding and review 
by the principal investigator were repeated until these classifications became stable.  This occurred on 
the fourth cycle of review during which there were minimal changes from the 3rd cycle.  The coding and 
analysis of subject responses was undertaken in two basic ways; 1) across all participants within a single 
question and 2) across all questions by participant.  Procedures used to reduce interviewer bias in coding 
results, included; a) the removal of overt participant identifiers in the Atlas.ti primary documents, and b) 
the use of repeated cycles of coding within each category of question, across all participants, to help 
ensure coding consistency.  
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The former approach was used to determine the set of issues (pros and cons) and overall 
acceptance across all respondents with regard to a given collaborative partnership model. While most 
collaborative partnership models were probed with a single question, detailed probing of three essential 
subcomponents of the direct service partnership model was undertaken.  Given HQP’s success using this 
model for regional expansion of its primary service area, it was a high priority for this study to assess the 
receptivity and feasibility of informant organization’s in using this model to support dissemination of 
advanced preventive care on a broader scale to areas beyond the existing HQP service area.  
For informants’ responses to be coded as providing an overall favorable rating for the direct services 
partnership collaborative model, an informant must have rated all 3 specific elements required for this 
model as favorable.  If all three specific model components were not rated favorably, then the overall 
rating for the direct service partnership defaulted to the lowest rating given any one of its sub-
components.  If one or more specific element was rated as neutral/ambivalent (and none was rated 
unfavorable/unfeasible), then the overall rating for the model was assigned as neutral/ambivalent.  
Similarly, if the one or more specific elements was rated as unfavorable/unfeasible, then the overall rating 
for the model was assigned as unfavorable/unfeasible.   
The purpose of assessing responses across all questions by participant was to assess the overall 
likelihood (as gestalt) that a participant would partner with the program’s developer (resource system) 
using any model. The pattern of responses for each informant across all questions as well as the verbal 
tone and inflection from the audio recording, and any ‘side’ comments was used to categorize what the 
principal investigator judged to be the likelihood that the informant would encourage their organization to 
engage in further exploration of any form of collaborative partnership (1 or more) with the program 
developers (resources system) on a relative scale of high, moderate, or low. 
 
Informant Self-Selection: Likely to Yield a Sample of “Early Adopters” 
By design, the study methodology virtually guarantees that the sample of informants participating in 
this study are essentially self-selected based on their interest in this topic and its importance to them and 
their organizations.  As such, there was no expectation that the results obtained from this study would be 
representative of or generalizable to hospital or physician organizations in the U.S. as a whole.  It was 
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anticipated that study participants would be much more likely to represent organizations with 
characteristics of what Everett Rogers described as “early adopters” (Rogers 2003, 283).  As HQP and 
other resource systems seek to make inroads in dissemination it is this class of organizations, the “early 
adopters” with which initial progress is most likely to occur and whose opinions about collaborative 
partnerships are most valuable.  Therefore, understanding what they would find useful in a collaborative 
partnership is an essential first step in broader dissemination. 
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CHAPTER 4 – RESULTS 
 
Of a total of 274 mailed invitations (194 to physician organizations and physician-health system 
alliances, 80 to hospital organizations) 16 respondents volunteered to participate in the study for a crude 
acceptance rate of 5.8%.  Thirty-one invitations (11.3%) were returned by the post-office for having an 
incorrect address (all but one from physician organizations or PHOs), leaving 243 invitations presumably 
reaching the intended organizations yielding an adjusted acceptance rate of 6.6%.   
 
Characteristics of Study Participants and their Organizations 
A total of 16 key informants completed telephone interviews with the duration of recorded questions 
and responses ranging from 27 minutes to 60 minutes (mean=41, median=40).  The sixteen study 
participants represented organizations located in; Michigan (4), New Mexico (4), Florida (4), Virginia (2), 
and Maryland (2).  No potential participants invited from Texas (20), Vermont (29), or Mississippi (25) 
volunteered to participate in this study.   
In total, 12 of 16 participants (75%) were from hospital organizations.  Nine were senior leaders of 
larger hospital-based health systems and three were from smaller (less than 100 bed) rural hospitals.  
Two of the 9 (22%) larger hospital organizations, also describe themselves as having an affiliated health 
insurance division. 
Four participants (25%) were senior leaders of physician organizations; 2 Independent Practice 
Associations (IPAs), 1 medical group, and 1 primary care practice.   
All participants had senior leadership roles within their organizations and seemed well positioned to 
influence decision-making related to care management strategies.  The leadership roles represented 
include; 3 Chief Operating Officers (COOs), 3 Executive Directors (EDs), 2 Chief Executive Officers 
(CEOs), 2 senior nursing leaders (Chief Nurse, Director of Nursing), 2 senior leaders for Community 
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Health (1 Senior Vice President, 1 Vice President), 1 Chief Medical Officer (CMO), 1 Vice President 
of Patient Care Services, 1 Director of Research and Planning, and 1 Practice owner/lead physician. 
On the next page is a summary table (Table 6) describing the key informants and the organizations 
they represented.  Subsequent pages contain the main results table that summarizes the key findings 
from the study (Tables 7, 8, and 9). 
   
Table 7 - Description of Key Informants and Organizations they Represent 
Study 
ID 
Key Informant Role Gender State Organization Type Other[1] Organization Descriptors Offered by Informant [2] 
1 Chief Operating Officer F MI Hospital Health System R small health system; hospital, SNF, LTC, HHA, 
Hospice 
2 Chief Nurse F NM Hospital Health System  public safety net and academic hospital system 
(multiple hospitals) 
3 Chief Operating Officer F NM Hospital Health System  hospital within a larger corporate health network 
5 Chief Executive Officer M NM Community Hospital R Small, non-profit community hospital 
6 Chief Medical Officer F NM Hospital Health System R small, non-profit community hospital, IDN, behavior 
health facility 
7 Vice-President for Community 
Health 
M MI Hospital Health System  regionally owned, non-profit health system, multiple 
hospitals, 250 employed providers 
8 Vice-President of Patient Care 
Services 
F VA Hospital Health System I large integrated health system; multiple hospitals, 
HCA, LTC, medical group, insurance arm 
9 Director of Nursing F MI Community Hospital R small, solo community hospital, physician services, 
clinics 
10 Corporate President and Chief 
Operating Officer 
M VA Hospital Health System I large integrated health system; multiple hospitals, 
HCA, LTC, Assisted Living, medical group, insurance 
arm 
11 Senior Vice-President for 
Community Health 
F MI Hospital Health System  large health system; academics and research  
12 Director of Research and 
Planning 
M FL Hospital Health System 
(originally ID'd as PHO) 
 large acute care academic public hospital; HHA, 
Hospice 
13 Chief Executive Officer M MD Hospital Health System 
(originally ID'd as PHO) 
 integrated health system with multiple hospitals, 
owned and affiliated physician practices 
14 Executive Director M FL Independent Practice 
Association 
 messenger type IPA (contracting) 
15 Executive Director F FL Independent Practice 
Association 
 messenger type IPA (contracting) 
16 Executive Director F FL Medical Group  multi-practice physician group network 
17 Lead Physician, Practice Owner F MD Physician Practice 
(independent) 
 small primary care practice with Level 3 NCQA PCMH 
accreditation 
 
[1] Other code: R = Rural, I = Insurance Division / Health Plan Offering 
[2] Key phrases and terms provided by Informants when asked, “How would you describe your organization?” 
Abbreviations: SNF = Skilled Nursing Facility, LTC = Long term care, HHA = Home Health Agency, IDN = Integrated Delivery Network, IPA = 
Independent Practice Association, NCQA = National Committee for Quality Assurance, PCMH = Patient-Centered Medical Home, Study ID = 
Primary Document (a unique ID #  created by the analytics software enabling the anonymous linking of various responses and quotes provided by 
each study participant)
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Table 8 - Main Results (Larger Hospital-based Health Systems) 
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Selected Comments and Observations from Interview 
Larger Hospital-based Health Systems 
1 limited, 
HF 
Pendin
g 
+ + + + + + + High Mission alignment; “… we really do need to develop more care outside the walls of 
the hospital and become less hospital-centric.”; cites value of developer’s “intellectual 
capital” 
2 PCMH Unsure + + + + 0 + + High Values the “rigor” of the model and availability of “somebody that really can help you 
get where you want to be faster” 
3 ER None, 
ACO 
interest 
+ + + + + + - High Recognizes that many care coordination models have had “limited success”; “I could 
see the benefit of bringing in the resource experts to replicate something that has 
been very successful …”; regional competition thwarted prior coop(erative) efforts 
7 HF (NP) 
transitio
n coach 
PCMH, 
PACE 
BPCI + + + 0 + + - High Alignment with new strategic plan of “… being a community catalyst and improving 
outcomes or care.”; “We have a bias toward wanting to implement evidence-based 
programs”; cited NFP and CenteringPregnancy as models also using disciplined 
designs; market dominance makes coop unappealing 
11 PACE None, 
ACO 
interest 
+ + + + 0 0 + Mod “It sounds pretty amazing.”; “We don't make everything from the ground up ... but we 
will need to add our perspective and shape things …”; “[APC is] reminiscent of … 
phenomenal … NFP model”; interested in incorporating Community Health Worker 
role into new models; 
12 None Pendin
g 
+ + + + + + + High “We’ve tried things … that have not had any sustainable power to this point.”; “I would 
be open to working with the developers”; “We need to have a group of key physician 
champions … I think we need that in place for us to be able to effectively collaborate 
with the developers of the program.” 
13 yes, not 
specified 
None + X + 0 0 - 0 Mod Strategic alignment; informant read Wash. Post article about HQP’s model and 
identified researcher [4]; focused on marketplace competitive advantage; past 
experience outsourcing services, but now wants in-house capability; “ … trying to 
build it on our own is the way we are going, but maybe it’s not in our DNA, and we 
have to hire somebody externally to help us do it.” 
= Positive/Favorable predominant sentiment (in the case of Q5 – DIY Imperative this means demonstrating a willingness to collaborate) 
= Neutral or Ambivalent predominant sentiment 
= Negative/Unfavorable predominant sentiment ‘X’ = Question was misunderstood by informant, and response discarded for analysis. 
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Table 9 - Main Results (Small, Rural Hospitals; Larger Health Systems with Insurance Divisions) 
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Selected Comments and Observations from Interview 
Small, Rural Hospitals (29, 60, 96 beds) 
5 not 
formal, 2 
MSWs 
Upside 
only 
gain 
share 
+ + + 0 - - 0 Mod “… any technical support we could get would be great ... maybe someone from your 
team is literally onsite for one or two months, helps with recruiting, gets all of the 
policies and procedures, … does the training … and then … wean away from the 
consultants.” Re: franchise, “I just don’t think it will be that difficult to do.” “Do I really 
need that kind of long term expertise?” IHI is “… incredibly helpful and successful.” 
6 nothing 
“formal” 
None + + + + + + + High Mission alignment; “I think this area is very much in need of it.”; Overlap of Native 
American service population with Indian Health Service; “… need to have more 
things done on a community level …”; “We would be willing to work with another 
organization.”; “In terms of co-managing employees for a program like this, I think 
this organization would be very interested in it.” 
9 PCMH Pending + + + + + + + High “… we’re an organization that likes to analyze what the program is, but does not 
want to reinvent the wheel …”; “ … for smaller community hospitals … the biggest 
challenge is what resources and what requirements would your hospital need to 
implement ...?” 
Larger Hospital-based Health Systems with a Health Insurance Division 
8 PCMH CIN 
planned 
+ + 0 + 0 - 0 Mod “Certainly sparks interest,” but no articulation of benefit working with developers; “I 
think, culturally we’re probably still in a place where it’s still kind of build-it-our own 
… we’re trying to move away from that”.; “As an institution, we like borrowing things 
that worked in other places …”; 
10 “entire 
division”, 
multiple 
products 
ACO 
pending
; will 
take 
risk of 
other 
payers 
+ + + 0 - 0 - Low “I mean my sense is that most of this stuff is fairly generic, is being studied widely 
and broadly from many different people across the country today, you know, you’ve 
got the Brookings Institute ACO [ACO Learning Network], you’ve got the Premier 
ACO, you’ve got IHI, you’ve got all kinds of organizations that are looking at best 
practice development.”  
= Positive/Favorable predominant sentiment (in the case of Q5 – DIY Imperative this means demonstrating a willingness to collaborate) 
= Neutral or Ambivalent predominant sentiment 
= Negative/Unfavorable predominant sentiment 
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Selected Comments and Observations from Interview 
Independent Practice Associations (messenger type, contracting entities) 
14 thru 
third-
party, 
ACO 
under-
writer 
MSSP 
ACO 
+ + - - 0 + + Low This IPA uses a third-party health plan as underwriter and supplier of care 
management services for the ACO in which it participates.  No downside risk for IPA.  
First savings goes to underwriter; but if sufficient savings is realized, IPA gets a 
percentage.  Informant suggested to researcher that HQP consider offering its 
products and services to such organizations.  “… because they’re in need of it, … 
[company name redacted] has 30 some odd [ACO partnerships].  So there’s a lot of 
them already out there.  And are they really as effective as they could be? …” 
15 None Pending + + - - - + - Low “… what’s in it for the doctors? … how are the doctors going to be effectively 
reimbursed for their time? … are you going to create more administrative work for 
the doctor’s office? … how are you going to support the doctors in various ways?”  
IPA does not have access to physician clinical or financial data.  Offices within the 
IPA have not yet started to pursue PCMH …” 
Medical Group 
16 Limited, 
diabetes 
ACO 
pending 
+ + + 0 0 - 0 Mod “I think we’d be very interested.  I think we’d embrace it.”; “We’re behind …, ‘OK, we 
have one patient liaison for diabetes, and one for heart failure, … but we could use 
10’.”; “I could see the healthcare system saying, ‘We’ve got this expertise [available], 
let’s bring them in.’ I could see the physicians saying, ‘We don’t need them … we 
could do this without them’.”; 
Primary Care Practice (1 physician + 1 nurse practitioner) 
17 PCMH None + 0 - NA - NA + Low “Services like you mentioned that are … comprehensive in their nature would be 
something that we’re very interested in.”; Informant is a strong advocate for PCMH 
with embedded resources under direct physician control [1] 
= Positive/Favorable predominant sentiment (in the case of Q5 – DIY Imperative this means demonstrating a willingness to collaborate) 
= Neutral or Ambivalent predominant sentiment 
= Negative/Unfavorable predominant sentiment 
[1] Not all questions were asked explicitly of this informant who redirected the interview.  Relevant replies that were obtained are coded 
using the same criteria as those applied to all other participants’ responses. 
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A Wide Range of Experience with Care Coordination/Management 
There was a wide range of experience with models of care coordination and care management 
among informants – some indicating their organization had little to no experience, to one (health system 
with an insurance division) as describing their organization as having “… an entire division that is our 
insurance products and care management products and processes”.  The most common (n=6) model that 
informants cited for care coordination and care management of the chronically ill was the Patient 
Centered Medical Home (PCMH).   Other program types cited were disease specific interventions (e.g., 
heart failure, diabetes), those occurring in a specific service location (Emergency Department – 
connecting patients to a primary care practice), alternatives to long term placement (e.g., PACE – 
Program of All-inclusive Care for the Elderly), or short-term interventions focusing on the transition of care 
from hospital to home.  Most informants describe their current efforts related to chronic care management 
as not being “formal”, or as “early”, and the results related to these initiatives as “preliminary”.  None of 
the descriptions of the care management programs in use sounded as if they would likely meet criteria for 
advanced preventive care, but details of each model were typically not provided, and therefore under 
recognition of more robust advanced preventive care-like models is possible.  
Heart Failure: 
“Yes. I would say that the program that best fits that description is our program for 
patients with congestive heart failure. And there we have a nurse practitioner who is a 
transition coach, and who works with congestive heart failure patients who are seen as 
in-patients in the hospital and are discharged to home, and actually does home visits, 
and works with them post-discharge to prevent readmission, and optimize their 
transition care.” 
Diabetes and Memory Disorders: 
“We initiated a care coordination for diabetes, probably, 12 months ago. And that’s in 
the primary care group. … And we are slowly developing a memory disorder with care 
coordination with that, but we—we’ve gone for grants, and it appears we’ve got some 
funding from some donors in the area.  But that’s probably as close as we get to that 
right now.” 
Analysis of program impacts have not begun or are still underway for most informants: 
“Yep. Very preliminary results, but they are still working through as we plug this full 
implementation now, really taking a look at have those initial results really kind of borne 
fruit, kind of, long term? We’re thinking they have, but they’re really working through, 
still, some of the data analysis on that…” 
Health system with a health plan described a broader array of care management services than most: 
  57 
“Yeah, we’ve got uh, the entire division that is our insurance products and care 
management products and processes. Care management we’ve got a number of senior 
leaders, we’ve got physician leaders with deep care management background and care 
management experience— we’ve got navigators, we’ve got health coaches. So one of 
the products we have is called, Transitions of Care. …, and we see them in one of our 
clinic sites across the region within five days post-discharge.” 
IPA Executive Director implementing an ACO with support from a health insurer:  
“The one program that we currently have is an ACO but we do not have the staffing to 
staff the care coordinators, but we are involved in bringing the ACO to this community. 
And we—the physicians that are in it—are in our IPA. So to what degree you want to 
consider that supporting care coordination—I’ll leave it to you to determine that. … 
Yeah. We’re going to have two full-time RN’s. And our covered lives are in this—under 
6000—between 5-6 thousand. So we actually are managing a smaller number than 
what they typically would allot for two RN’s—two full-time RN’s. It’s—it’s total care 
coordination, social—even to the degree of assisting with social services, and all the 
way through to their care with in-patient discharge and follow-up—out-patient follow-up 
and I don’t know--that pretty much covers the entire gamut, I believe. Yes. They’ll be 
interacting with 17 practices, 28 providers.” 
 
Care Management of Chronically Ill Older Adults Will Require More Resources 
Informants universally agreed (n=16, 100%) that their organizations will be allocating more resources 
to better manage chronically ill older adults in the future.  Many informants cited reasons related to; 
demographic forces (an aging population with increasing health needs) and changes in health care policy 
and payment mechanisms.  There was a widely held expectation that payment systems will continue to 
shift from fee-for-service to more risk and population-based payment models or that, at the very least, 
newer payment models will increasingly penalize systems having poor population health outcomes or 
excessively high acute care utilization (e.g., CMS penalty for high hospital readmission rates among 
traditional Medicare beneficiaries).  
The perspective of one health system CEO: 
“More, substantially more. Well, there’s a couple of issues. We increasingly have 
incentives that are built around management of populations, and relate to lowering re-
admissions, they relate to health status, depending on the population, and reducing 
overall cost, they relate to value-based purchasing incentives, that are increasingly 
becoming a part of our world. And it’s caused our strategies to shift from from being 
largely facility-based sick care to population-health. Which is why, I referenced when 
you asked me about a brief description of [health system name redacted], you noticed 
that I indicated that it was largely sick care focused today, well that’s why our strategy 
for five years is - at least five years, I’m certain longer - to move toward population 
based care.” 
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Experience with Risk Contracting 
Only one organization participating in the CMS Bundled Payment for Care Improvement (BPCI) 
initiative described having a contract exposing them to any downside financial risk.  Nearly all had either 
just entered into or were planning to enter into some form of gain sharing or value-based performance 
agreements with upside only reward potential.  One organization was actively participating in a Medicare 
Shared Savings Program (MSSP) Accountable Care Organization (ACO) at the time of the interview, 
while four others were exploring or close to concluding agreements to join or establish an ACO. Several 
mentioned working on establishing additional gain sharing or “upside only” incentive models with other 
insurers as well. 
Health system COO describes preparing their ACO: 
“Yes. I mean, we will have an ACO, within our health plan options. We’re currently 
developing our ACO and it’s called [Name of ACO redacted], and that is our partnership 
with our doctors around integrated care that we will offer through our insurance 
products and we’ll also contract with other insurance carriers as we take bundled risk or 
capitated risk going forward.” 
Medical Group Executive Director describes the group’s participation in a hospital ACO preparing to 
launch: 
“Yes, the hospital expects to have a full-blown ACO by January of 2014. We’ve already 
got three payers on board.”  
 
General Concept of Collaborating with Program Developers is Appealing 
All study participants (n=16, 100%) responded positively to the prospect of collaborating, in some 
general (unspecified) way, with the exemplar program developers to help them deliver the program to 
their service populations.  Initial phrasing of this question was intentionally vague and did not specify the 
specific means or financial requirements for such collaboration to occur.  The goal was simply to elicit a 
general feeling about creating a resource system–user system linkage of some (any) type.  Left 
undefined, responses to this question probably best correspond to a participant’s interest in some form of 
flexible, general consultancy or knowledge transfer, the parameters of which would be defined according 
to the user organization’s preferences.  It is also possible that some informants, despite the wording of 
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the question14, responded more to the idea of using the model than collaborating with the inventors.  
Some measure of caution as to what, precisely, respondents actually felt positive about is therefore 
warranted. 
Throughout the interview, if respondents asked about the financial implication of any of the 
collaborative models explored, they were encouraged to work under the general assumption that the net 
financial impact to the organization would be neutral or slightly positive.  Respondents were remarkably 
open to “going with” this assumption and seemed relatively willing to set aside financial considerations for 
the purposes of the interview, though there were frequent reminders that the cost and return on 
investment (ROI) of such a program would be an important consideration.  
From the Chief Nurse of a hospital system: 
“… I know that this type of rigor can really help a program be successful.” 
The ‘no need to reinvent the wheel’ response came up often: 
“we would love it. I mean, we—I don’t need to reinvent the wheel, so any technical 
support we could get would be great … ‘cause we sort of have training wheels, we’re 
sort of learning as you go …” 
In advance of specifying the types of collaborative partnerships to consider, this health system COO 
appears to have assumed that collaboration would come in some form of a learning collaborative as 
popularized by several leading knowledge purveyors: 
“I think it’d be a great idea. That only thing that comes to mind, is there’s lots of 
collaboratives out there today. So I would say one of the barriers is collaboration 
overload. You know there’s IHI, there’s Premier, and there’s a number of different 
groups out there, ACO collaboratives, all kinds of different collaboratives out there. So 
it’s really thinking through—and most of them don’t have proven approaches or 
products. They’re all out there, hypothesizing, and trying to stitch together evidence-
based elements to create a comprehensive program, so I would say one, the barrier is 
overload in collaboration, but I think two—I think most major health systems are trying 
to achieve this goal.” 
From a senior leader whose organization had previously adopted well-recognized models, but found 
they lacked sustained impact: 
“How would I feel about it? I would feel, optimistic. I think it’s different—you know, we 
have tried—I hope you don’t mind if I stray here, but we have tried things like the 
traditional parish nurse programs-and we’ve worked with some folks at [institution name 
redacted], looking at care management models that have not had any sustainable 
                                                       
14 “How would you view the possibility of collaborating with the developers of this program so that they 
could help you deliver the program to your patients?” 
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power to this point in time, I think probably, they’ve had some good training programs, 
but what they didn’t have is a performance reporting in a real structured management 
approach to the process, so it just kind of an undefined intervention. But yes, I would be 
open to working with the developers to consider it.” 
The interviewer’s identity and the HQP program was recognized by this informant thanks to prior 
newspaper coverage (Washington Post) shortly before the interview: 
Informant: “Are you involved in that demonstration project?”  
Researcher: “Yeah, I’m actually, as it turns out the head of the team that’s doing 
that.”  
Informant: “Oh man, how wonderful, is this? That’s—I just read the Ezra Klein 
article, and I had a friend of mine who called me, actually, the 
Comptroller of the state of Maryland, and said, ‘Is this what you’ve 
been trying to describe for me for the last five years?’ And I said, ‘Yeah, 
this is pretty much what I’m trying to tell you is the future of 
healthcare.’”  
 
Analysis by Collaborative Partnership Model 
A NEW Model Emerges from the Research: Replication Consultancy 
In response to the general question about their view of collaborating (in an unspecified way) with the 
exemplar program’s developers, a hospital CEO suggested an approach to make it happen: 
“… that’s why I say maybe … we contract with … your company for some sort of 
training, mentoring, on the job sort of thing for some period of time to help us build the 
program, and then off you go to the next one … I think it might be an interesting model 
to look at—maybe you already have — maybe where somebody from your team is 
literally onsite for one or two months, helps with recruiting, gets all of the policies and 
procedures, all that stuff, does the training, and then go to, once a month—doing a site 
visit once a month, once a quarter—some sort of regular phone calls, and maybe that 
kind of a model, where you really run your own program, and sort of wean, wean away 
from the consultants…. then you could—within the people that purchase this from you, 
you could share all the benchmarks and the metrics, and then… you could do the user 
group meetings.” 
 
This informant response along with others from this study was a major catalyst for HQP’s 
subsequent development of a new collaborative partnership model - replication consultancy.  This 
collaborative partnership model (described more fully in the Implementation Plan) consists of an intensive 
consultancy engagement the duration of which is dynamically assessed and defined by the user system’s 
demonstrated ability to implement advanced preventive care.  Several other informants either directly 
expressed or alluded to their interest in a consulting model that might be larger, longer, and more 
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involved than average consulting engagements, but still had a delimited timeline, scope of work, and led 
eventually to independence from the consulting organization / program innovators.  The end goal being 
that the user organization achieves a new level of capability with which they can continue to operate 
independently, having assimilated the new innovation and made it their own.  Several informants 
spontaneously expressed interest in this form of assistance emphasizing their strong desire to have their 
organizations become fully capable and independent in providing services like the exemplar program 
described in the interview. 
A health system VPCH, CIO expressed several concerns voiced by other informants related to 
collaborative partnership models needing to enable full assimilation of the model and the capabilities 
required to provide it for strategic, cultural, and integration reasons: 
“if we’re going to be investing in this, as an organization, I would want us to invest in it 
as a long term, strategic capability. And I would have concerns that an arrangement 
that was anything less than a fully employed arrangement would not give us a long-term 
sustainable capability, strategically, as an organization, that we would own, develop, 
and leverage in other ways. So that would be another concern. The third concern I 
would have has to do with culture. And we as an organization have taken the view that 
our culture is critical to our success, and I do have concerns that where you have an 
arrangement where you don’t employ folks—that you don’t have the same sense of—or 
the same - consistency of culture. And I think that is a potential problem in being able to 
accomplish our vision in the community and in the region. … I think that anything less 
than a full employment or fully integrated model runs the risk of further fragmenting 
healthcare delivery, rather than contributing to its integration.”   
A health system COO put it this way: 
“… we want to do is build this competency ourselves.  And not that we have to do it 
ourselves, but we believe that this core competency that you’ve just described is really 
the key competency of any future successful health system. So leasing that out and 
creating a distance from that competency, long term would-would be problematic.” 
 
Because the replication consultancy model was constructed through the analysis of data from this 
study after all interviews were completed and coded, it was not possible to collect reactions to or measure 
favorability ratings specifically for this model in the interviews.  However, the recognition of this interest, 
so strongly and clearly articulated by a number of senior leaders from hospital organizations in this study 
along with subsequent confirmatory impressions from others with whom HQP collaborated, led to the 
development of a replication consultancy model of collaborative partnership for use by HQP in 2014.  The 
first successful deployment of the replication consultancy model by HQP occurred in partnership with an 
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ACO in 2015.  This initial experience and plans for further development of and likely prospects for 
replication consultancy are described in the Implementation Plan and Discussion sections. 
 
Summary of Findings for Collaborative Partnership Models Assessed 
Across all informants and organizational types, 8 of 16 (50%) had a favorable opinion of the regional 
cooperative model, 7 of 16 (44%) had a favorable opinion of the direct service partnership model, and 6 
of 16 (38%) had a favorable opinion of the franchise model.  Across all informants and organizational 
types, there was also a roughly equal distribution of neutral/ambivalent and unfavorable/unfeasible ratings 
across the models as depicted in the figure below. 
 
 
The pattern changes however, when analysis is conducted within each major organizational type.  
Analyzing hospital organizations only (n=12); a roughly equal number of subjects rated the three primary 
models favorably (7 for direct service partnership, 6 for franchise, and 6 for regional cooperative), but the 
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Figure 5 - Favorability Ratings of Collaborative Partnership Models (All Organization Types, n=16) 
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direct service partnership had the least negative (unfavorable/unfeasible) ratings (0), while the coop 
model had the most negative ratings (3).  This is represented in Figure 5 below. 
 
Among physician organizations, the only collaborative model with any favorable rating was the 
regional cooperative model – (2 out of 4, 50%).  In contrast to hospital organizations which rated the 
direct service partnership as most favorable, physician organizations rated it as the most 
unfavorable/unfeasible model (3 out of 4, 75%) as shown in Figure 6 below. 
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Direct Service Partnership 
Overall, 7 participants (44%), (5 from larger health systems, 2 from smaller, rural hospitals) reported 
being able and willing to provide all 3 support elements required for the direct service partnership model.  
Most informants from hospital organizations seemed to have relatively little difficulty imagining using this 
model, recounting that they already had experience with the specific logistical subcomponents of this 
model: facilitating collaboration with PCPs, sharing data, and leasing back employees. Those favoring the 
approach saw certain advantages for their organization as noted in the quotes below. 
CEO: 
“I could conceivably see the same thing with that kind of program where, you guys or 
this vendor, or whoever it is, builds up a cadre of experienced managers—and, you 
know, basically—it’s our program, so to speak, but we hire you to manage it.” 
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Chief Medical Officer: 
“But in terms of co-managing employees for a program like this, I think that this 
organization would be very interested in it. Just because the mission and the principle 
behind it are very community-oriented, and this collaboration would expedite what we 
could do in this community with the patients that we have.” 
 
Four of five informants representing hospital organizations that were neutral or ambivalent about the 
direct service partnership model were unsure of the employee lease back component.  Two may have felt 
this way because they believed such measures were unnecessary to implement advanced preventive 
care; 
CEO: 
“I just don’t think it will be that difficult to do.” 
Corporate President, COO: 
“… my sense is that most of this stuff is fairly generic …” 
 
This raises the interesting question as to whether these potential users are underestimating the 
challenge of effectively implementing advanced preventive care or whether the program developers are 
overestimating the challenge.  These same two informants also hinted that the motivation of generating 
revenues and surpluses for the developer was perhaps an issue as well – quite apart from the ROI that 
might be realized by the adopting institution. 
CEO: 
“… somebody’s gotta make money, so there will be some sort of fee in there for you 
guys.  Which means it’s a more expensive program. … I guess the question is … do I 
really feel that’s a program that I couldn’t do on our own? …” 
Corporate President, COO: 
“… I think it depends on what’s the goal of the body that has the intellectual property.  Is 
the goal you know, advancing better healthcare and more coordinated care, advancing 
societal health status, or is the purpose making money …” 
 
These perspectives may indicate that some leaders are inclined to view with immediate suspicion a 
resource system support model that is perceived as intensive or expensive (even if this is objectively 
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necessary for program fidelity and reproducible effectiveness) as overpriced for something some systems 
already presume themselves capable of doing, should they choose to prioritize the development of such 
programs.  These are the kinds of perspectives that were considered (along with the organizational 
cultures preference for building programs themselves) in assessing an informant’s overall likelihood of 
partnering with the resource system – as discussed later in the analysis section. 
Other hospital leaders that were neutral or ambivalent about the direct service partnership model 
conveyed the sense that they wished to have the program was more completely under their control and 
more fully integrated as a core capability of their organization. 
CEO: 
“... I have to put on my competitive hat.  We as an organization want to own this as part 
of our core strategy, and so, I would not be very interested in putting someone into the 
mix who was not working on behalf of [organization’s name redacted] health care 
market position, relative to this. … We’re clearly interested in building a cadre of 
individuals who have this as a competence for the organization. So in the end we’re not 
interested in – we may not be, I don’t know yet – interested in someone to ultimately 
manage this on our behalf …” 
 
None of the four physician organizations in the study rated the direct service partnership model 
favorably.  For three (the two IPAs and one primary care practice) it was because some elements of the 
model such as data sharing and employee lease back options were not logistically feasible for them.  For 
the fourth, a medical group, it seemed less about feasibility and more about gaining a consensus between 
administrative and physician leaders; 
Executive Director: 
“I could see the health care system saying, ‘We’ve got this expertise [available], let’s 
bring them in.’  I could see the physicians saying, ‘We don’t need them … we could do 
this without them’.” 
 
Franchise Model 
Six participants, all hospital organizations (4 health systems and 2 smaller rural hospitals), had a 
favorable opinion about the franchise model. The reasons for supporting the franchise model included the 
opportunity for reproducible impacts and program consistency, rigorous management, and a sense of 
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positively combining direct local control of service excellence and customer experience with proven 
outside expertise.   
COO: 
“Well, the advantage that I would see is that you’ve got capitol intellect-that you’ll have 
more resources, more capitol intellect to pull from, so if the wheel’s been invented you 
don’t have to invent it and both can be resource-intense if you’re trying to do it from 
scratch on your own.” 
COO: 
“… I think it again goes to the idea of a little bit of innovation, it also goes toward having 
something that is sound, and that I know is sound, and why not allow that to be 
utilized?” 
Director of Research and Planning: 
“I think it has some potential to enhance, I have to say from a selfish standpoint—if the 
franchiser is—has a good image, brand, could link it to our local brand, I would hope it 
would strengthen the value that our residents would see that [Organization Name] is 
bringing to them.” 
VP Patient Care Services: 
“I think the thing that would be attractive—of course—is that you would have the model, 
but that you would have a little more control of the model. So that you get given kind of 
the blueprint but at the end of the day you’re really still kind of controlling the people 
and the processes, so you know, that may actually meet our needs more than some 
other models, where they’re more joint venture and you lose control of the people.” 
 
On the other hand, some informants perceived the franchise model as either unnecessary or a 
symbol of corporate business objectives that could run counter to person-centered care. 
CEO: 
“If I thought I couldn’t get qualified people, or I thought it was that complicated to 
manage, then I might consider that, but I just don’t see that as a problem. … what we’re 
thinking is, as the inpatient business shrinks I will shift people, and train people into 
more of the outpatient area to do this. So I just don’t anticipate it will be that difficult to 
do.” 
Corporate President, COO: 
“… it could be-it could be monetized through franchiser-franchisee relationship, but 
again, from [Organization's Name redacted] perspective, we believe that this is core 
and central to basic content knowledge and core competencies for any successful 
healthcare system going forward.” 
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IPA Executive Director: 
“My initial reaction to that is negative, just overall.  It just smacks of government 
bureaucracy and it further removes the doctor from the patient relationship. In order to 
do something like that, IPA’s would have to restructure—would definitely have to 
restructure, to have something like that.” 
Primary Care Physician, Practice Owner: 
“So franchises, you know, they’re branded. When I think of franchises, I think of 
McDonalds, you know? And franchises are business models and if you think of 
McDonalds, you know, the motto of reproducibility and efficiency etc., etc, all that stuff, 
that is of business, you know, we must be business people. But there’s a lot of business 
of medicine that has really driven our whole healthcare system in a totally ridiculously 
wrong direction and that’s what we’re trying to fix, so I think that the reason why I’m 
hesitant to allow a franchise to take over is that I just think that all of those sort of 
tendencies of businesses to get profit-minded and you know, to be bottom-line-minded 
could pose a real threat to patient centeredness.” 
 
Two interesting dimensions about the franchise model surfaced in the course of the interviews; 
branding (public vs. private) and the corporate status of the franchiser (profit vs. non-profit).  With respect 
to branding, while some informants suggested that a strong public brand might be welcome and adopted 
by their organizations, other informants were clear that that would be unacceptable and that a private 
label option would be necessary. 
VP Community Health: 
“I’d want to understand any branding issues, um, that might come with that, if we’re 
talking about private label franchising, versus branded franchising, you know, that might 
make a difference, but I can see the advantage to a franchise model.” 
CEO: 
“Absolutely. I don’t want anybody’s name between my market and the organization.” 
 
There was a range of opinion related to the importance of the corporate status of the franchiser with 
a somewhat greater overall preference favoring a non-profit status. 
COO: 
“If you have a-a real for-profit mentality coming into a real not-for-profit mentality, the 
clash there could get in the way.” 
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Chief Nurse: 
“I’m a nurse, and pretty naive about some things, but if I knew that somebody’s whole 
premise was that they wanted to help people, and that it was non-profit, and something 
came up that none of us anticipated, something beyond somebody’s control, I would 
tend to be a lot more forgiving than somebody that, every time I have a phone call, their 
hand is out. And especially when I see their name on the stock exchange or something 
like that.” 
COO: 
“It would not make a difference. Probably because of the culture here.” 
CEO: 
“You know, if you’re running your business the right way, whether your non-profit or for-
profit, I’m not sure there’s a whole lot of difference anymore.” 
VP Community Health: 
“… but I think if it were to be a branded franchise, then I would have concerns about it 
in any case, but if it was a for-profit organization, I would have even more concerns 
about that. Because I think there would be some challenges to our culture, if—as a non-
profit—this locally owned organization—if we were in the business of promoting a for-
profit national brand.” 
VP Patient Care Services: 
“I think our board of directors, certainly a place that was a not-for-profit probably feels a 
little better to them, since we’re a not-for-profit organization, but again, I think, you 
know, if we work through this, that is not a major deterrent. I do think at first blush, you 
know, our board of directors is always more interested in doing work and having 
partnerships with other places that are not-for-profit.” 
CEO: 
“It probably doesn’t matter. We’ve worked with both for-profit and not-for-profit.” 
Med Group, Executive Director: 
“I’d probably prefer it be it be a not-for-profit. But then, I’m a not-for-profit, and I think the 
goals are aligned differently in a profit and a not-for-profit. … when you talk about it 
being a for-profit organization, you kinda go, ‘well why wouldn’t we just figure it out 
ourselves? Instead of just using them’.” 
 
Regional Cooperative Model 
Eight participants in total; 6 hospital organizations (4 health systems and 2 smaller, rural hospitals), 1 
IPA, and 1 primary care practice rated the regional cooperative model favorably.  In the regional 
cooperative model developers can collaborate with an entity dedicated to creating a shared capability to 
deliver advanced preventive care across the population served by several health systems in a 
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geographical region.  The interest in a regional cooperative varied greatly based on the competitive 
landscape of an informant organization’s service area and the relative position of the participant’s 
organization within that marketplace landscape.  In areas where competition is stiff, health systems 
minimally communicate or coordinate efforts with one another, or prior cooperative efforts have failed, or 
the organization is the dominant player in the market, there is little appetite for this form of collaborative 
partnership. 
COO: 
“I think it’d be hard to pull off in this market. Each of the health care … are highly 
competitive with one another, each of the hospitals owns its own health plan. So the 
health plans compete with member’s lives. Each of the hospitals we compete head-to-
head very aggressively with one another… I think would be harder in the New Mexico 
community to pull off because of the competitive nature of health care in this 
community.” 
VP Community Health: 
“I think there would be greater value in integrating care within our continuum at 
[Organization Name redacted] than there would be in the value of collaborating across 
organizations. And I’d say that’s in part because we own such a dominant market-share 
in our region. You know, I think if we were a smaller player, from a market-share 
perspective then I might have a different view about that.” 
Corporate Pres, COO: 
“My opinion on that is that for smaller, less sophisticated systems, that that may be a 
reasonable solution.  I think that for larger, more complex systems, I think we would 
take a more collaborative model but with us driving our own future destiny.” 
CEO: 
“Well, if I got to pick and choose who the other individual organizations were in the 
collaborative I think we would be open to that.  If it allowed us to create you know, a 
competitive position, but if what it did was create value for the consortium and reduce 
the value of the underlying organization we’d be challenged with that.” 
IPA Exec Dir: 
“I doubt it. There’s gonna be mistrust, competition, uh—I really can’t see the hospitals 
working very closely with the practices, no. I don’t see that as something they'd jump on 
right away.” 
 
By contrast, in more rural or less competitive areas, and where there has been a prior track record of 
healthcare organizations within a region jointly cooperating this way, the regional cooperative model was 
very favorably received. 
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COO: 
“We serve about 22 counties … we do have some regionalization …	It wouldn’t be a 
huge challenge for us, here.”	
Chief Nurse: 
“That’s not dissimilar to some other things we’ve done on a small scale. … if it could be 
done, it would be very favorable. ‘Cause then potentially, you know, you wouldn’t each 
have to have … 10 of their own people doing things; you could potentially share 
resources.” 
CMO: 
“… there’s already been a lot of people who feel that the best way to bring healthcare 
here is to collaborate very closely with the Indian Health Service. Because that’s 
probably where we have most of the duplication of services, and people getting lost 
between the two hospitals—between the two services. So a regional one that actually 
looks at the total community needs, to me, would be better than, just like, this hospital 
participating, or the Indian Health hospital participating. … and there’s such a 
disconnect, and that’s probably one of our biggest population needs—in terms of 
chronic care and follow up, that’s one of the biggest populations. And if we did it with 
both hospitals, the results would be much better than if just one hospital did it by 
themselves.” 
Director of Nursing: 
“In our area, I think a model like that would probably actually work, we have other 
collaborative cooperatives going on right now with—we have [geographic region name 
redacted] Health Plan that’s a cooperative of all the health care organizations in the 
[geographic region reference], so there are other collaborations that are—that are done 
in this area, so I think that that would be something that could work.  I think um, the 
enticing part would be: …  maybe share resources, and, you know, maybe lower costs 
by the group taking on initiatives” 
Director of Research and Planning: 
“Very supportive. That’s what we’re intending to do, anyway, is create exactly that type 
of structure. For a lot of clinical service lines—you know, you’ve got three organizations 
in a triangle, geographically, between [Organization Name1, Organization Name2, 
Organization Name3 - redacted], we don’t overlap in markets, we have to be leveraging 
one another’s talents, and we haven’t done that historically, … We’re working on 
developing that. We’re using 3 or 4 critical specialties that give us the highest degree of 
what we think is the highest potential and probability of success and those are coming 
in to play over the next few months and I would say they will be fairly robust within a 12-
month period. And then we'll springboard from that into clinical service lines to show the 
rest of the physicians that they don’t need to be threatened by their peers in the 
communities a 100 miles away.” 
Primary Care Physician, Practice Owner: 
“I mean, I think that strikes me as way more appealing than joining a hospital-based 
ACO, because I feel like the hospitals are at cross-purposes, they might wind up being 
unified for purposes with us, but it’s a lot more appealing for us to think about this 
matter, as far as a regional sharing rather than a hospital-specific sharing… So patients 
like mine go to any number of four different hospitals, so it’s really made it impossible 
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for me, and very unfavorable, in addition to impossible, to really join an ACO that’s 
hospital-based.” 
 
The regional cooperative collaborative partnership model was the only collaborative model that 
received a favorable rating from any of the physician organizations.  The potential of realizing a regional 
cooperative model through its implementation within the structure of an ACO is an intriguing possibility 
explored more in the Implementation Plan.  
 
Table 11 - Count of organizations favorable to Three, Two, One, or None of the three collaborative 
partnership models investigated by organization type. 
 Three Models Two Models One Model None 
Hospital Organizations n=12 4 3 1      4 [a] 
Physician Organizations n=4 0 0 2 2 
Totals 4 3 3 6 
[a] 2 of the 4 informants from hospital organizations unfavorable to the models explicitly tested were self-
advocating what is described here as the replication consultancy model and seemed favorable to 
collaborating with program developers through that model. 
 
Who is Most Likely to Collaborate with Developers? 
High Likelihood of Collaborating 
Seven participants (44% of all study participants) were classified as having a HIGH likelihood of 
collaborating with the exemplar program developers (resource system) to bring advanced preventive care 
to their service populations, using one or more of the specific collaborative partnership models described.  
Of these, four were favorable to all three collaborative models.  Two had unfavorable assessments of the 
regional cooperative model and one of these was also neutral/ambivalent about the direct service 
partnership model.  Another was neutral/ambivalent about the franchise model. 
This cohort of likely collaborators also all (n=7) represented hospital organizations and had a 
favorable score on the “Do-It-Yourself Imperative” question, meaning that they described their 
organizations as positively valuing and/or had engaged in collaborative partnerships or had adopted 
programs developed by others.  They did not have an organizational culture that expected new programs 
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to be created only by their organizations.  Several also voiced their understanding of the difficulty in 
successfully and reliably implementing robust models like advance preventive care. 
There are significant limitations and systematic biases inherent in this study design that need to be 
carefully considered in drawing any conclusions about the likelihood of a collaborative partnership 
occurring between organizations like those represented in this study and the exemplar program 
developer.  These are considered in the Discussion section of this dissertation.  The pattern of past 
actions, operational context, and logical arguments provided by some informants in response to the 
questions asked in this study, strongly suggest that program innovators have an opportunity to facilitate 
dissemination of advanced preventive care by actively collaborating with at least some early adopter 
organizations. 
 
Lower Likelihood of Collaborating 
There was a wide range of factors that led to nine participants (56%) being classified as having a 
Low (n=4) or Moderate (n=5) likelihood of collaborating with exemplar program developers.  For three of 
these organizations, including the two particular IPAs and one primary care practice participating in the 
study, this was due to business limitations based on the size and nature of their organizations.  The same 
limitations might not necessarily apply to other IPAs or practices that did not participate in the study.  For 
other organizations (n=3) the “Do-it-Yourself Imperative” was unfavorable to adopting programs from 
outside the organization or working collaboratively with external partners to implement new programs.  
For others it was a combination of underestimating the rigor and need for disciplined implementation of 
the exemplar advanced preventive care model or preferring a level of support that wasn’t available in the 
collaborative models offered – especially one that was less permanent than the collaborative models 
tested, all of which obliged the adopting organization to sustain some type of perpetual linkage with the 
program developers. 
For many organizations the requirement of a perpetual linkage to the program developers appeared 
to significantly impede what otherwise might have been an enthusiastic willingness to collaborate with 
program developers even if for an extended period of time, but not an unlimited or undefinable period of 
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time.  For those participants, the replication consultancy model would provide a robust collaborative 
resource-user system engagement that is time-limited. 
 
Other Ideas Offered by Informants at the Close of the Interview 
The interview’s closing question soliciting any other thoughts the subject had about useful ways to help 
make the innovation (advanced preventive care) available to the populations served by their organization 
evoked a wide range of responses.  Below is a sample of some that seemed more useful in considering 
future strategies for dissemination. 
 
COO reaffirmed that the expertise of the innovators is not widely available: 
“Well, and I think you certainly—what you bring, that is intriguing to me, is a level of 
expertise that, again, I don’t have locally in the market. And my parent organization 
doesn’t have it.  My current organization already has a lot of wonderful resources for 
me. We have a Chief Medical Officer for Quality, we have a Vice President for Health 
Information Management, but for Care Coordination, we don’t have anyone. … There’s 
always a benefit to being a participant member in these types of things and that’s kind 
of my goal—is to be able to get your end product and see what I can learn to better 
myself and this organization from it.” 
 
CMO reiterated need to redesign care to be more community-integrated, proactive, and preventive: 
“Well, one of the reasons, after reading your initial letter, that I wanted to have this 
conversation, is that we definitely realize the need to have more things be done on a 
community level, like the health coaches—or whatever you want to call them—but it’s 
been difficult in this area and if there’s some kind of a program that could help us bring 
it here especially to those populations - the dialysis population and the diabetic 
population - that would be huge in decreasing our hospital readmissions and all those 
kinds of things. Which of course, in the future we’re not going to get paid for anyway.” 
 
VP for Community Health suggested that demonstrating the value of the innovation (if possible) 
within the context of a major payment reform initiative would promote dissemination: 
“If you could tie it to—for example, a CMS initiative-if there’s a way to tie it to—a benefit 
in a program that folks already have, you know a commitment to, and an engagement 
with, and be able to demonstrate that this program can add value in those areas—I 
think that would be—I think that would be helpful. And I think it would to the extent that 
you’re question’s about, how to better market this, and what would make it more 
appealing, I think that that would do both.” 
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VP(s) for Community Health (as well as other informants) saw similarities in key attributes of the 
HQP model of advanced preventive care to other well-tested programs with disciplined designs and an 
expectation of fidelity in replication, raising the question of whether dissemination strategies similar to 
theirs might also work for HQP: 
“I’m thinking about other models that are, maybe analogous to what you’re describing 
… the Nurse Family Partnership and the Centering Pregnancy. Or Centering Care. … 
those are, fairly proscribed models of care delivery—in the case of Nurse Family 
Partnership, it’s a model of care coordination—that are community-based and … health 
system-based—and have been promoted successfully around the country—adopted 
successfully around the country—where, essentially, the Centering Pregnancy is a 
franchise model where you pay a fee to be able to use their materials, and to be able to 
have training services, but you have to meet certain requirements in order to be able to 
participate. So anyway, those are a couple models that come to mind that have been 
successful and that we are using in our community— not [Organization Name], 
specifically, but our Health Department’s using the Nurse Family Partnership, and our 
competitor in town is using Centering Pregnancy, but I think they might be some models 
that you might look into, that might offer insight into how to do this, with the care 
coordination approach you’re talking about.” 
 
Corporate President and COO made a point about the innovator’s motivation and goal determining 
the approach to dissemination.  [Researcher Note (as CEO of HQP) – HQP believes that collaborative 
partnering to assist health care organizations to implement advanced preventive care may be necessary, 
not primarily to generate revenues for HQP as a business strategy, but to ensure faithful replication with 
sustained model effectiveness.]: 
“If the goal is, you know, evidenced based research and evidenced based program 
development, I think there’s plenty of great ways to share that in the industry today, 
through the Advisory Board, through various collaboratives that currently exist so I think 
there’s plenty of ways to share the information. Now as you transition to trying to 
understand a model, to trying to implement a model, you can sell consulting services, 
and programmatic implementation services and some of those you kind of mentioned 
today, with different relationship models, like employee lease-back and other regional 
oversight groups. But I think it depends on what’s the goal of the body that has the 
intellectual property. Is the goal you know, advancing better healthcare and more 
coordinated care, advancing societal health status, or is the purpose making money? 
So those are really different objectives. Not to say you can’t do both of ‘em at the same 
time but, I mean there’s probably twelve national collaboratives of significance, of 
stature, of credibility working on these accountable care methodologies and care 
management models, today. You know, so there’s plenty of ways to plug in if the goal is 
altruistic. If the goal is altruistic and to make money, then that’s a different model.” 
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SVP for Community Health, as did other informants, drew an analogy with the Nurse Family 
Partnership model and also suggested the use of community health workers in future models: 
“…this is reminiscent of a model that I’ve had some experience with, and I think it’s a 
phenomenal model, and that’s the Nurse Family Partnership model. But I’d also like the 
thought around having people that have a different skill set, maybe included or 
considered on this team. And I’m referring to community health workers, and the value 
that they bring to the table in terms of helping people navigate some of the more sort of, 
what we call social determinants of health.  … in terms of those social determinants, 
and those skills around navigating those elements just maybe consider adding another 
member to the team, or adding a nurse that also has a strong background in social 
work … But what’s great about the community health workers are they are a um—
particularly they are you know, natural members of the community, they have at least a 
high school diploma, but some of them don’t have much more than that, but they have a 
tremendous ability to get people to the resources and you know, really help move them 
from one point to another, whereas a nurse you know, I mean, she gets paid at a much 
higher pay rate, so--she can’t accompany a patient to an appointment, she can’t help, 
you know, make sure that the transportation connections get made, and you know, and 
I’ll sit here and wait to make sure--I mean, the nurse may make more phone calls, it’s 
just—in some ways that’s not the best use of the nurse’s time.  … And so one of the 
models emerging is we have community workers in neighborhoods and some of these 
people are from these neighborhoods. So they’re trusted, they’re respected, and that 
goes a long way, in terms of getting people motivated to do some of the right things.  
Coming from a trusted member of the community. And not to say that people don’t trust 
your nurses, but they trust them with medical things, but they may not trust them for 
those other elements that actually are a key part of health too.” 
Executive Director working with an outside company enabling ACO participation by physician groups 
suggests talking with such companies to offer the HQP model of advanced preventive care to improve 
their performance: 
“You probably would want to approach a [company name redacted]-type of company 
and say, “Look, I know you’re doing ACO’s, we have another very similar model and 
you’re already helping establish these. What about this concept? Could you roll it into 
the portfolio that you offer? Or could you take what we’ve done that you may not be 
doing in your ACO infrastructure to make it even more effective so that you’d achieve 
this 28% savings in delivering healthcare.” Because I don’t know if they’re achieving 
that, and when they aren’t, that’s money out of their pocket.” 
 
Executive Director described the challenge of being in the transition state between delivering care in 
a system optimized for fee for service reimbursements versus one designed to optimize the population’s 
health: 
“… we’re behind what you described, but we have the initiatives going on to get there. 
… the healthcare system’s been focusing on the ACO and the risk and so, for those of 
us in kind of the day-to-day arena, we’re struggling with saying, “Ok, we have one 
patient liaison for diabetes and one for you know, heart, but we could use 10, and you 
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know,” but the financing’s not there, and the way to pay for it’s not there. So, that’s kind 
of where we are.” 
 
Summary of Results: 
Among a likely set of early adopters of innovative models of care delivery, there appears to be 
positive interest in collaborating with program developers as a means to support the adoption and 
implementation of an exemplar model of advanced preventive care.  Hospital organizations appear more 
likely to utilize such collaborative partnerships than physician organizations, though the small number of 
informants from physician organizations is reason for caution in drawing this conclusion. 
None of the 3 collaborative models investigated was universally viewed favorably or unfavorably by 
informants.  All three had contexts in which they seemed likely to be supported by some informants. 
Among healthcare organizations that could reasonably be classified as “early adopters” of 
innovations in population health management and chronic care management, there is interest in engaging 
in collaborative partnerships with the original program developers of an innovation like advanced 
preventive care for chronically ill older adults.  Larger hospital-based health systems and smaller rural 
hospitals seem most interested in and capable of such collaborations.  In contrast, health systems with 
their own insurance divisions, independent practice associations, medical groups, and primary care 
practices were less inclined and/or have less capability to pursue such collaborations.  The small 
numbers of these latter groups of organizations participating in this study does not allow valid 
generalization broadly across these sectors of the health care industry. 
 
Even among early adopters there is a big drop-off between the level of general enthusiasm for adopting 
the model through collaboration with the innovators absent any specific criteria for how such a partnership 
is modeled as compared to reaction to specific forms of various collaborative models.   
 
Conclusion – The design and criteria set for collaborative partnership models impacts the potential for 
resource systems to play a role with user systems in adopting, implementing, and assimilating an 
innovation.  For those organizations highly motivated to adopt this innovation and to collaborate with the 
developers to do so, multiple strategies for collaborative partnering were viewed positively.  Among these 
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most motivated organizations, the direct service partnership, replication consultancy, franchise, and 
regional cooperative models all enjoyed some measure of support.   
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CHAPTER 5 – IMPLEMENTATION PLAN 
 
Overview and Aims of an Implementation Plan 
The aim of this implementation plan is to further the development of promising models of 
collaborative partnerships based on the results and insights obtained from this study.  More broadly the 
implementation plan is to advance HQP’s mission of developing and disseminating new, more effective 
models of advanced preventive care to improve the health outcomes of vulnerable populations, especially 
chronically ill older adults.  There are two dimensions of applied R&D related to improving prevention 
models in order for such work to make a significant contribution to public health; 1) developing effective 
programs and system redesigns that improve health outcomes, and 2) developing effective mechanisms 
to disseminate models proven to be effective.  This study has focused on investigating various forms of 
collaborative partnerships that might exist between program developers and program adopters to enable 
dissemination of advanced preventive care.  Both of these dimensions are daunting and complex and 
both require intentional planning, constancy to purpose, and committed resources.  Health Quality 
Partners has tried to pursue both of these areas of work in a manner that enables it, as a non-profit 
organization, to do so in a sustainable manner.    
The results of this study informs the implementation plan in several ways.  First, and most 
importantly, is the recognition that among early adopters there is a willingness to consider implementing 
advanced preventive care by directly collaborating with the program’s developers.  Among organizations 
appearing most likely to adopt advanced preventive care one or more models of collaboration were 
viewed positively, but no single collaborative partnership model was acceptable to all interested 
organizations.  Therefore, to the extent feasible, offering a few different models of collaboration would 
increase the probability of establishing productive linkages with organizations to facilitate program 
dissemination.  Second, informants spontaneously expressed their desire for an alternative collaborative 
option not presented to them during the research interviews.  The alternative model that emerged from
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 this research would enable HQP to intensively support, train, and advise the staff of another organization 
to learn the program, assimilate it, and implement it with fidelity, eventually becoming independent in 
doing so.  This new model of replication consultancy would allow organizations to gradually wean 
themselves off of HQP’s comprehensive and intensive support over time. 
What follows is a description of the variables taken into consideration in creating the implementation 
plan as well as the specific action steps it requires.  The key elements of this plan were presented to and 
approved by the HQP Board of Directors on March 25, 2016 as a strategy to achieve greater resilience 
and mission fulfillment. 
 
Resources: People, Funds, and Infrastructure Elements 
People 
HQP’s Board of directors, executive team, and staff, as well as HQP’s consultants (providing legal, 
business, IT development, and analytic services) would all be engaged to support this implementation 
plan.  Because of its long-standing work in this domain, HQP has developed a highly skilled and 
knowledgeable team of people with the experience and capabilities needed to execute an implementation 
plan such as the one described here. At its current staff size (n=22), HQP could implement, at most, 3 or 
4 simultaneous dissemination projects – depending on their size, scope, location, and timing.  While this 
organizational size is a limitation it has also proven to be an advantage in terms of maintaining a highly 
efficient, lower-cost structure enabling the team to weather significant discontinuities in projects and 
funding. 
Enlisting talented people through organizational partnerships has been critical to growing HQP’s 
organizational capabilities to support this work.  HQP currently has a legal/business consultant that has 
helped HQP configure effective contracts for work.  An IT development partner aligned through a shared 
revenue business arrangement as well as a shared mission has been instrumental in allowing HQP to 
develop a robust software application to support the large scale implementation and management of 
advanced preventive care.  HQP’s research partnership with the NewCourtland Center for Transitions 
and Health (University of Pennsylvania), has yielded several studies related to advanced preventive care 
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now in various stages of publication with more planned.  These organizational partnerships have been 
and will remain essential to HQP’s ongoing implementation plan. 
 
Funds 
In most cases, adopting organizations will also be the primary funding source, but supplemental 
funding may be possible in some cases through foundation or government grants or contracts.  Over the 
past 15 years, HQP has contracted with CMS, a health insurance plan, an ACO, and multiple health 
systems.  In all such cases these have been demonstrations programs or special projects by which 
sponsoring organization have funded HQP’s work through cooperative agreements or contracts for 
services and not through any ‘standard’ or ‘mainstream’ health care provider billing or payment 
mechanisms.  Nearly all of HQP’s program development and innovation costs have been covered through 
surpluses associated with these contracts (i.e., self-funded R&D).  It is expected that similar funding 
sources through new contracts with organizations desiring to adopt and implement or have HQP provide 
advanced preventive care will continue to support the implementation plan described here.  The funding 
from upcoming projects will depend on the size, scope, and duration of each project and the negotiated 
price for services between HQP and the adopting organization.  To date, HQP’s Board has not supported 
charitable fund raising as a funding option.  There is active consideration re: pursuing foundation or 
research grant funding either alone, or more likely, in partnership with other organizations already being 
funded through such sources.  For fiscal year 2015 (ending June 30, 2015), HQP had total revenues just 
under $3.5 million. 
As a rule of thumb, HQP prices its engagements to cover its costs (primarily staff salaries, benefits, 
and overhead on a time and effort basis) plus a 10% to 20% “mission/innovation fee”.  The mission fee is 
intended to provide ongoing support for new research and development including; the design and testing 
of new care models, research studies, or software development.  In situations where this pricing approach 
is not possible for a particular project that offers an especially good opportunity to advance HQP’s 
mission or strategic aims and objectives, HQP may forego the mission fee or cross-subsidize a project 
from the mission fees collected on other projects to enable such an engagement to move forward. 
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Infrastructure Elements 
A key infrastructure element required for utilizing collaborative partnership models to disseminate 
advanced preventive care is an IT application to support implementation in order to scale and standardize 
processes, training, and analytics to support program management to achieve fidelity to the model and 
service reliability.  For the past two years, HQP has been developing an IT application named SPERO® - 
(Latin meaning ‘I hope’) which is specifically designed to support teams to implement the HQP model of 
advanced preventive care.  In the development of this application, HQP has partnered with software 
development and data analytics company with experience creating such applications for use in health 
care.   
Integrated within the SPERO® platform are several infrastructural elements designed to support 5 
operational domains for reliable program implementation; policies and procedures, staff education, 
participant education, data management, and analytics (primarily management reports that assess 
performance and identify unwarranted variation).  SPERO® is deployed as a secure, scalable, cloud-
based, software as a service – requiring an ongoing subscription.  Through HQP’s partnership with an IT 
company helping to develop the application, the integration of large amounts of data is provided as part of 
the software subscription (e.g., CMS claims data supporting ACO operations).  The development of 
custom interfaces with electronic medical records or other systems is possible, but Web service and API 
(application programming interface) mechanisms for interacting with other systems is anticipated to be the 
most common means by which SPERO® will interact with other existing IT systems. 
The first deployment of this application occurred in July 2015 with an ACO collaborative partner 
using the application in the context of a replication consultancy agreement with HQP.  Subsequent to 
several improvements, version 2.1 of the application was released in June 2016.  HQP and its 
collaborative partners are expected to be fully utilizing this tool to deliver advanced preventive care before 
the end of 2016.  This asset, which will continue to evolve in terms of functionality and ease of use, will 
greatly assist in executing on the implementation plan described here. 
Because of the unique nature of this work and structure of the contracts required to support it, the 
contractual framework for such agreements might also be considered a valuable ‘infrastructural element’ 
for implementation.  The terms and conditions of such contracts have evolved over several years to better 
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support this work; some with pricing models based on FTEs and overhead costs, some on a PMPM basis, 
and others using a ‘hybrid’ PMPM plus gain share methodology.  The scope of services and each party’s 
expectations and accountabilities has also been refined in such agreements. 
 
Players Affecting the Change Including Key Stakeholders 
User Systems (Program Adopters) 
Based on the results of this study and the innovative nature and organizational commitment required 
to implement HQP’s model of advanced preventive care relatively few organizations are likely to be ready 
to adopt this model of care – perhaps 2% to 6% of hospital organizations (perhaps 8%+ if HQP brought 
the funding required through a third-party).  See the Discussion section for the rationale behind this crude 
working estimate.  With 3,183 community hospitals in the United States belonging to a health system15 
those percentages work out to an estimated count of 64 to 191 hospital organizations that are likely to be 
strongly interested in collaborating with HQP to adopt advanced preventive care.  Applying the same 
estimated uptake percentages to the 1,619 hospitals in a network in the U.S.9 yields 32 to 97 solid 
prospects for collaborating with HQP.  Though these numbers are relatively small as a potential 
“customer base”, given HQP’s corporate structure and mission, the fact that HQP doesn’t need (nor could 
it accommodate) more than 3 or 4 such projects of this type at one time, and that the goal is to credibly 
demonstrate proof of successful model replication with preserved (or enhanced) effectiveness, these 
estimates suggest that it is plausible that HQP could find a sufficient number of committed organizations 
to pursue this plan.  This is especially true if one considers that other types of health care organizations 
that might want to use HQP’s model of advanced preventive care did not participate in this study – for 
example, health insurance plans and ACOs.  There are currently 444 ACOs in the U.S. according to the 
Center for Medicare and Medicaid Innovation website.16  It is likely that at least a small minority of ACOs 
and health insurers would also be interested in adopting HQP’s model of advanced preventive care (HQP 
having already provided services under contract to one ACO and one health plan).  The numbers of 
                                                       
15 From American Hospital Association, Fast Facts 2016, http://www.aha.org/research/rc/stat-studies/fast-
facts.shtml  
 
16 Related web pages and links accessible from https://innovation.cms.gov/initiatives/aco/  
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serious inquiries and negotiations that HQP has recently concluded or is currently engaged in with health 
systems, ACO’s, and Medicare Advantage plans, offers further assurance that there is sufficient demand 
for HQP’s model to be able to launch a few collaborative partnerships to assess the feasibility of using 
these to test a resource system-facilitated approach to dissemination. 
Another group of stakeholders and potential program adopters HQP has not yet worked with are 
public health organizations at the federal, state, or local levels.  At the federal level this would more likely 
involve educational offerings, campaigns, or information sharing and possibly support for research 
assessing the impacts of advanced preventive care on population health and health disparities.  At the 
state and local levels there is a greater opportunity to potentially partner with public health departments 
capable of directly delivering advanced preventive care or partnering with other health care delivery 
organizations to do so – especially in the service of vulnerable populations identified by public health 
units.  In states in which the department of health has an active role in shaping health policy, 
collaborations have the potential to influence policy to encourage the adoption and broader testing of 
effective models of advanced preventive care.  Such was the case when HQP had the privilege to serve 
as the lead consultant on behalf of the Maryland Department of Health and Mental Hygiene in 2013 in 
support of a federally funded (CMS) state innovation planning grant. 
Identifying the minority of organizations that are early adopters and most likely to be interested in 
advanced preventive care has not been easy, especially absent a marketing function within HQP.  To 
date, the CEO and Medical Director at HQP has been primarily responsible for identifying and connecting 
with prospect organizations largely as the results of conference presentations, word of mouth referrals, 
inquiries prompted by journal publications, and HQP’s web presence. 
 
Tentative Timeline of New Program Engagements 
Given the typically long and unpredictable lead times required to identify collaborative partners and 
negotiate final agreements, the timeline for this implementation plan is unavoidably imprecise.  Broadly 
speaking, the goal is to engage three partners in the replication consultancy model; one by 1/1/2017, a 
second by 7/1/2017, and a third by 1/1/2018.  Each of these engagements is tentatively envisioned to last 
3 years and every effort will be made to incorporate a robust evaluation of the impact of model adoption 
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and implementation in each of these new settings – made easier through data capture and analytics 
available using SPERO®.  It is anticipated that these evaluations will support broader dissemination 
efforts (to the degree this set of replications is successful) or identify ways to redesign the replication 
consultancy partnership model to be more effective, or (most likely) a partial mix of both of these 
outcomes.  Should alternative opportunities arise, one or more of these intended replication consultancy 
projects could be substituted with; a regional cooperative implementation, expansion of an existing 
partnership contract, or other emerging opportunities. 
 
Candidate Target Populations 
There is no shortage of Medicare beneficiaries who could benefit from HQP’s model of advanced 
preventive care and who could contribute to generating a positive return on investment (ROI) - provided 
that reducing net total health care cost is a prerequisite for a positive ROI.  One estimate of this, based on 
the findings from the Medicare Coordinated Care Demonstration is that approximately 18.4% of all fee-
for-service Medicare beneficiaries would benefit from HQP’s model of advanced preventive care and 
provide a net savings to Medicare.17  According to CMS data18 there were 55.5 million Medicare 
beneficiaries in the U.S. in 2015 (both Original Medicare and Medicare Advantage members).  Eighteen 
percent of this population represents approximately 10 million beneficiaries nationwide that would be 
expected to benefit from advanced preventive care.  When targeting this higher-risk population by 
geographic region, there is typically an ample concentration of eligible beneficiaries to support efficient 
deployment of resources for advanced preventive care in an area.  However, this might not be the case in 
some sparsely populated rural areas or when the target population is further subdivided on the basis of 
other criteria, for example by particular insurance plan (in the case of Medicare Advantage).  In such 
                                                       
17 Based on unpublished analyses of MCCD data done under contract by Mathematica Policy Research, 
Inc. on behalf of the Medicare Chronic Care Practice Research Network (MCCPRN) and presented to 
MCCPRN stakeholder organizations February 2008.  The defined higher-risk group consisted of 
beneficiaries having (HF, CAD, or COPD and 1 or more hospitalizations in the prior year) OR (2 or more 
hospitalizations in the prior 2 years regardless of diagnoses). 
 
18 Available through Henry J. Kaiser Family Foundation at http://kff.org/medicare/state-indicator/total-
medicare-beneficiaries/#graph 
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cases, HQP has found mapping the distribution of home residence of target populations a useful means 
to assess the feasibility of program deployment in a given region for a given target subpopulation. 
Other vulnerable populations are also likely to benefit from models of advanced preventive care 
designed specifically to meet the multi-dimensional health risks prevalent in those populations, for 
example, younger Medicaid populations with high cost, frequent health care utilization, and poor health 
outcomes.  HQP will seek opportunities to apply its knowledge of and capabilities in program design and 
implementation to partner with organizations caring for such populations in order to help create or 
improve existing preventive care models for those vulnerable populations. 
 
Decision-makers 
To date, decision-making at the HQP organizational level has been relatively nimble and adaptive 
and generally does not pose a significant barrier to moving forward with this implementation plan.  The 
complexity of decision-making within potential adopting organizations varies widely – from being relatively 
straightforward with a single primary decision-maker to a complex array of decision-makers which some 
organizations coordinate fluidly and others barely at all.  For health systems, typically the CEO will have 
final approval responsibility for an engagement with the size, duration, and scope typical of advanced 
preventive care.  For health plans, a regional business unit head typically is the decision-maker.   
In HQP’s experience, the lead time from initial discussion to final contract has varied from 4 months 
to 2.5 years with most in the 4- to 6-month range.  HQP has adopted a standard approach of first 
providing organizations interested in collaborating with HQP a “concept proposal” and then a non-binding 
“terms and conditions” sheet prior to committing legal and senior team resources to drafting a binding 
contract.  Roughly half of all organizations provided a “concept proposal” do not ultimately engage HQP.  
Given the unpredictability of concluding a final agreement in any given time period, HQP often 
simultaneously negotiates more potential agreements than projects it can support in order to ensure that 
one or two come to fruition in time to sustain stable revenues and work. 
Similarly, once a project is underway, early contract termination can occur unpredictably.  In the case 
of the two most recent terminations, these were not because the model failed to perform well, financially 
or operationally, or because there was dissatisfaction with the service provided by HQP.  In both cases, it 
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appears that a “corporate” decision above the level of the implementing unit was made to change 
strategy, programs, or vendors. Shortened engagements are disruptive to proving the effectiveness and 
replicability of models and to the operational and financial stability of HQP.  Increasingly, HQP is 
attempting to develop contracts requiring a longer-term engagement (for example, three to five years) that 
include early withdrawal penalties. 
 
Contextual Parameters 
As noted in the overview at the start of this chapter, two streams of development are needed to 
achieve widespread use of effective models of advanced preventive care; 1) the design, testing, and 
validation of advanced preventive care delivery models, and 2) the design, testing, and validation of 
models for disseminating these care innovations.  These two streams of work are unique, but 
interdependent, and can inform one another if conceptualized as parallel development tracks.  HQP is 
firmly committed to advancing applied R&D to both these streams of development.  Though ambitious, 
such a ‘dual-aim’ may be necessary to fulfill HQP’s mission and to sustain its funding, provided that 
helping others adopt advanced preventive care provides a revenue stream to support HQP’s ongoing 
R&D.  The contextual parameters relevant to HQP’s continued efforts to advance both these streams of 
work are considered. 
 
U.S. Domestic Policy 
In the current context of U.S. health care, policy-makers and payers are demanding greater 
accountability for the quality and cost of care.  This has spawned an explosion of entrepreneurial activity 
with many new products and services (mostly software and analytics) geared toward population health, 
care coordination, and care management being offered in the marketplace.  Meanwhile, the amount and 
quality of research directed toward creating more effective models and systems of care has in many ways 
lagged behind.  It would appear that the prevailing assumption is that if health care systems are subjected 
to increasingly strong financial incentives to move from “volume to value” that they will find both the 
motivation and the wherewithal (resources, knowledge, skills, and practical know how) to conduct 
whatever R&D is necessary to successfully redesign the system of care. 
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To date, the principal approach CMS has taken to support care delivery innovation (distinct from 
payment reforms) has been to promote the discovery of new models of care that can reduce health care 
costs while sustaining or improving quality by providing nearly $900 million dollars in funding through the 
CMMI-sponsored Health Care Innovations Award (HCIA) program.  Through this program, CMS 
competitively selected and funded three-year evaluations of 146 projects (107 in round one and 39 in 
round two) from around the country that health care organizations proposed to CMS.  The first (and to 
date only) program evaluated in the HCIA that has been certified by the Medicare actuary as cost-savings 
to Medicare is a lifestyle intervention program to prevent diabetes among individuals with pre-diabetes.19  
The overall value of the HCIA program with regard to identifying and promoting more effective models of 
care delivery will probably not be evident for several more years.  In partnership with another health care 
organization, HQP submitted one of the nearly 3,000 applications to the HCIA program that was not 
funded in round one.  
The impetus to drive change through financial incentives comes from many sources, most notably 
the federal government policymakers at CMS utilizing a variety of initiatives that include; hospital (as well 
as skilled nursing and home health) value-based purchasing20, hospital readmission reduction program21, 
bundled payment programs (BPCI22 and CJR23), accountable care organizations24 (Pioneer, Medicare 
Shared Savings Program, Advanced Payment ACO, Next Generation ACO), and the merit-based 
                                                       
19 It is interesting to note that a preventive lifestyle intervention of this kind could as easily, and for some, 
more appropriately, be thought of as a public health as opposed to a health care service.  The fact that it 
is being considered for authorization as a billable service within the fee-for-service Medicare program 
raises some interesting questions regarding the jurisdiction and influence between U.S. federal agencies 
responsible for health care financing and public health.  Does this suggest that public health policy in the 
U.S. will increasingly be defined by CMS? 
 
20 https://www.cms.gov/Medicare/Quality-initiatives-patient-assessment-instruments/hospital-value-based-
purchasing/index.html  
 
21 https://www.cms.gov/medicare/medicare-fee-for-service-payment/acuteinpatientpps/readmissions-
reduction-program.html  
 
22 https://innovation.cms.gov/initiatives/bundled-payments/  
 
23 https://innovation.cms.gov/initiatives/cjr  
 
24 https://www.cms.gov/Medicare/Medicare-Fee-for-Service-Payment/ACO/  
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incentive payment system25.  In January 2015, the Secretary of Health and Human Services, Sylvia 
Burwell, announced the agency’s goal to have 50% of all payments for Original (fee-for-service) Medicare 
to be made through Alternative Payment Models by the end of 2018 and 90% of all payments tied to 
quality or value in that same time frame.  The expectation is that the incentives in the Medicare Access 
and CHIP Reauthorization Act of 2015 (MACRA), which repealed the Sustainable Growth Rate (SGR) 
formula, will further augment the achievement of these goals by providing strong economic incentives for 
physicians to participate in eligible Alternative Payment Models. 
In many cases, non-governmental health insurers have adopted similar, or complementary incentive 
programs.  Such policy initiatives have been essential in motivating health care organizations to consider 
adopting more care coordination, care management, population health management, and preventive care 
strategies in order to optimize the related array of financial penalties and incentives. 
 
U.S. Health Care Marketplace 
There has been considerable consolidation in the provider, insurance, consulting and management 
sectors intended to enlarge the number of “lives” under care or insurance coverage.  The impetus to get 
bigger has been fueled by the shift toward population-based payment models.  There are now 444 CMS-
sponsored Accountable Care Organizations in the U.S.  Most of these are newly developed and are still 
struggling to implement infrastructures and systems to support the population health and care 
management interventions that are believed to be necessary to succeed over the long run in such 
payment models.  Most have not yet begun to transition to assuming financial risk for the overall cost of 
care to the populations they have enrolled.  For some policy makers the current status is seen as a 
transitional state along an evolutionary path from traditional fee-for-service payment to full capitated risk.   
Along with the rise of the ACO model has come increasing discussion among health systems 
regarding the strategic value of implementing their own health insurance offerings.  In some cases, health 
insurance companies are exploring creative ways to partner with health systems to provide such 
offerings.  This volatile marketplace environment has fueled the growth of health care consulting and IT 
                                                       
25 https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Value-Based-
Programs/MACRA-MIPS-and-APMs/MACRA-MIPS-and-APMs.html  
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services, and various types of multi-provider convener and management service organizations.   Most of 
these services focus more on the business (strategic and transactional) requirements of new payment 
models and seizing marketplace opportunities than on care delivery models, though they may 
acknowledge the importance of or provide limited care coordination.  Notwithstanding the overlap with 
some of these services, HQP has a distinct history, experience, evidence-base, and comprehensive 
approach to advanced preventive care that helps to distinguish and differentiate it from other offerings in 
the marketplace. 
The complexity of the marketplace can even make utilizing incentives challenging.  For example, 
allocating shared savings resulting when a reduction in cost can be achieved has become increasingly 
complex with multiple parties often seeking to be identified as contributing to such savings.  Questions 
about who gets credit for savings and how rewards are shared grow more complex as the number of 
players interacting in novel new organizational or financial arrangements increases. 
Market forces have also stoked the proliferation of and competition among health care quality, 
management, and IT knowledge purveyors.  In this study, some informants were very satisfied with and 
clearly favored receiving support for adopting innovations from well-known knowledge purveyors.   These 
informants seemed unconvinced that the experience and expertise of a resource system was necessary 
or more valuable than the advice of knowledge purveyors, which were often seen as easier to access and 
more cost effective.  It seems unlikely that organizations with a strong preference for working with 
knowledge purveyors would be persuaded to invest more time, money, and commitment to a developer-
supported method of adoption and implementation.   These would not be considered good prospects for 
HQP to target for possible collaboration.   
It has been HQP’s experience that organizations interested in investing resources for care delivery 
redesign most often have tried less intensive approaches to care coordination or population health 
management and found them to be inadequate.  There appears to be an organizational learning curve 
that obliges many organizations to try out lower cost, less intensive and complex interventions before they 
are prepared to consider more robust models like advanced preventive care. 
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International Context and Opportunities 
The need to find more effective care delivery models for aging populations with multiple chronic 
conditions is not unique to the U.S.  To date, HQP’s presentation of its model of advanced preventive 
care to a limited set of international audiences has been well received.  Discussion is currently underway 
with one non-profit secondary health plan in Australia that is considering introducing HQP’s model of 
advanced preventive care in that country.  It could help to develop opportunities for HQP by finding the 
means to establish more collaborations with organizations and governmental policy makers outside the 
U.S. 
 
Actions to be Taken by Health Quality Partners 
Develop a Portfolio of Collaborative Partnership Models 
With the addition of the replication consultancy model HQP now has two defined collaborative 
partnerships models with which it has operational experience and a proven business and contractual 
framework; direct service partnership and replication consultancy.  The next collaborative partnership 
model HQP would like to add to its growing portfolio is the regional cooperative, though doing so will take 
the existence of a use case that combines multiple health care systems willing to cooperate with one 
another in a given region and a funding stream and business model that could conceivably sustain such 
work.  These circumstances seem increasingly likely where multiple small regional providers organize to 
form Clinically Integrated Networks (CIN) and ACOs in order to respond to changing health care market 
forces and pursue emerging alternative payment mechanisms.  In this context it is entirely possible that 
the two models of replication consultancy and regional cooperative will overlap or both be applicable in 
some circumstances. 
The franchise model has an appeal and might be both a viable business model and a useful 
mechanism for disseminating advanced preventive care, but requires considerable business strategy, 
legal development, capital investment, and marketing; none of which are assets that HQP has or wishes 
to develop at the expense of its core mission.  There is also a greater business risk associated with this 
model.  As such, the franchise model would be more suitable if HQP was working in partnership with one 
or more corporate entities interested in developing such a model.  Even if this was the case, there is a 
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risk of HQP’s work being redirected from its core mission of undertaking applied R&D to growing a 
business venture. 
 
Develop Replication Consultancy as primary means of dissemination 
At the time the study interviews were conducted, HQP had not tried to implement a project using 
replication consultancy and had not begun to develop a set of criteria for such a model.  While the 
replication consultancy model was not explicitly probed in this study, nearly all of the study participants 
with a high (n=7) or moderate (n=5) likelihood of engaging in collaboration with a resource system 
expressed their interest in some level of consultation from the “experts” (program developers).  A key 
parameter, not quantified in this study, is how much service they would agree to in terms of intensity, 
duration, and scope. 
As key informant interviews were being transcribed, reviewed, and preliminary analysis performed in 
2014, a new form of collaborative partnership began to come into focus.  In the course of discussions in 
late 2014 with organizations expressing interest in adopting HQP’s model, the details of the scope of 
services, duration, and legal terms for replication consultancy were defined.  Beginning in January 2015, 
the first use of this model enabled HQP to assist an ACO in Pennsylvania, comprised of 3 separate 
organizations, and responsible for 33,000 beneficiaries in the Medicare Shared Savings Program (MSSP) 
to begin to implement HQP’s model of advanced preventive care.  The work included HQP supporting the 
ACO’s selection, training, and mentoring of nurse care managers and senior management.  Data 
analytics for population targeting and outreach, and an IT platform (SPERO®) designed by HQP for 
supporting teams to undertake and manage day-to-day implementation of the model was also provided to 
the ACO.  The experience from this first attempt to utilize the replication consultancy model confirmed its 
utility and feasibility.   
The model seems especially well-suited in cases where HQP is not bringing the funding for program 
implementation and local staff implementing the program are directly and solely employed and managed 
by the adopting/implementing organization.  HQP is now in discussions with other organizations 
interested in receiving the same kind of collaborative partnership support.  The model establishes a 
framework of rigor, intensity, and sustained commitment that HQP’s program developers believe is 
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essential, while providing an opportunity for customization of the implementation plan to support a range 
of client preferences and needs. 
 
SPECIFIC ACTION STEPS (in 2016):   
HQP will seek to execute a new contract with at least one organization to implement HQP’s 
model of advanced preventive care using the replication consultancy model.26 
 
HQP will propose to a major health insurance company a pilot test of replication to serve 
higher risk Medicare Advantage members in areas beyond southeast Pennsylvania using the 
replication consultancy model. 
 
Continue using Direct Service Partnership for local service 
Of the 7 participants most likely to partner with the developer, 6 (86%) indicated that they were able 
and willing to support the elements of the direct service partnership model.  This model has been used 
successfully for many years to support delivery of advanced preventive care by HQP in southeast 
Pennsylvania.   
HQP has been able to provide advanced preventive care to; 1) selected higher risk Medicare 
Advantage members in 6 counties of southeastern PA (now in year 7), 2) beneficiaries previously 
participating in the MCCD (4/2002 thru 12/2014), and 3) heart failure patients previously participating in a 
Model 2 version of CMS’ Bundled Payment for Care Improvement (BPCI) (1/2014 thru 12/2015).  These 
projects were made possible by HQP collaboratively partnering with regional hospital-based health 
systems using the direct service partnership model. In this collaborative partnership model, partnering 
health systems provide HQP with HR support, including recruiting and hiring staff which are then leased 
back to HQP, data related to hospital discharges and diagnosis codes, and introductions to system-
affiliated primary care and specialty practices. 
                                                       
26 HQP is currently in contract negotiations with a large out-of-state (non-Pennsylvania) medical group 
that also has a Medicare Advantage plan interested in utilizing replication consultancy to implement 
advanced preventive care for their Medicare Advantage members. 
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In March 2016, HQP began serving a hospital-based health system under a 5-year agreement to 
provide a range of services including; system redesign to establish care management across the 
continuum of care, analytical and consultative services, and a nursing team to deliver HQP’s advanced 
preventive care to help transform the organization into one with a robust population health management 
capability.  The advanced preventive care component of this engagement is being implemented by HQP 
through a direct service partnership. 
Though there are several benefits to the direct service partnership model used by HQP, there are 
significant limitations, in its current format – most notably the need for management and supervisory staff 
at HQP to be geographically accessible to implementation regions in order to directly manage the 
program on a day-to-day basis.  To date, HQP leadership has been reluctant to attempt the level of 
management oversight, staff training, development, and mentorship the model requires by remote 
distance telecommunications methods alone.  Applying this approach at greater distances will require 
innovation by HQP with respect to providing senior management support through more ‘virtual’ web and 
teleconferencing and/or by temporarily posting senior nurse care management staff on-site in the early 
stages of program implementation.  The model is also most readily adopted when program funding flows 
through HQP. 
For these reasons, despite the fact that several study participants indicated they would be able and 
willing to provide the three elements required by HQP to implement a direct service partnership (HR 
support and employee lease-backs, data, and introductions to primary care providers), this model is 
probably less feasible for HQP to use for dissemination than the replication consultancy model. 
 
SPECIFIC ACTION STEPS: 
HQP will continue to use the direct service partnership model to deliver services in its 
primary service area of southeast Pennsylvania. 
 
HQP will utilize the direct service partnership model for dissemination only as a secondary 
alternative to replication consultancy if specific circumstances warrant and appropriate 
adaptation could be made. 
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Develop an IT Platform (SPERO®) to Support Dissemination 
Though not the primary focus of this research, a full implementation plan must include the 
development of an information technology tool that can help guide and support organizations wishing to 
adopt and assimilate HQP’s model of advanced preventive cares.  For the past two years, HQP has been 
developing its third-generation application to support implementation of advanced preventive care in 
collaboration with an IT software development firm.  Version 2.1 was released June 2016.  It is capable of 
supporting scalable dissemination and would be included as part of the full offering made available to 
adopting organizations through a replication consultancy engagement.  Because advanced preventive 
care involves much more than merely learning a suite of IT applications, HQP’s current plan, is to make 
SPERO® available only to organizations engaging HQP through replication consultancy. 
 
SPECIFIC ACTION STEPS: 
HQP will use SPERO® for its own delivery of advanced preventive care and to support all new 
replication consultancy partnerships. 
 
SPERO® will not be offered as a stand-alone software product at this time, but might be after 
proof of successful model replication in one or more sites has been confirmed. 
 
Enhance Research Partnerships  
For the past few years, HQP has cultivated a collaborative partnership with the team of researchers 
at the NewCourtland Center for Transitions and Health at the University of Pennsylvania, directed by 
Mary Naylor, PhD, FAAN, RN who is also member of the Board of Directors at HQP.  As a result of this 
collaborative research, joint publications are expected on several key elements of advanced preventive 
care, including; advanced planning and end of life care, participant engagement, and assessing risk 
factors and determinants of health. The first article published as a result of this partnership focused on the 
relationship between the pattern of nurse care manager contacts and sustained participant engagement 
(Toles et al. 2015). 
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The research emerging from this partnership has several benefits including; improving the 
knowledge base related to advanced preventive care, helping to market HQP’s work (at least for in some 
circles), and helping to influence policy and achieve sustainability by demonstrating credible evidence of 
effectiveness. 
 
SPECIFIC ACTION STEPS: 
HQP will continue to work with the research team at the University of Pennsylvania to 
complete research projects underway and to proactively identify new research opportunities 
related to upcoming dissemination projects (e.g. replication consultancy) undertaken by 
HQP. 
 
HQP remains open to research collaborations with other academic teams in nursing, health 
services research, public health, system analysis, and health economics. 
 
Establish opportunity development partnerships 
HQP was recently invited by the Camden Coalition of Healthcare Providers (CCHP), located in 
Camden, NJ and led by its Executive Director, Dr. Jeffrey Brenner, to consider how it might participate in 
helping CCHP develop a National Center for innovating and disseminating models of care for vulnerable, 
complex populations.  Several foundations interested in developing such a center are reported to have 
committed $8.7 million in funding.  Discussions are currently underway between the leadership of CCHP 
and HQP to explore areas of overlap between the emerging goals of the National Center and those of 
HQP as outlined in this implementation plan.  Collaboration of this type could help HQP garner additional 
support for elements of the implementation plan described here and further the mission of the National 
Center. 
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SPECIFIC ACTION STEPS: 
HQP will explore the possibilities of participating in and supporting the National Center being 
developed by the CCHP.  HQP will also seek to participate in or, as appropriate, lead projects 
sponsored by the National Center. 
 
HQP will continue to seek collaborative partnerships or organizational affiliations that can 
further its mission and has the potential to advance this implementation plan. 
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CHAPTER 6 – DISCUSSION 
 
Limitations 
There are many potential limitations, biases, and errors to consider in attempting to categorize a 
study participants’ overall willingness to engage in collaborating with developers of a program of 
advanced preventive care as presented in this study.  These include, but are not limited to; 1) intentional 
suspension of concerns related to financial requirements for implementation, 2) participant recognition of 
interviewer and exemplar program developer as one and the same (interviewer not a disinterested party), 
3) error in the researcher’s basic characterization of participant responses to specific individual questions 
and overall likelihood to collaborate with the program developer, and 4) the subjectivity of the 
researcher’s judgment in assigning an overall likelihood of interest in adopting one or more collaborative 
partnership model to work with the program developer based on the pattern of informant responses 
across all questions.   
In some cases, the strength and/or nature of the affinity or rejection of certain models by 
respondents was relatively clear cut and straightforward as was their overall enthusiasm or skepticism 
about collaborating with program innovators.  In any case, this kind of “reading” of another person’s 
interest level or intention is a process that goes on daily in exploring the potential for collaboration so it is, 
in a sense, the very imperfect human process upon which most real world collaborative relationships are 
built (or not).  To the extent the researcher has participated in many partnership explorations over his 
career; many of which have succeeded and considerably more that have failed, he is likely to be no less 
and perhaps somewhat more qualified to make such assessments than less experienced individuals.   
The fact that these respondents were highly self-selected, introduces a systemic bias that frames 
this entire set of results, which should not be presumed to represent the general thinking of health care 
executives from these organizations broadly across the U.S.  Given the framing of the research provided 
in the invitation letter, it is much more likely that those agreeing to participate in this study already view 
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this topic as important and worthy of their limited time and attention.  It would not therefore, be 
unreasonable to hypothesize that, as a group, these informants are better informed about and supportive 
of championing models of care coordination, care management, and population health management. 
It is impossible to control for the recognition by many participants that the interviewer was an 
invested and not disinterested party.  This could have led to an overly positive response by participants.  
Consideration in the planning phase of the research was given to hiring a neutral third-party to conduct 
the interviews, but cost, logistics, and the learning opportunity afforded to the investigator by conducting 
the interviews was determined to be the more important set of considerations.  It is noteworthy, however, 
that even with whatever global bias toward greater participant positivity this may have created, many 
participants did nonetheless, express keen differences in their preference for specific collaborative 
partnership models.  Hence, it is likely that in spite of this global bias, useful information was garnered. 
 
Leading with Exemplary R&D to Propel Advanced Preventive Care 
The Implementation Plan is premised on the belief that additional evidence of real-world 
effectiveness of advanced preventive care and the demonstration that it can be disseminated will compel 
changes in health policy, health care financing, and market forces that will enable broader dissemination 
of this and like models of advanced preventive care to a degree that will ultimately improve the public 
health. An alternative plan, by which HQP would seek to maximally leverage the existing evidence-base 
demonstrating the effectiveness of the HQP model and prioritize business development to offer products 
and services currently in demand in the marketplace in order to optimize revenues was rejected on the 
grounds that it is less aligned with the mission of the organization and values of its staff, would diminish 
HQP’s distinctive “brand” and identity that differentiates it from many others in the marketplace, and 
would diminish participating in the significant applied research still needed in this field to advance it 
further.   
The plan also depends on its execution being feasible – that there are sufficient practical 
opportunities to demonstrate dissemination with sustained effectiveness for there to be a chance for it to 
work.  While plausible, this road is long and the challenges daunting, especially for a relatively small 
organization with limited funding.  Fortunately, HQP and other organizations like it can gain strength and 
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capacity through partnerships and can take advantage of a well formed vision, a deep commitment to 
mission, and constancy to purpose.  These attributes are likely essential for developing new, more 
demanding, but more effective models of preventive care – especially if they are unlikely to be financially 
profitable in the short term.  
The full potential for achieving the possibilities described will also depend, as the evidence grows, on 
political advocacy and public awareness through news and other media outlets.  HQP has past 
experience with both; having mobilized support from the Pennsylvania Congressional delegation and 
other members of the U.S. Congress to extend the MCCD, and having collaborated with journalists to 
provide excellent coverage of HQP’s accomplishments and care model through easy to understand 
stories (Klein 2013). 
 
Crude estimation of HQP’s opportunities to execute the Implementation Plan 
Of the seven most likely collaborators, all are hospital organizations; five are hospital-based health 
systems and two are small rural hospitals.  If one focuses only on hospitals organizations, then these 7 
came from a pool of 12 such organizations participating in the study yielding a crude point estimate for 
collaboration among hospital organizations of 7/12 = 58% (with a 95% confidence interval lower limit of 
30%).  The current study was not designed to accurately measure this rate, but as a ‘thought experiment’ 
for strategic planning and feasibility assessment purposes further extrapolation is useful. 
The crude point estimate of 58% of hospital organizations collaborating with a HQP-like resource 
system under the conditions of the study, significantly over-estimates the percent of hospital 
organizations nationally likely to engage in collaboration with exemplar program innovators for at least 
three major reasons.  First, knowing or suspecting that the interviewer was the lead developer of the 
program being discussed, informants are more likely to have been positive about developer-user 
collaborative partnerships and the exemplar program during the interview out of social politeness and 
courtesy.  Second, even if the sentiments and opinions of informants were honest that still is no 
guarantee that they would, in fact, act in accordance with their answers.  Third, the interview approach did 
not consider any financial constraints exist in any actual implementation and would further reduce the 
number of interested organizations able to pursue such an initiative.  And finally, as previously described, 
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the self-selected set of informants participating in this study are more likely to be “early adopters” of 
innovation than would members of a random sample of U.S. health care organizations.   
Applying the very general and arguably debatable rough estimate that 13.5% of all organizations in 
any industrial sector have attributes of early adopters (Rogers 2003, 281), one can “adjust” the 
collaboration rate for hospital organizations derived from this study to estimate the general rate among all 
hospital organizations.  Multiplying the current study estimate for hospital collaboration by the fraction of 
organizations believed to be early adopters yields a very rough approximation of 58% (CI95: 30%, 86%) x 
13.5% = 8% (range of 4-12%) of all hospital-based organizations in the U.S. being likely to collaborate 
with HQP to adopt advanced preventive care for chronically ill older adults (less whatever number of 
organizations believe they have already adopted an equivalent model, which, based on interviews in this 
study, is likely to be a small percentage).  But even this estimate may be too optimistic for real-world 
utility, because it ignores the financial impacts and costs that must be considered for actual collaboration 
and program implementation.   
Since this study did not include considerations of how or to what extent user systems can finance the 
adoption of advanced preventive care programs or support collaborative relationships such challenges 
must be considered in developing an actual implementation plan for diffusing this model of care.  
Similarly, the study did not assess the extent to which marketplace competitors (with or without evidence-
based programs) vying for this same business with health systems might erode opportunities for 
collaborative partnerships between organizations like HQP and user systems.  Based on these other 
factors, it might be prudent to cut the earlier estimate in half – to say 2% to 6%.  As a rough, working rule 
of thumb, HQP will apply this estimated range for modeling the potential number of hospital organizations 
(2-6%) interested in engaging in a collaborative partnership with HQP to help them adopt, implement, and 
assimilate advanced preventive care. 
Another practical way to think about this challenge is to assume that if HQP can fully finance the 
project itself (for example through grants, demonstrations, or third-party payers or investors) or a health 
system already has a compelling business case for a return on investment (ROI) – the likely uptake rate 
of collaborative partnering with hospital-based organizations might well be closer to 8%.  This equates to 
roughly one out of every 12-13 health systems/hospitals. 
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With current health care payment and insurance reforms underway, the likelihood that hospital 
organizations will have or will become part of a larger network of organizations that will have a compelling 
business case for implementing effective advanced preventive care is increasing.  Even if HQP cannot 
bring full funding on its own, the advanced preventive care program will likely become more attractive to 
health systems and hospitals as payers increasingly push these organizations toward more population 
and value-based payment models, including various types of risk-contracting.  For example, while most 
study participants were not involved in risk contracts at the time of their interview, 10 of 16 (63%) 
anticipated exploring or implementing these kinds of payment models in the near future.  These forces 
would be expected to increase the ROI and downstream cost offset for advanced preventive care 
programs from the health systems’ perspective.  HQP has observed this to be true as reflected by a 
greater number of inquiries it has received from health systems, hospitals, and clinically integrated 
networks participating in ACOs in the past two years. 
From the perspective of many growth-driven organizations seeking to increase revenues, this 
relatively small customer segment of early adopters may lack the critical mass needed to achieve certain 
business objectives.  From the perspective of a small, non-profit resource system with a mission of 
undertaking applied R&D to advance better models of health care for vulnerable populations, the 
relatively small number of potential adoption partners is not a problem, provided they can be identified, 
contacted, and engaged. 
 
Policy Implications 
Presumably as evidence of program effectiveness and the feasibility of dissemination is 
strengthened and becomes more widely appreciated, policy makers will want to develop new standards 
and incentives for health care organizations to adopt and utilize such models broadly.  For this new 
category of intervention, given that the effectiveness of program heavily depends on the quality and 
reliability of its implementation, it may be especially challenging for policymakers to design policies, 
regulations, and billable services to ensure that the benefits of advanced preventive care are realized.  To 
support these models to be effective on a large scale, policymakers may need to either; a) be very 
prescriptive in regulations setting out implementation standards and requirements, b) develop payment 
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models that strongly reward measurably improving health on a population basis (thus incenting health 
systems to voluntarily implement proven models with high fidelity, in order to achieve program 
effectiveness), or c) both.    
New, sustained funding to promote the development of more resource systems to undertake the 
rigorous and long-term R&D required to innovate better models of advanced preventive care would be a 
much-needed complement to the short-term strategies to promote care delivery innovations used to date 
by the Center for Medicare and Medicaid Innovation.  Policymakers could help ensure that two main 
constituent groups are well-served by funded innovation efforts; 1) Vulnerable populations including 
complex, chronically ill older adults who need better models of care, and 2) groups vital to future 
innovations that have not, historically always had a seat at the table re: health system design, research, 
and diffusion, including health care providers across multiple disciplines (nursing, pharmacy, PT, OT, 
behavioral health, etc.), community and social service providers, local government, and public health 
agencies.  Incentives for current power-holders in health care (e.g., physicians, hospitals, Pharma, 
insurance, etc.) must be realigned to reward them for supporting, participating, and assisting multi-
stakeholder applied R&D groups to be effective and build momentum in the discovery of knowledge 
needed to further this work. 
 
Research Implications 
Research addressing the dissemination of health care delivery model innovation, preventive care 
models, and system design could blossom by having a disciplined framework within which various models 
of collaborative partnerships are designed and tested.  A significant amount of research is still needed to 
continue to hone advanced preventive care models for different populations.  System design as a field 
within health services research has been under-utilized, but may be crucial for the further development of 
multi- and cross- discipline models for population health management and could be promoted in this 
approach.  
Sustained funding for a new type of research organization that effectively, and with a high degree of 
fidelity, implements new models of care to test and evaluate on a larger scale is crucial.  What’s needed 
are initial trials to demonstrate model effectiveness, with larger expanded trials involving more regions, 
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settings, and populations to learn about model replication and dissemination as well as to validate results 
of initial trials.  Performance evaluations and continued funding of such research organizations must 
primarily focus on how well they execute on implementing the model tested rather than on whether it 
“worked” or not in achieving desired population health outcomes.  If a given preventive care model being 
tested doesn’t improve health outcomes, but it was executed exactly as designed and intended, then the 
model is likely ineffective and needs to be redesigned.  Whereas, if a given preventive care model fails to 
improve health outcomes, but its implementation was poorly executed and not as designed and intended, 
it becomes impossible to assess whether the program, its implementation, or both were flawed. 
   
Public Health Implications 
If schema like the one proposed here describing attributes of a model of advanced preventive care 
prove useful in developing better systems of preventive care for vulnerable populations and mechanisms 
to effectively disseminate such models are discovered and used widely, the opportunity for this line of 
work to improve the overall health of higher-risk populations with chronic disease in the U.S. and globally 
may be significant.  Though such a grand vision may seem very optimistic, glimpses of solid evidence 
exist that support its plausibility.  Whether the many current and future barriers can be overcome to 
ultimately achieve the desired outcome remains to be seen, but the justification for undertaking the quest 
is solid. 
A separate question concerns the future role of public health in the U.S. and globally as it relates to 
designing, implementing, monitoring, researching, or improving new models of prevention and systems of 
management for chronic diseases.  While primary prevention has long been recognized as a core domain 
for public health, secondary, tertiary, and even quaternary prevention for populations with established 
chronic conditions and frailty due to aging have, at best, been incompletely addressed by the traditional 
public health and medical establishments.  Should leaders of public health focus primarily on defending 
and bolstering traditional public health functions and not be distracted by the population health 
management buzz among health systems that are increasingly merging, growing larger, and beginning to 
develop capabilities in this area to succeed under new payment models?  Would doing so cause public 
health to be left on the sidelines leaving the health care industrial complex to monopolize new services 
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related to models like advanced preventive care that could just as easily and perhaps more effectively, 
equitably, and inexpensively be provided by or delivered in partnership with public health units?  Should 
public health departments seek to serve as or contribute to the new additions of “population health” or 
“community health” divisions of health systems?  How do the two connect in the future? 
Early in the planning of this study, consideration was given to including leaders of public health 
departments as key informants.  In the opinion of this investigator, that research is still very much needed.  
In HQP’s limited experience exploring the possibility of assisting a county department of health to 
implement advanced preventive care, the budgetary constraints of the department were prohibitive, 
though they were perfectly poised with qualified staff, strong leadership, and support of the regional 
health system.  If HQP can find ways to reduce the cost of supporting regional consultancy and health 
departments had more funds to implement such models, it could become feasible to use HQP-public 
health collaborative partnerships for model dissemination.  
If what we most want and need, as a society, is a comprehensive system safeguarding the health of 
our communities then perhaps we’d best design it together and include: public health practitioners, health 
care providers, hospital-based health systems, community leaders, social service providers, business 
leaders, health insurance companies, and others.  Undertaking a grand system design of preventive care 
involving multiple stakeholders contributing what each is most qualified and best positioned to contribute, 
with each accountable to a system that is collaboratively implemented and rigorously tested in a defined 
geographical region or target population might yield the greatest innovation to the public health in the 
modern era.  To make such an endeavor possible, radical new funding mechanisms might be required, 
such as allocating monies by means of global budgets for target populations to support all public health, 
medical care, and social services in a shared and transparent manner.  In this context, the wisdom, skill, 
and capacity to collaboratively design, implement, and problem-solve on behalf of the greater good, by 
the leaders involved in such a project would likely determine its outcome.
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APPENDIX A – TABLE OF INTERVENTIONS IN HQP’S ADVANCED PREVENTIVE CARE PROGRAM 
 
Intervention Description Application Protocol / Standard 
Intake Assessment Sutter Health Questionnaire (SHQ) - 
a validated geriatric risk assessment; 
patient self-report, nurse 
administered; scored by algorithm 
and identifies patients at high risk for 
death, hospitalization, nursing home 
placement or other adverse events 
All participants  Completed following patient 
consent and prior to 
randomization; nurse 
administered based on patient 
self-report; nurse reviewed for 
omissions, discrepancies, 
conflicts 
Initial Geriatric 
Assessment 
Comprehensive, multidimensional in-
home assessment of physical, 
functional, cognitive, psychological, 
behavioral, social and environmental 
needs.  Specific tools used to conduct 
this assessment are described in 
Methods : Intervention section   
All intervention 
participants who 
scored ‘high risk’  
on the SHQ 
Completed within 30 days of 
randomization utilizing the 
structured screening and 
assessment tools  
Individualized Plan Developed initially and updated each 
encounter based on: the patient’s 
self-identified primary concerns and 
unmet needs; findings from their 
initial and ongoing assessments; and 
the patient’s motivational stage of 
change 
All intervention 
participants 
Developed following initial 
geriatric assessment and during 
each structured encounter 
Action Plans Individualized plan that identifies 
when the patient is to call the nurse 
care manager, the physician, and 
when to call 911 (general and 
disease specific)  
All intervention 
participants receive 
a general action 
plan and condition 
specific plan(s) as 
appropriate 
Initially within 30 days of 
randomization and updated and 
reviewed with the patient on 
each subsequent encounter 
Ongoing Assessments 
and Screenings 
Ongoing assessments and 
screenings utilizing structured tools 
for the standard encounter and 
screening for depression, domestic 
violence, abuse, neglect and 
preventive care and immunizations. 
All intervention 
participants 
Structured assessments 
completed monthly utilizing the 
HQP structured encounter; 
annual screenings and 
preventive care according to 
guidelines 
Medication 
Reconciliation and 
Management 
The process of identifying and 
creating an accurate list of the 
patient’s current medications; 
reconciling errors/omissions with the 
prescribing physicians; assessment 
of patient adherence (obtaining and 
taking medications as prescribed), 
and assisting in organizing, managing 
and educating the patient about their 
medication regimen to support 
adherence; identify root causes for 
non-adherence and utilize 
collaborative problem solving to 
address barriers 
All intervention 
participants  
Medication review and 
reconciliation on the initial 
assessment and during each 
subsequent contact and during 
care transitions 
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Intervention Description Application Protocol / Standard 
Care Transitions  Intensification of assessment, 
coordination and visits by the nurse 
care manager when the patient is 
admitted/discharged from hospital, 
nursing home and home care; timely 
assessments and visits with patients 
to ensure safe and well coordinated 
care transitions with follow through on 
instructions, medications, and 
treatment plans  
Intervention 
participants with a 
visit to an 
emergency 
department or 
admission to a 
hospital 
Protocol guides coordination 
with healthcare providers, follow 
up calls and frequency of visit 
with patient during the care 
transition periods 
Education and Self-
Management Training 
Comprehensive structured curriculum 
for disease specific education and 
self-management training for asthma, 
cardiovascular diseases, and 
diabetes – provided one to one or in a 
small group of participants 
Condition specific; 
based on 
assessment finding 
of the patient’s 
knowledge and 
skills, needs, 
priorities and risks 
Provided for all patients and 
customized based on disease 
state, patient needs and 
priorities with ongoing 
assessment and tracking 
through a structured education 
plan 
Assessment and 
counseling for behavior 
change 
The Transtheoretical Model of 
Behavior Change is used by care 
managers to continually assess 
patients’ motivational stage for 
behavior change (lifestyle behaviors, 
self-management and self-monitoring 
skills) and supporting patients with 
appropriate cognitive or behavioral 
strategies 
Assess participants’ 
stage of behavior 
change and match 
interventions to 
their stage of 
readiness 
Assess and provided based on 
the patients’ needs and priorities 
Nutritional Education 
and Counseling  
 
Individualized patient education and 
counseling for low sodium; reduced 
fat; carbohydrate counting; meal 
planning, portion control, calories. 
 
Patient and 
condition specific 
based on 
motivational stage 
and individual need  
Assess and provided based on 
the patients’ needs and priorities 
Physical Activity 
Education and 
Counseling 
Individual patient education and 
counseling to adopt a more active 
lifestyle as well as more formal 
exercise prescriptions  
Patient and 
condition specific 
based on 
motivational stage 
and individual need 
Assess and provided based on 
the patients’ needs and priorities 
Stress Management 
Education and 
Counseling 
Assess the factors that are 
contributing to stress and identify the 
resources and techniques to manage 
stress 
Patient specific Assess and provided based on 
the patients’ needs and priorities 
Quit smoking Education 
and Counseling 
Assess readiness to quit; provide 
appropriate cognitive or behavior 
strategies and collaborating with 
primary care physicians for 
pharmacological treatment 
Participants who 
smoke  
For people who currently smoke, 
assess readiness to quit at each 
encounter 
Advance Directives 
Education 
Identify the presence of current 
advance directives (durable power of 
attorney for health care decisions, 
and living will) and provide patients 
education regarding their right to self-
determination and preferences for 
choosing a decision maker and to 
designate their individual preferences 
for care at the end of life.   
All intervention 
participants 
Identify presence and location of 
patients’ advance directives 
initially and periodically re-
assess and review advance 
directives with patients  
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Intervention Description Application Protocol / Standard 
Advanced Care 
Planning 
Anticipation of patients’ future care 
needs and assisting patients and 
families with planning to meet those 
needs – treatment, end of life options, 
living situation, etc. 
All intervention 
participants  
Consider advance care planning 
based on patient age and nature 
of illnesses and patient specific 
situation 
Medical Management 
with Physicians 
Collaboration with physicians to 
report new or worsening symptoms, 
abnormal findings, psychosocial 
issues and recommendations 
regarding treatment plan and/or 
routine preventive care 
All intervention 
participants as 
needs are identified 
Care Manager contacts 
physician by telephone, fax or 
physician preferred method of 
contact   
Psychosocial Needs 
Assessment & 
Information and 
Referral 
Assess patients’ needs for services, 
Federal state and county services 
(pharmaceutical assistance, in home 
care), non-covered services (DME, 
meals, private care), service 
monitoring and follow up, behavioral 
health services 
All intervention 
participants as 
needs are identified 
Initial and ongoing as needed 
Coordinating Care Based on patients’ needs 
collaboration with family, and other 
health and social service providers to 
communicate changes in treatment 
plan, medication management, home 
environment and safety, monitoring of 
services and providers involved in the 
patients care 
All intervention 
participants as 
needs are identified  
Initial and ongoing as needed 
LEARN® Weight 
Management Group  
A 16 week, structured group program 
facilitated by care managers, 
addresses the multiple factors 
associated with sustainable weight 
loss 
Intervention 
participants with a 
BMI > 30 in the 
‘action’ stage of 
change 
Periodic assessment of patients’ 
motivational stage of readiness 
for weight loss through this 
behavioral intervention 
Weight Loss 
Maintenance Group 
A monthly group program that is care 
manager facilitated and provides 
ongoing education and support for 
participants who have lost weight and 
for weight maintenance. Education 
and reinforcement on behavioral 
strategies, nutrition, physical activity 
and regular weight monitoring 
Intervention 
patients who have 
completed a weight 
loss program or 
who want to keep 
from gaining weight 
Recommend as a follow on to 
the LEARN Weight Management 
Program  
Seated Exercise Group Weekly group program that is 
supervised by a care manager and 
guided by video of seated exercises 
and stretching as a way for 
participants to learn and practice daily 
physical activities 
All intervention 
participants who are 
functionally able to 
safely participate 
Encourage attendance for 
participants who are appropriate 
for participating in seated 
exercise in a community based 
group setting  
Diabetes Conversation 
Map® 
A five week small group interactive 
workshop, facilitated by care 
managers for diabetes education, and 
self-management skill development 
based on current practice guidelines 
Intervention 
participants with a 
diagnosis of 
diabetes  
Encourage participation by 
participants with a diagnosis of 
diabetes, for support, education, 
skill development and problem 
solving related to the 
multidimensional problem of 
diabetes 
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Intervention Description Application Protocol / Standard 
FallProof™  
Groups 
An intensive 10 week 18 session 
group program facilitated by nurses 
that includes a pre/post program 
evaluation for balance and mobility 
assessment and training  
Participants with 
history of falls  
Assess incidence of falls each 
contact; if positive for falls, 
consider for FallProof™ 
program, physical therapy or 
home exercise program  
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APPENDIX B – TABLE OF MANAGEMENT ELEMENTS IN HQP’S ADVANCED PREVENTIVE CARE 
PROGRAM 
 
Management tool Description Major Elements included 
Pre-service training  A comprehensive and 
closely managed six – 
nine month orientation 
and training program 
that involves didactic 
education, self-learning, 
participant observation, 
role play, case review; 
while building a full 
patient caseload.   
• Initial and ongoing assessments and screenings – risk 
screenings nutrition; fall, domestic violence, abuse, 
neglect, exploitation, mental status, cognition, depression, 
suicide, substance, home safety, medications 
• Patient engagement 
• Person centered approach 
• Visit preparation 
• Behavior change theory 
• Motivational interviewing 
• Evidence-based clinical practice guidelines 
• Provider communication  
• Patient goal setting 
• Patient education curriculum 
• Action plans 
• Information systems 
• Best practices in time management 
• Patient and caseload reports 
• Community resources 
• Group program interventions – LEARN®, Weight loss 
maintenance, seated exercise, FallProof™, Diabetes 
Conversation Map® 
Coaching and 
supervision 
• Following pre-
service training; 
regular and 
ongoing individual 
meetings between 
the supervisor and 
care manager for 
caseload 
monitoring and 
review. 
• Weekly team 
huddles for 
communication 
updates, continuing 
education and 
nursing 
development, case 
and standards 
review 
• Review of all patients with nurses, utilizing quality reports 
with special focus on complex patients and those recently 
hospitalized;  
• Periodic chart reviews to evaluate interventions and 
documentation;  
• Structured observation visits to observe pre-visit 
preparation, nurse-patient interactions, including person-
centeredness; assessment, screening interventions, 
education, goals setting, etc. 
• CM consultation with nursing leads for advise and support 
in managing patients with difficult, complex, and safety 
issues (medical, psychiatric, social environmental);  
• Regular performance review and feedback 
Protocols / Guidelines • Protocols to guide 
CM processes and 
interventions;  
• Evidence-based 
clinical practice 
guidelines 
• Policies, procedures, and standard operating procedures 
for  
o patient screenings (e.g. depression, abuse, 
neglect, exploitation), and for positive findings;  
o assessments,  
o care transitions,  
o medication management and reconciliation;  
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Management tool Description Major Elements included 
o timing of follow up contacts;  
o guidelines for cardiovascular disease, diabetes, 
chronic lung disease, preventive care, physical 
activity, weight loss, smoking cessation 
Performance standards, 
metrics and reports 
 
Role specific standards 
of performance 
reinforced by 
guidelines, protocols, 
operating procedures  
Evaluated with approximately 200 metrics using a data system 
with near real time reports, supervisory observation visits and 
patient surveys and call backs 
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APPENDIX C – LITERATURE SEARCH ALGORITHMS USED  
AND COUNT OF ARTICLES RETURNED 
 
Search terms Database Total 
references 
returned 
Title/Abstract 
reviews 
Full 
article 
reviews 
Relevant 
articles 
General topic of “innovation” and 
“diffusion” has a very large 
reference set 
     
innovation + diffusion Google Scholar 728,000 
approximate 
- - - 
allintitle: innovation + diffusion Google Scholar 1,630 - - - 
Narrowed broad general topic of 
innovation and diffusion by using 
title terms only and adding “health” 
     
allintitle: innovation + diffusion + 
health 
Google Scholar 35 35 9 1 
High specificity focus (title/abstract 
terms) on “innovator” and 
“diffusion”/”dissemination” yields 
very few references 
     
allintitle: innovator + diffusion Google 5 5 0 0 
 Google Scholar 2 2 0 0 
allintitle: innovator + dissemination Google 0 - - - 
 Google Scholar 0 - - - 
(innovator[Title/Abstract] AND 
diffusion[Title/Abstract]) AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 9 9 0 0 
(innovator[Title/Abstract] AND 
dissemination[Title/Abstract]) AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 1 1 0 0 
Various synonyms for “innovator” 
(theory term is “resource system”) 
were tried, including “pioneer”, 
“originator”, “inventor”, and 
“developer” still with tight 
specificity using title/abstract terms, 
but yielded little 
     
allintitle: pioneer + diffusion Google 30 30 0 0 
allintitle: pioneer + diffusion Google Scholar 8 8 0 0 
allintitle: pioneer + dissemination Google 0 - - - 
allintitle: pioneer + dissemination Google Scholar 2 2 0 0 
(pioneer[Title/Abstract] AND 
diffusion[Title/Abstract]) AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 15 15 1 0 
(pioneer[Title/Abstract] AND 
dissemination[Title/Abstract]) AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 10 10 2 2 
alltitle: originator + diffusion Google 1 1 0 0 
 Google Scholar 0 - - - 
(originator[Title/Abstract] AND 
diffusion[Title/Abstract]) AND 
PubMed 2 2 0 0 
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Search terms Database Total 
references 
returned 
Title/Abstract 
reviews 
Full 
article 
reviews 
Relevant 
articles 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
alltitle: originator + 
dissemination 
Google 3 3 0 0 
 Google Scholar 0 - - - 
(originator[Title/Abstract] AND 
dissemination[Title/Abstract]) 
AND ("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 0 - - - 
alltitle: inventor + diffusion Google 1 1 0 0 
 Google Scholar 1 1 0 0 
(inventor[Title/Abstract] AND 
diffusion[Title/Abstract]) AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 0 - - - 
alltitle: inventor + dissemination Google 1 1 0 0 
 Google Scholar 0 - - - 
(inventor[Title/Abstract] AND 
dissemination[Title/Abstract]) 
AND ("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 3 3 0 0 
alltitle: developer + diffusion Google 8 8 0 0 
 Google Scholar 3 3 0 0 
(developer[Title/Abstract] AND 
diffusion[Title/Abstract]) AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 6 6 0 0 
alltitle: developer + 
dissemination 
Google 0 - - - 
 Google Scholar 1 1 0 0 
(developer[Title/Abstract] AND 
dissemination[Title/Abstract]) 
AND ("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 6 6 3 1 
resource system [Title/Abstract] 
AND ("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 35 35 0 0 
Progressively broaden search by 
relaxing fields to include other than 
title/abstract 
     
innovator[All Fields] AND 
("diffusion"[MeSH Terms] OR 
"diffusion"[All Fields]) AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 30 30 0 0 
innovator[All Fields] AND 
dissemination[All Fields] AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 4 4 0 0 
"resource system"[All Fields] 
AND ("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 40 40 0 0 
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Search terms Database Total 
references 
returned 
Title/Abstract 
reviews 
Full 
article 
reviews 
Relevant 
articles 
healthcare "resource system" -
TEKS innovation 
Google Scholar 1230 1230 42 8 
("research personnel"[MeSH 
Terms] OR ("research"[All 
Fields] AND "personnel"[All 
Fields]) OR "research 
personnel"[All Fields] OR 
"researcher"[All Fields]) AND 
("diffusion"[MeSH Terms] OR 
"diffusion"[All Fields]) AND 
("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 949 949 38 13 
All citations to Greenhalgh 
(2008) 
Google Scholar 518 518 28 
1NAvail 
2 
Using PubMed to identify articles 
associated with the Nurse Family 
Partnership (NFP) 
     
"nurse-family partnership"[All 
Fields] AND ("2005/01/01"[PDAT] : 
"2015/12/31"[PDAT]) 
PubMed 73 73 26 1 (best) 
article 
was used 
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Emai l :  bcoburn@hqp3.org   
Cel l :  (908)  635-1649 
 
 
Recipient Name 
Recipient Tit le 
Company Name 
Address Line1 
Address Line2 
 
 
Dear Mr/Ms/Dr ___________________, 
 
My name is Ken Coburn, MD, MPH.  I am a health care researcher and doctoral candidate in 
public health at the UNC Gillings School of Global Public Health and have 11 years of 
experience developing and testing models of community-based care management for 
chronically ill older adults.  I invite you to participate in a research study to understand how 
health care leaders think about collaborating with organizations that have developed advanced 
preventive services, such as effective community-based care management.  The study has been 
approved by the University of North Carolina (UNC) Institutional Review Board (IRB) and 
has the potential to benefit society by providing insights into how health care organizations 
might work together more effectively to disseminate innovations that benefit population 
health. 
 
Your participation would involve a single, 45 to 60 minute telephone interview.  Alternatively, 
any senior executive with decision-making authority for your organization related to 
collaborative partnerships could participate.  In appreciation of your time, I will forward you a 
summary of key findings from the study once the analysis is complete.  To indicate your 
willingness to participate or to find out more about this research please contact my research 
assistant, Ms. Borah Coburn, by email or phone; bcoburn@hqp3.org, 908 635-1649. 
 
Thank you. 
 
 
 
Ken Coburn, MD, MPH 
Principal Investigator 
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Interview Guide:  Coburn, Disseminating Innovations in Chronic Care 
UNC DrPH Dissertation Research   1 of 3
 
Q1 a, b: 
a  How would you describe your organization?  b  What is your role in the 
organization? 
 
Q2 a, b, c: 
a. Does your (health system/physician group/ health system-physician alliance) 
currently support a care coordination or care management program for 
chronically ill older adults living in the community?  [If so, ask for a brief 
description.]  b. Over the next few years, do you expect to be allocating more, 
less, or about the same resources to care coordination or care management 
services for chronically ill older adults?  Why? c. Do you have or soon expect to 
have any risk-bearing contracts with payers? (including ACO participation) 
 
PROGRAM DESCRIPTION: 
 
I’d like to take a few minutes to briefly describe a new model of community-based 
nurse care management for chronically ill older adults.  The model has been 
rigorously tested for over ten years in a Medicare demonstration project.  It is a 
highly effective program, but one that is demanding to implement.  It represents 
an innovation with the potential to improve our health care system if it could be 
effectively deployed on a large scale.  After I describe the program, I will ask you 
questions about some approaches to enable a (health system/physician group/ 
health system-physician alliance) to provide this program to their patients. 
 
The program utilizes experienced nurses who receive 6 to 9 months of intensive 
pre-service training followed by ongoing supervision and mentorship.  These 
nurses deliver a broad portfolio of evidence-based preventive interventions in the 
community through frequent in-person contacts, group programs, and telephone 
monitoring in collaboration with a participant’s primary care provider. 
 
The program is administered and tightly managed according to explicit protocols 
using a customized data and reporting system.  Patients receive an average of 2 
to 3 contacts per month, to provide a set of services that match their needs as 
their condition changes over a long-term follow up period.  These services 
include chronic disease self-management coaching, healthy life style behavior 
change coaching, structured group education, physical activity, gait and balance 
training, medication reconciliation, transition of care support, ongoing 
assessments and monitoring, and help coordinating medical care and 
community-services. 
 
According to results of a carefully done randomized trial, for high-risk individuals, 
the program reduced hospitalizations 39%, decreased emergency room visits 
37%, lowered all-cause mortality 30%, and reduced net health care costs 28%.  
  117 
 
Interview Guide:  Coburn, Disseminating Innovations in Chronic Care 
UNC DrPH Dissertation Research   2 of 3
Other models of care coordination and care management tested by CMS have 
not been as effective and it is believed that tight adherence to the program’s 
rigorous process specifications, training, performance reporting, and 
management practices are essential for its effectiveness. 
 
Before I ask you questions about how your organization might view utilizing a 
program like this, do you have any questions about the program I’ve just 
described or anything that you’d like me to repeat or review? 
 
 
Q3 a, b, c, & d: 
a  How would you view the possibility of collaborating with the developers of this 
program so that they could help you deliver the program to your patients?  Why? 
–and/or- What would most entice or deter you from doing so? 
 
[As appropriate, (for example the subject rejects the idea of collaboration for fear 
of an adverse financial impact), instruct interviewee to answer the question under 
the assumption that payment models and incentives in place would yield a break-
even or modest net improvement in their organization’s ‘bottom line’ for 
supporting and encouraging the use of this model.]  
 
Specifically, how would you feel if such a collaboration required your (health 
system/physician group/ health system-physician alliance) to …; 
 
b  Assist in making introductions to and help establishing relationships with the 
(primary care physicians/health systems) in your community 
 
c  Share clinical and billing data to support case-finding and ongoing 
management 
 
d  Lease your employees to enable delivery of the program.  Through a lease 
back agreement, the developers of the program would directly manage the staff 
(in accordance with your HR standards), and reimburse your organization for 
staff salary and benefits.  This facilitates recruitment of qualified nurses in your 
area and cultivates expertise for this work among your employees. 
 
Q4: 
How would you view the possibility of directly delivering this program as a 
licensed franchisee with oversight, training, tools, and monitoring provided by the 
developers of the model acting as the franchiser?  Why? -or- What would most 
entice or deter you from doing so? 
 
[As appropriate, instruct interviewee to answer the question under the 
assumption that payment models and incentives in place would yield a relative 
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modest net improvement in their organization’s ‘bottom line’ for signing on as a 
franchisee.]  
 
 
Q5: 
Would you prefer to create your own care coordination or care management 
program rather than collaborate with and adopt a program developed by others, 
or rather than franchise such a program?  Why?  Do you think your feelings on 
this issue reflect the prevailing sentiment of your organization overall? 
 
 
Q6: 
How would you view the possibility of participating in a regional cooperative that 
would have responsibility for delivering this program in your area?  Under this 
scenario, an organization jointly owned and governed by a consortium of 
member health care organizations from your area would receive guidance and 
technical support from the originators of the program and would be responsible 
for delivering the program in your area.  Why? -or- What would most entice or 
deter you from doing so? 
 
 
Q7: 
Do you have any other thoughts about the best way to make this program 
available to the population served by your (health system/physician group/ health 
system-physician alliance)? 
 
 
Thank you very much for your time and thoughtful answers. 
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